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Brief Summary 
Progress in public health retains the greatest potential to advance global health and 
innovation through research. The research arena has revolutionized through many 
methodological changes:  changing research environments require changes to ethical 
practices.  This is especially crucial in contexts where ethical growths are deve lopmental.  The 
health and demographic surveillance system (HDSS) is a public health model in the Global South 
which provides critical data for evidence generation.  The model is common in countries where data 
availability for public health and for research is otherwise limited because of inadequate resources.  
Resource limitations and the general dwindling of global funding internationally require strategic 
alignment of health goals with cost effective research methodologies like research using public 
health data (RUPD).  RUPD has therefore become a key tool in developing countries’ research 
progress towards meeting global health goals like the Sustainable Development Goals (SDGs).  
Africa is poised to meet the SDGs with RUPD as an efficient option for increasing scientific 
productivity without tallying up cost.   The role of RUPD in the continent’s public health agenda is 
established. Like every new endeavor however, RUPD raises its own set of features, changes, and 
challenges for which there exists a comparatively narrower frame of opportunities for ethical practice 
than in traditional research.   The goal of this project was primarily to evaluate whether and how to 
optimize or make the most possible good of traditional research ethics principles in RUPD.  
Optimization of ethical principles would offer the best protection of the interests and wellbeing of 
RUPD populations.  This empirical study adopts a critical applied ethics approach, comprising a 
quantitative survey and qualitative interviews involving practitioners knowledgeable about RUPD in 
Ethiopia, Ghana, and Tanzania. The main findings are that the HDSS model offers a fertile environment 
for optimizing ethics in RUPD beyond the commonly required practice of research ethics review and 
protection of confidentiality.   Optimizing the longstanding ethical principles that have brought major 
successes to the biomedical research arena is desirable for RUPD populations, science, and for the 
general development of ethics in the South.  This study shows that doing so is possible without 
necessarily sacrificing values of comparable worth.  Using critical applied ethics also permitted 
consideration to emerging global issues of important implications for the future of RUPD. Therefore, 
this thesis secondarily presents empirical views encapsulating both the affirmation and skepticism 
about public health data sharing from Africa.  Such views are largely absent in ongoing data sharing 
deliberations and in the literature.  They highlight issues affecting the under-resourced data-
producing scientist and the new challenges in data sharing.  Of additional interest to this study was 
the arrival of the new CIOMS Guidelines this past month in December 2016.  It is better suited to 
RUPD than previous versions, but still leaves room for more to be done towards ethics in RUPD.   
 
 
 
 
x 
Thesis Outline 
Chapter One gives an overview of RUPD and briefly analyzes ethical developments.  This 
background information is situated within the literature on HDSSs in the Global South, and Africa in 
particular, to explain the knowledge and contextual base of RUPD and to identify the ethical gaps 
that justify the aim and objectives of this project.  This chapter also outlines the peer-reviewed 
articles and manuscripts that form the basis of this thesis as well as details concerning contributions 
to them.  
  Chapter Two provides a detailed overall description of the study methods for this PhD 
project.  It comprises the methodological approach to the project and my experiences during the 
different research processes I went through.  I explain the design of the study tools, pre-testing and 
data collection (fieldwork) phases of the study, data entry, analysis, and interpretation of the results.   
Chapter Three involves the results from the quantitative survey discussing the application of 
ethical principles to RUPD.  It enhances the limited empirical data regarding ethics for RUPD while 
coming to grips with the differences in the application of traditional norms that are set for research 
ethics principles and their implementation in RUPD practice.   It posits what could be ideal to 
advance and safeguard the collective interests of populations based on the study findings. 
Chapter Four focuses on findings from qualitative interviews, highlighting the ethical issues 
surrounding the growing international requirements for public health data sharing and how they 
influence and are influenced by some under-studied issues pertaining to professionals and processes, 
commitments, investments, careers, and ethical-legal governance structures.  The findings explain 
ways of optimizing the benefits of data sharing especially to data producing regions of the South. 
Chapter Five offers a theoretical analysis infused by empirical findings on acknowledging 
global inequalities and how to promote fairness in RUPD data sharing in an unfair world.  
Chapter Six provides an empirical probe to the views of key stakeholders on what they think 
is the “missing link” in the gamut of factors which account for their knowledge about and practice of 
ethics in RUPD.1  The chapter also proposes how these gaps could be closed. 
Chapter Seven draws on the key findings and discussions of the articles constituting the main 
results of the thesis to facilitate a general discussion of the entire study.  A summary of the general 
limitations to the study are then given.  The thesis ultimately culminates into conclusions, 
implications, and recommendations, including those for future research in Chapter Eight. 
                                                          
1
 Throughout this project, ethics in RUPD, ethics for RUPD, and the ethics of RUPD are used interchangeably. 
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1.0 General Introduction 
1.1 Background 
1.1.1 International data collection for public health 
Progress in public health requires advances and innovation in knowledge through 
evidence generation from data (Public Health Ontario, 2012).  In the current global 
technological and information age, public health data serves both as a critical resource for 
decision making in population health and as a research tool for the promotion of global 
health.  At community levels, data enables the monitoring of the health of populations who 
supply it and ensure the quality of ongoing interventions.  At national, sub-continental, and 
global levels, public health data assists in the planning of health programs on the basis of 
available resources and the levels of disease burdens borne by different regions (C.J. Murray, 
2007, W.G. van Panhuis et al., 2014).  Measuring progress in health and development as in 
the measurements of the erstwhile Millennium Development Goals (MDGs) and the current 
Sustainable Development Goals (SDGs) are rendered accurate from public health data.  
Identifying new issues of public health interests, disease burdens, containing threats to our 
global health and assessing what works and what does not all require public health data (C.J. 
Murray, 2007).  Given such immeasurable importance of public health data, interests and 
activities for realizing public health data are often undertaken as a legal established function 
of governments (R. Bayer and A. Fairchild, 2004).  
In the Global North comprising mostly developed countries, national level data for 
planning public health is generally available from routine government implemented vital 
registration systems. Projects like the SAPALDIA cohort of Switzerland (The SAPALDIA, 2015) 
and the health care co-operatives of Canada (Health Care Co-operatives Federation of 
Canada, 2016) are notable examples.  These projects potentially serve as data sources for a 
wide range of health related activities including research and as auxiliary data resource to 
aid in measurements of the determinants of health. 
 In the Global South or the South, that is developing countries primarily in the 
southern hemisphere (United Nations Development Programme, 2016), national level public 
health data collection and availability is generally impeded by resource constraints.  Rather, 
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pseudo-government models like the Demographic Health Survey program (DHS) and the 
health and demographic surveillance system (HDSS) exist.  The  former, ran by the USAID for 
instance undertakes smaller scale sub-national data collection across vast regions in Africa, 
Asia, Latin America, the Caribbean, and Europe (Demographic and Health Surveys Program, 
2016).  The latter HDSS, which is currently unified under the International Network for the 
Demographic Evaluation of Populations and their Health (INDEPTH Network) has a current 
membership of 49 field sites in 43 research centers across 19 countries in Africa, Asia, 
Oceania, and Central America.   
The INDEPTH HDSS collectively observes an estimated 3.8 million people (INDEPTH, 
c2018, F. Levira et al., 2014, K. Herbst et al., 2015, INDEPTH, 2016a).  It has developed to 
become a critical resource of evidence for informing public health in the South, particularly in 
sub-Saharan Africa. In addition to the primary uses of both the DHS and HDSS as general 
public health systems, the data they produce serve for important secondary uses in the 
conduct of health-related research.  For the purposes of this project, such research enabled 
by pre-collected public health data, retrospective or prospective, without necessitation 
further human contact, in the conduct of health related research is referred to as research 
using public-health data (RUPD). 
In this thesis, we use the HDSS as a relevant profile example of public health systems 
in the South which routinely collect population-level data and use same in the conduct or 
support of RUPD.  We further present the INDEPTH-HDSS as representing some of the most 
widely collected data in the sub-region, some of the most underused data sources needed 
for the conduct of global health research, a source of contemporary interest in data sharing 
discourses, and one of the most important complements of RUPD in the sub region.  
1.1.2 The health and demographic surveillance systems of Africa 
Starting from the 1940s in South Africa and in the 1960s in Senegal, West Africa (Y. 
Yazoume et al., 2012), the HDSS has developed to become internationally identified public 
health systems that operate under domestic laws and regulatory institutional policies in their 
host countries.  Contexts targeted in sub-Saharan Africa for building HDSSs usually 
have high disease burdens, inadequate health infrastructure, health inequalities, and poor 
availability of data to direct public health decisions (WHO, 2013, F. Levira et al., 2014, O. 
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Sankoh and P. Byass, 2012).  The HDSS has been notable for its strategy  of  longitudinally 
documenting millions of person-years and vital statistics which are permanently related to 
individuals in specific communities which would otherwise remain less known (O. Sankoh 
and P. Byass, 2012). House to house visits are conducted on annual, biannual, or quarterly 
basis depending on resource availability to collect the HDSS data.  The data generally covers 
various indicators including births, deaths, migration, marital status and or changes, health 
seeking behavior, lifestyle, social, and economic circumstances of the communities, at the 
population level (INDEPTH Network, 2013, INDEPTH, 2013, F. Levira et al., 2014).  The system 
thereby provides an invaluable platform to accommodate varied public health needs and 
activities such as the assessment of health service effectiveness, interventions, mortality and 
morbidity surveillance (O. Sankoh, 2015).  It also accommodates contemporary interventions 
such as population level pharmacovigilance of susceptible groups to clinical issues of global 
health interests (F. Kirakoya-Samadoulougou et al., 2016).  
Another key advantage of the HDSS is its unified characteristic under the INDEPTH 
Network (INDEPTH Network, 2017).  Headquartered in Accra, Ghana the Network has since 
its inception in 1998 worked to enable the standardization of data collection and 
management across member-HDSS sites.  It provides the needed training, skillsets, and 
assistance in tackling the technical challenges associated with the complexity and dynamism 
of HDSS databases. (O. Sankoh and C. IJsselmuiden, 2011) INDEPTH has undertaken several 
innovative programs.  Its latest concept called the Comprehensive Health and 
Epidemiological Surveillance System (CHESS) is under continuing integration to link 
traditional HDSS information on individuals to their health data which is held within the 
respective local health facilities, using unique electronic individual identification systems.   
The new phase of the HDSS under CHESS will introduce additional depth of data from 
clinical, laboratory, environmental, health systems, and other contextual data on their 
respective populations (F. Kirakoya-Samadoulougou et al., 2016, O. Sankoh, 2015).  In other 
words, as the CHESS integration comes into full force, not only will it add to the already 
available HDSS data as well as the inclusion and provision of empirical unbiased data, but it 
would add to data reliability and comprehensiveness in use for public health and for 
research.  For instance, mortality data captured within the system encapsulates both regular 
data from health facilities via medical certificates on cause of death as well as specially 
integrated verbal autopsies carried out in the community (O. Sankoh, 2015, O. Sankoh and C. 
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IJsselmuiden, 2011, F. Kirakoya-Samadoulougou et al., 2016).  What is thus missed by 
hospitals in poor countries by way of unreported deaths would for instance be more easily 
picked up by the HDSS via CHESS.   
 
1.1.3 RUPD and data sharing 
Given the foregoing data opportunities, generating sufficient sample sizes for various 
population groups and for varied research questions is possible.  Whether in crude, 
corrected, or predicted forms (C.J. Murray, 2007), the depth of HDSS data now empowers 
otherwise under-resourced institutions to mirror data repositories across the world as a 
useful source of analytical processing for public health activities and for RUPD (INDEPTH 
Network, 2013, INDEPTH, 2013, F. Levira et al., 2014). New rounds of data collection provide 
new chances for growing already existing data or introducing new modules of public health or 
research interests subject to national and regulatory approvals.  Combined with the ongoing 
acceleration of technological and analytical advances, the possibilities for increasing 
scientific productivity using RUPD are immense.  The HDSS therefore offers an effective 
alternative for testing new hypotheses through RUPD without the rigors of starting research 
from scratch or contacting research participants prospectively.  Moreover, RUPD data can be 
shared to enable the conduct of multiple-site RUPD.   
The advantages to sharing RUPD data for science in the South are similar to those 
espoused in the literature in relation to other health related data.  They include the 
following: they enable reproducibility of research; maximize cost efficiency; prevent 
duplication of research, participant contact, and other redundancies; foster transparency;  
accelerate the production of new knowledge; and help save lives (C.J. Murray, 2007, W.G. 
van Panhuis et al., 2014).  However, optimizing ethics in public health data sharing and use in 
research (RUPD) are not quite simple.  They go beyond technical, economic, and scientific 
issues to encapsulate issues underlain by reciprocity, justice, trust, and confidence between 
those in need of or able to optimize data for science and those from whom such data is 
attainable. 
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1.1.4 Towards achieving global health goals with RUPD 
 
Having failed to meet the MDGs, Africa is poised to meet the new SDGs in spite of the 
region’s deep rooted systemic challenges. The INDEPTH HDSSs can help speed the realization 
of these goals as they target hard to reach communities as a means of addressing hard to 
preempt hurdles to these goals.  They can also help by using and or sharing the data they 
collect to further research. RUPD’s justification as a strategic tool for meeting the SDGs in 
the South and Africa in particular is also founded on utilitarian and deontological arguments.  
In this sense, practitioners’ ability to fulfill their professional obl igations (deontology) to 
global health efforts by making the most benefit out of available data for public health  
and research purposes would translate into improved health outcomes for populations 
at the community level and beyond (utilitarianism).  Further, in regions like sub-Saharan 
Africa which largely depend on external investments for research, RUPD arguably offers the 
most cost effective strategy for increasing research productivity without additional costs.  
This is of particular importance given the general  dwindling of funding for health endeavors 
including research (Rani and Buckley, 2012).  It is my view therefore, that RUPD could be the 
best staple research strategy for sub-Saharan Africa and the South in general.  
With the right balance of technical and ethical provisions, RUPD is capable of 
accelerating the chances of African countries to achieve the SDGs especially by improving 
health outcomes in communities to which the poorest national health indices could 
otherwise be attributed.  Yet, RUPD depends largely on the corporate and individual 
commitments of scientists and institutions to use and share public health data.  Various 
global actors and the scholarly literature have argued for the importance of data sharing in 
its general role of enabling research to increase scientific productivity ( E. Pisani et al., 2018, 
E. Pisani et al., 2016, S. Bull et al., 2015).   Despite the advantages, public health data sharing 
is challenging in real practice (W.G. van Panhuis et al., 2014, M. Brack and T. Castillo, 2015, S. 
Dallmeier-Tiessen et al., 2014).  Although there has been scholarly contributions of varying 
relevance or scope of applications (S. Bull et al., 2015), there is yet to be a global systematic 
framework or guidelines on data sharing (S.G. Denny et al., 2015, W.G. van Panhuis et al., 
2014).   
Technical barriers to data sharing may be easy to theoretically address, but there are 
ethical issues to consider about relational, professional, and personal matters of importance 
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to scientists, regulators, and other stakeholders that have potential to sharpen possible 
tensions between international requirements and local adherence to data sharing.  These 
factors have attracted limited attention in the literature, but need to feature as a priority 
area in the data sharing and RUPD development discourse.   Therefore, this thesis ultimately 
argues that to make the most of RUPD for scientific or research productivity and more 
importantly for the promotion of global health towards the SDGs, optimizing the use of 
public health data must be met with commensurate attention to the issues that influence 
the stakeholders who make RUPD possible.  
 
1.1.5 RUPD and ethics  
Data emanating from core HDSS activities and also health research undertaken within 
HDSS systems are combined to undertake RUPD.  Literature on policy, ethical and legal 
developments (Public Health Ontario, 2012, Council for International Organizations of 
Medical Sciences, 2002)  support RUPD as a clear means of maximizing the public good 
beyond the narrower purposes for which public health data is originally collected.  Yet in 
the context of contemporary research ethics, there is a growing debate as to what applicable 
ethical principles can be practiced in the interest of the people who provide RUPD data 
(research participants), the scientists who invest in collecting the data and holding same for 
future research (producing scientists), and scientists who may not have contributed to data 
collection, but could make the most optimal creation of new knowledge (user scientists).   
The traditional ethical model of research ethics principles generally focuses on the individual, 
the research participant.  Translating these principles to apply to populations and worse 
scientists, is therefore less straightforward, more challenging and in terms of contemporary 
writing, seemingly impractical.   
Research ethics principles however remain ideal in letter and in spirit for every 
research: the letter may be challenging, but the spirit will always remain invaluable and full of 
benefit to all stakeholders, but particularly to populations who are yet to benefit fully from 
scientific developments.  Communities in the South are typical examples.  For instance, 
informed consent is being heavily challenged in epidemiological and database studies (S.S. 
Cargill, 2016, J. Sim and A. Dawson, 2012 , Hawkins and Longstaff, 2015), but indeed the 
arguments put forward can rarely challenge the essence of fulfilling the elements of 
disclosure of information, its comprehension, recipient’s voluntariness, capacity in decision-
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making, and authorization before being involved in an endeavor which concerns them.  It is 
therefore my firm belief that general arguments made that  the longstanding research ethics 
principles that have evidently developed research in other fields to heights otherwise 
unachievable should be under-emphasized for RUPD and more generally for public health 
data sharing are not ideal.  Various reasons bordering on cost and impracticality and  
supported by utilitarian principles are given for such  stands (CIOMS, 2016a, U.S. NIH, c2016).  
And it is such arguments that have successfully led to worldwide decisions to mostly limit the 
ethics of RUPD to the sole step of protocol approval by a research ethics committee (REC).   
It is also true that there are major challenges to research ethical practice in RUPD 
which are posed by the sheer numbers involved as well as the inseparable link of RUPD 
activities with public health activities (core HDSS activities).  So, while REC approval alone 
may sound acceptable in the interest of speed and scientific productivity, such a narrow 
view of ethical requirements for RUPD and little to none for data sharing fails to recognize 
that science is a means to an end.  Its progress rests in the health, interests, and well-being 
of key stakeholders other than the research participant who make data possible.  If science 
must increase, it must increase along with its impact on research populations and all other 
stakeholders.  Research ethics is a proven way of ensuring these ideals and more (CIOMS, 
2016b, CIOMS, 2016a, IOM, 2015, Nuffield Council on Bioethics, 2002).  
For contexts with developmental ethical and or legal systems such as is common in 
sub-Saharan Africa, RUPD Ethics can perhaps, be explained as an under-explored strategy.  
This is because of the existence of generally weaker ethical structures, stronger research 
naivety among research populations (R.L. Klitzman, 2012), and social justice concerns (S. Bull 
et al., 2015) that systemically posit apriori grounds for limiting the optimization of research 
ethics in favor of overall scientific productivity and health benefits.  Any effort to promote 
the growth, awareness, and practice of research ethics and particularly in newer research 
dimensions like RUPD is necessary.  Moreover, the expansive reach of HDSSs for data, 
research, and sharing provides an unparalleled fertile option for reaching institutions, 
scientists, and populations with formal ethics structures.  Those reached can then effect 
changes towards stronger ethical safeguards and encourage the best possible practices for 
the best science and health outcomes in the sub-region and the South in general.   I 
therefore entreat on utilitarian basis that there is need for a balance between increasing 
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scientific productivity and optimizing benefits to communities, scientists, and the millions of 
populations who make RUPD possible, as long as these benefits remain comparably higher in 
moral worth than any sacrifices that would be made in the process such as  speed and ease 
of science (Singer, 2009).  
1.1.5.1   Ethical considerations for RUPD populations 
In December 2016, the Council for International Organizations of Medical Sciences 
(CIOMS) released its latest guidelines for health-related research involving humans.  Before 
this, the vacuum of ethics for RUPD was much larger.  The current CIOMS document has 
turned out to be the best available international ethics guidelines for RUPD.   Its provisions 
under Guidelines 3, 7, 8, 12, and 24 are largely aligned with expectations of ethical practice 
in RUPD.  For instance, Guideline 3 on “Equitable distribution of benefits and burdens in the 
selection of individuals and groups of participants in research” inherently addresses 
collective risks as detailed in manuscript 1 and 4 included in this thesis.  Guideline 7, 
“Community engagement” calls for attention to the engagement of communities in 
sustained and meaningful participatory processes that involves them in research, and in the 
dissemination of results as espoused in this project (Manuscript 1) as well.  Guideline 8 on 
“Collaborative partnership and capacity building for research and review” is discussed in the 
document as a crucial need for research and a responsibility to be spearheaded by 
governmental health-related institutions oversee research involving human participants.  In 
respect of RUPD, the CIOMS provision engenders community trust for research as important 
for capacity-building for research and review.  Both are clearly argued for RUPD in the survey 
results (Manuscript 1 and 4) of this project.  RUPD is argued to thrive on this as collaborative 
partnership improves trust both on the part of communities or populations and on the part 
of scientists (Manuscript 3).   
CIOMS’ (2016) Guideline 12 on the “Collection, storage and use of data in health-
related research” has arguably the greatest link to RUPD.  It stipulates requirement for 
stored data and essential governance systems for acceptable authorization for future use in 
research.   By way of application, RUPD researchers have a duty to ensure that their use, 
storage and further use of data for primary and secondary RUPD “do not adversely affect the 
rights and welfare of individuals from whom the data were collected” (CIOMS, 2016a).  Last 
but not least, Guideline 24 on “Public accountability for health-related research” which links 
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the realization of social and scientific value (E.J. Emanuel et al., 2004) for health-related 
research is a critical pillar in RUPD ethics. As I discuss this primarily in Chapters 3 (Manuscript 
1) and 6 (Manuscript 4), I entreat  researchers, sponsors, RECs, funders, editors, and 
publishers on their joint quest to make data sharing obligatory to also recognize the 
challenges this would pose to the under-resourced sections of the scientific community in 
Chapters 4 (Manuscript 2) and 5 (Manuscript 3).  This project further aligns its findings to the 
CIOMS’ on sharing the  results of data in a timely manner to improve RUPD benefits to 
populations and prevent fatigue or demotivation of communities in contributing data.  The 
importance of the REC is as usual dominant through all the cited guidelines of the CIOMS 
document.  It is similarly reported in this thesis. 
Despite the importance these new ethical additions bring to bear on RUPD and its 
future, there still remain gaps.  This is partly because the guidelines are rightly made to 
generally fit with the current examples of international database frameworks like databanks 
that hold biological data and repositories, but may not necessarily require routine 
longitudinal updates and other community level characteristics.  The stakes are therefore 
different when these frameworks are compared to RUPD given the earlier explained features 
of routine HDSS contacts and ease of possibility to locate and individualize data.  The 
virtuous RUPD practitioner, REC member, or stakeholder does not have a straightforward 
framework even in the newest version of CIOMS to guide their conduct in RUPD.  Rather 
they have to still maneuver and use discretionary “good effort” extrapolations or deductive 
analysis to define what is ethical to do.  The corollary is that, RUPD systems in sub-Saharan 
Africa with slow growths in ethics could suffer sub-optimal research ethics practices.  The 
potential vacuum between what is expected and what could be achieved for populations 
given the ideals of the new CIOMS document (CIOMS, 2016a) and other guidelines which 
have proven successful and dependable in building the biomedical research arena is still 
worth new considerations. 
1.1.5.2  Ethical considerations for RUPD scientists  
Early on in 2016, a proposal to make data sharing a new norm following publications 
was made by the International Committee of Medical Journal Editors (ICMJE), an 
authoritative committee of thirteen general medical journals.  The proposal has since 
attracted much interest and debate (D.B. Taichman et al., 2017, D.B. Taichman et al., 2016).  
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Several global funding actors had also issued directives obliging data sharing particularly in 
clinical trials prior to the ICMJE’s.  These developments have much potential influence on 
RUPD and to scientists involved in it.  For sub-Saharan Africa, they raise additional issues 
associated with the continent’s systemic inadequacies which are in turn rooted in its 
economic, technological, and structural limitations.  These challenges in turn influence public 
health and RUPD in ways farther and more difficult to deal with than dealing with the 
incoming new risks of data sharing to scientists whose productivity are affected by Africa’s 
systemic situations.  I therefore further argue in this thesis that if RUPD can be increased in 
sustainable ways at the global level to match the needs of our fast and changing 
technological world, a new dynamic of ethics aimed at safeguarding the interests and 
protections of at risk scientists is necessary.   
Under-resourced scientists, mostly in the Global South face many challenges in their 
quest to increase scientific productivity.   While data sharing opportunities for enhanced and 
cheaper science grows worldwide, key ethical principles based broadly on fairness and 
reciprocity are needed to promote a balance between the rights and responsibilities of 
scientists and institutions who analyze and publish results using their data (CIOMS, 2016a, O. 
Sankoh and C. IJsselmuiden, 2011).  The skepticism that thrives in spite of the many 
advantages and general positive attitudes to global data sharing benefits ( E. Pisani et al.,  
2018, J.E. Sieber, 2015, E. Pisani et al., 2016, E. Pisani et al., 2010) are greater for under 
resourced contexts and thus must not be ignored.  Moreover, the true extent of the 
implications of data sharing cannot be easily predicted yet (M. Brack and T. Castillo, 2015).  
Giving attention to how the data evolution is going to be shaped by the new calls for sharing 
relative to the scientific community’s interest in data production, recognition for efforts in 
data collection and management, funding prospects subsequent to easy and cheaper access 
to data, and how these can be guided to avoid any negative impact on the South remain a 
significant ethical challenge and a critical research gap.  Addressing this gap will require 
international dialogue among stakeholders from the different sections of the scientific 
community.   
1.2 The Research Gap 
From the foregoing, any notion equating RUPD to traditional database studies and 
limiting it to an ethic of REC review and confidentiality protection alone is flawed.  Similarly, 
 
 
 
 
11 
the focus of today’s science on increasing productivity without the requisite attention to 
professional risks to scientists, especially the under resourced members of the community is 
problematic.  The gap in ethics for RUPD can therefore be seen from a dual perspective: 
ethical issues critical to traditional provisions to safeguard research populations’ interests 
and wellbeing; and ethical issues surrounding the implications of international stipulations 
like data sharing on RUPD scientists. 
A good approach to addressing this gap is via critical applied ethics.  This approach 
requires basing enquiries on empirical findings to explain normative issues.  In other words,  
empirical evidence from the lived experiences of RUPD practitioners that include both 
affirmations and skepticism about what is known and what is the norm for the respective 
situation is used to guide the ensuing discussion (A.M. Hedgecoe, 2004).  Consequently, this 
thesis makes considerations of moral theory and research practice using both the theoretical 
literature and the empirical findings resulting from this project as means of contributing 
agreements and contrary views to the ongoing discourse and to the literature on the overall 
ethics of RUPD and data sharing.   
1.2.1 Research justification, aims, and objectives 
The primary goal of this project was to explore the differences between RUPD and 
traditional health research that encourage variations in its research ethics applications in 
order to make a case, if feasible, for change.  A secondary aim was to explore and explain 
what data sharing means for scientists in the under-resourced sections of the global scientific 
community and in sub-Saharan Africa in particular to help unveil some under-studied issues 
that could impede data sharing.   The overall goal was to suggest a guiding framework for a 
fuller realization of research ethics principles in RUPD in contrast to general suggestions for 
limiting RUPD ethics to REC review and anonymization processes.  Motivation for this PhD 
study and for change lies in a utilitarian beneficence argument (Singer, 2009) which I argue 
out as follows: as long as benefits realizable from research ethics principles for populations 
and scientists involved in RUPD remain incomparable in moral worth to the costs of 
optimizing the principles, we ought to seek and implement them.  This thesis is ultimately a 
modest attempt at contributing ideas that can help in closing ethical gaps in RUPD and also 
contributing to the limited empirical research on data sharing in public health research and 
by association, RUPD. 
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Against this backdrop, I set out primarily to question if and which research ethics 
principles are necessary for the ethics of RUPD and what matters to stakeholders in the 
South in general and sub-Saharan Africa in particular about data sharing.  The thesis 
focuses on the following specific objectives: 
1. To reveal the unique features of HDSSs and RUPD in order to understand the current 
knowledge and practice base for conceptualizing an ideal ethic for RUPD.  
2. To explore challenges faced by scientists and stakeholders who operate in 
environments where the completion of data cycles from data production to 
knowledge production (publications) is generally slow in order to identify the real 
reasons surrounding hesitations to share data.  
3. To document perceived and real gaps to ethical practice in RUPD from the 
perspective of practitioners and REC members whose work are related to RUPD. 
4. To examine the values, norms, and assumptions found in the study in order to design 
a basic ethical framework for RUPD and data sharing. 
1.3 Contributions and publications making up this thesis 
The main work for this thesis was conceived, designed, and undertaken by me under 
the close supervision of my internal PhD advisors (Prof. Elger, Prof. Tanner, and Dr. 
Wangmo) as well as a field referee (Prof. Sankoh).  I developed the data collection tools with 
their support.  In the course of the project, I sought independent ethical review from seven 
research ethics committees in Switzerland, Ghana, Tanzania, and Uganda.  The data 
collection was done solely by me as follows: (1) I conducted a pre-test of the study tools; (2) I 
completed the field work necessary for the quantitative survey in Ethiopia; (3) I undertook a 
survey and conducted 46 qualitative interviews in Ghana and Tanzania; (4) Subsequently, I 
carried out the data entry, transcriptions, analysis, and result interpretation leading to the 
writing of the articles in this thesis.  Dr. Wangmo, my immediate supervisor offered me 
technical support in developing the appropriate data entry templates in the IBM SPSS 
Statistics Version 21 for the quantitative data entry and management.  For the qualitative 
data, we worked together to develop a template using MaxQDA software Version 12.  This 
software program is specially designed for computer-assisted qualitative and mixed methods 
data, text, and multimedia analysis. As part of the initial coding process and quality 
assurance in identifying essential concepts and ideas in the data for accurate interpretations,  
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my supervisor doubled up as a co-analyst in concurrently reading a selected sample of ten 
transcripts from the number completed.  Doing this together improved accuracy and 
reliability in developing the coding frame.  I solely completed the rest of the coding and 
analysis.   
I drafted all first-authored articles and critically revised them, based on the critique of 
members of the supervisory team, who are also co-authors in the papers.  Other articles I 
have co-authored (three) and have included as appendices form part of the broader original 
public health ethics project plan which I initiated with a colleague, Dr. Claire Leonie Ward 
towards an overall collaborative project.  This collaboration ultimately encapsulates Dr. 
Ward’s work on vaccine trials as an example of key activities undertaken by HDSSs, the 
profile example of new models for public health research in resource limited countries in this 
thesis.  Dr. Ward also made intellectual input in the writing of my second Paper and is thus a 
co-author.  The four manuscripts to which I am first author form the main basis of this thesis 
while the other three form the thesis of Dr. Ward’s: 
1. Anane-Sarpong E, Wangmo T,   Sankoh O,  Tanner M,  &  Elger B.S. (2018) Application 
of Ethical Principles to Research Using Public Health Data in the Global South: 
Perspectives from Africa. Developing World Bioethics; 18(2):98-108. doi: 
10.1111/dewb.12138. Epub 2016 Dec 22. 
2. Anane-Sarpong E, Wangmo T, Ward CL, Sankoh O, Tanner M, & Elger B.S. (2018) “You 
cannot collect data using your own resources and go and put it on open access”: 
Perspectives from Africa about public health data sharing. Developing World 
Bioethics; 18(4):394-405. doi: 10.1111/dewb.12159. Epub 2017 Jul 25. 
3. Anane-Sarpong E, Wangmo T, & Tanner M. (2019)   Ethical principles for promoting 
health research data sharing with sub-Saharan Africa. Developing World Bioethics 
Accepted for publication. 
4. Anane-Sarpong E, Wangmo T, Tanner M, Sankoh O, &  Elger B.S.  Probing and 
Addressing Missing Links in the Ethics of Research Using Public Health Data: A 
Qualitative African Study. Journal of Public Health in Africa. Under review. 
5. Ward CL, Shaw D, Anane-Sarpong E, Sankoh O, Tanner M, Elger B.S. (2018)  The 
ethics of health care delivery in a pediatric malaria vaccine trial (PMVT): The 
perspective of stakeholders from the malaria vaccine candidate trial RTS,S in Ghana 
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and Tanzania.  Journal of Empirical Research on Human Research Ethics; 13(1):26-41. 
doi: 10.1177/1556264617742236. Epub 2017 Nov 28. 
6. Ward CL, Shaw D, Anane-Sarpong E, Sankoh O, Tanner M, Elger B.S. (2018) Defining 
Health Research for Development (HRD): The Perspective of Stakeholders from an 
International Health Research Partnership in Ghana and Tanzania. Developing World 
Bioethics; 18(4):331-340. doi: 10.1111/dewb.12144. Epub 2017 May 3.  
7. Ward CL, Shaw D, Anane‐Sarpong E, Sankoh O, Tanner M, & Elger B. (2017) The 
Ethics of End of Trial Obligations in a Paediatric Malaria Vaccine Trial: The 
Perspectives of Stakeholders From Ghana And Tanzania. Journal of Empirical 
Research on Human Research Ethics; 13(3):258-269. doi: 10.1177/15562 
64618771809. Epub 2018 May 13. 
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2.0  Methodology 
2.1 Outline  
This study was conceived to address gaps in ethical notions, practice, and 
guidance in RUPD as well as related issues of contemporary connections to RUPD, 
through reflections on shared real life experiences relative to the normative literature.  
The project forms part of a broad collaborative venture between the Institute for Biomedical 
Ethics and the Swiss Tropical and Public Health Institute, designed to enable a northern and 
southern scholar to conduct self-selected research in public health, including research, and 
ethics.   The supervisory team comprised Prof. Bernice Simone Elger, Dr. Tenzin Wangmo, and 
Prof. Marcel Tanner all of the University of Basel and Prof. Osman Sankoh of the INDEPTH 
Network, Accra, Ghana. Some initial support was offered by Prof. Dr. Angus Dawson of the 
University of Sydney.  The objective of the project was not to oppose international ideals set 
generally for research that share similar characteristics with RUPD, but to make a strong case 
for more ethical considerations to be given to RUPD using the many available opportunities 
made possible by the numerous activities undertaken by the mother HDSS.  To the best of 
our knowledge, this is the first empirical project on the ethics of RUPD in HDSSs.   
The project officially took off in February 2014 and was completed and defended in 
May 2017.  The rest of this chapter describes the methodological approaches used in the 
entire study phases, from scoping visits and data collection to normative and empirical 
analysis of the data.   More details are provided as part of each of the manuscripts included, 
hence the following paragraphs give a more general description of the methods.    
2.1.1 Study design  
The study design was cross sectional, involving multi-center participation from HDSS 
member sites (Figure 1), using a mixed methods approach (B. Dawson and R.G. Trapp, 2004, 
N Mays and C. Pope, 1995 , G. Guest et al., 2012).  The empirical phases were preceded by a 
review of the theoretical literature which subsequently informed reflections on the ideal 
ethics for RUPD in Chapters 3, 4, and 6.  A theoretical approach was used in writing 
Chapter 5 and for explaining concepts and principles in the examination of the literature for 
issues imputed by respondents in the empirical chapters.  
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Three INDEPTH-member HDSS sites in Tanzania and two in Ghana, six RECs, and 
three institutions affiliated to ministerial agencies, academia, or legal institutions in each 
country were involved in the qualitative aspects of the project.   The selection of Ghana and 
Tanzania was convenient: the PhD candidate who comes from Ghana is familiar with the 
national terrain, and could better assist her northern colleague on conducting her project on-
site in her familiar home base.  The Swiss TPH which sponsored the project has 
longstanding academic and research collaborations with Tanzania leading to its selection as 
the second study area. A third country, Ethiopia, was purposively added for the conduct of 
a survey (quantitative side of the project).  Ethiopia’s selection was as a result of INDEPTH’s 
decision to use it as the venue for its Scientific Conference, following a cancelled earlier plan 
to hold the conference in Uganda.   The project plans for Uganda, as evident in ethics 
approval from a Ugandan REC, was cancelled in the aftermath of the Ebola epidemic in three 
countries of the West African sub-region. Although institutional permissions had been sought, 
ethics review processes completed, and preparations to visit were well advanced, the site had 
to be excluded.  This unexpected but cautious cancellation of the Uganda meeting affected 
the data collection schedule and delayed the finding of an alternative for thirteen months.  
In the interim, administering the survey online became a viable option.  However, after 
much preparation, completion, notifications, and advertisements with the kind help of the 
Executive Director and staff of the INDEPTH Network in Accra, the online survey yielded a 
woefully inadequate participation.  Following a two month extension, announcements in 
two consecutive newsletters of the INDEPTH Network, personal reminders via emails with 
links to the survey, and twelve respondents (including incomplete forms), the last alternative 
option of physical presence at the conference had to be necessarily waited for. 
2.1.2 Study sampling  
Sampling for the qualitative interviews was purposive (N. Mays and C. Pope, 1995, V. 
Braun and V. Clarke, 2006) to include predefined persons who were knowledgeable of the 
research question and willing to consent to participation. Members of RECs with oversight 
responsibility over the HDSSs work were approached through their chairpersons and 
administrators.  Participants from HDSSs were approached mainly through institutional 
directors and unit heads.   
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A snowball approach was used: heads of institutions generally recommended 
potential participants or directly asked others if they could participate and they in turn 
recommended others to contact.  A large number of the interviewees were enrolled by this 
approach.  It was also useful for identifying the participants independent of the HDSSs, that is 
the experts and policy makers working in ministerial and other agencies of public health, 
national and international who are involved in public health research and decision-making in 
Africa.  Special effort was made to include independent experts with training in the Law 
given the discipline’s close proximity to deliberations in ethics and the role it plays in ethical 
developments in the region.  One participant each in Ghana and Tanzania were from 
European affiliated institutions and based in Africa.  
Figure 1: World Map showing countries where INDEPTH member-HDSSs are located  
  
Source: http://indepth-network.org/about-us  
Combined, the multi-center participants of both the quantitative survey which 
yielded participation from 18 countries viz. comprising thirteen Southern countries (Ghana, 
Nigeria, Burkina Faso, Mali, Senegal, the Gambia, Kenya, Uganda, Ethiopia, Tanzania, South 
Africa, Malawi, Mozambique and Bangladesh) and four Northern countries with a critical 
stake in HDSSs (Sweden, Switzerland, the Netherlands,  and the United States) and the 
qualitative interviews from the two countries, Ghana and Tanzania constituted a reasonable 
representation of HDSSs to inform this project’s reflection and the achievement of the study 
objectives. 
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2.2 Development of study tools, field work, and data collection  
2.2.1 Qualitative interviews 
A thematic review of existing literature was conducted to inform decision making on 
the best approaches to use.  In-depth data that could not be obtained using 
questionnaires was collected via interviews. Once the decision for conducting both a 
quantitative survey and qualitative interviews was made, scoping visits to Ghana and 
Tanzania were carried out to discuss the acceptability or otherwise of the project, feasibility 
of the proposed methods, and local regulatory and procedural requirements.  
An interview guide was finalized after the scoping visits.  The interview questions 
were semi-structured to allow for openness to useful emerging concepts and allow 
participants the opportunities to probe responses (See Appendix 4).   Interviews were audio-
taped, continued until theoretical saturation was attained and thereafter, continued to clarify 
grey areas and unclear responses earlier received from other interviewees. Side notes of 
relevant comments were also taken with permission from interviewees to be used to support 
data analysis, where necessary. 
The key-informant face-to-face interviews were conducted with an effective 
sample of 46 participants from November 2014 to February 2015.  The HDSS affiliated 
participants were as follows:  five HDSS directors or ex directors, thirteen unit heads including 
field supervisors, and eight scientists.  From RECs, participants were made up of eight 
members including two chairpersons and six REC administrators.  Four participants were from 
the national ministries of health and two from the country offices of the WHO, speaking on 
their personal professional experiences rather than positing views on behalf of the 
international body. 
The substantive and procedural steps to obtain institutional permissions for 
inclusion and individual informed consent were undertaken for each participant.  Efforts to 
assure confidentiality were made throughout the project by delinking consent documents 
from interview records and transcripts.  Participants were given token souvenirs of Basel-
embossed pens, travel tags, or post cards for their participation, time, and inconvenience.  
Debriefing sessions were held on-site with center leaders before departure from each 
institution with plans of final dissemination to the rest of staff before the project ends. 
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2.2.2 Quantitative survey 
A detailed literature search involving the keywords and terms similar in experiential 
application to RUPD was undertaken using search engines including PubMed, MedLine, 
Hinari, CINAHL, Web of Science, and Google Scholar.  While these searched were largely 
targeted at the theoretical aspects of the project, it was useful for identifying content, 
methodological approaches, challenges, and gaps in their application to RUPD to inform 
the questionnaire development.  The literature search was also very relevant to the critical 
applied ethics approach I adopted to help explain normative issues surrounding RUPD and 
the sub-discussion on data-sharing using empirical findings from various lived experiences of 
RUPD practitioners (A.M. Hedgecoe, 2004).   
No validated study tool was found suited to our population and research questions.  
Hence, a provisional collection of questions was made during the literature review to inform a 
first attempt at conceptualizing the outputs of this project. This review also informed the 
construction of the survey vignette to mimic real-life RUPD scenarios based on HDSS-RUPD 
contexts, the study objectives, and expected outcomes. This choice of using vignettes in the 
quantitative survey yielded the following advantages: (1) Ability to orient respondents to the 
issues of interest given the use of a common scenario; (2) Assurance of face validity; (B. 
Dawson and R.G. Trapp, 2004) (3) Better elicitation of answers relevant to the project; (4) 
Enabling participants’ agreements and dissenting opinions to be narrowed to a common 
scenario for ease of comparison; and (4) It ensured the practicality of questions without 
making participants feel personal about it or incriminated if their  practices were not aligned 
with ethical ideals featured in some sections of the questionnaire.  Moreover, the decision to 
use a vignette with a common scenario proved very useful given the reality that often there is 
more than one way to behave ethically because ethical principles can be prioritized 
differently (T.L. Beauchamp and J.F. Childress, 2001). Both closed and open-ended questions 
were used (See Appendix 2).   
Despite the initial disruptions to the quantitative data collection due to program 
cancellations from October 2014 to November 2015, the replacement conference in Addis 
Ababa was worth the wait.  It offered a sizeable number of participants to enable analysis, 
although the number was still below expectation.  By this time however, the survey 
completion had to be left to participants’ benevolence, interest in capturing knowledgeable 
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participants’ experiences, and a confidence that representativeness or the lack of it took 
little away from the importance of the shared views on RUPD (K.J. Rothman et al., 2013).  
Effective participation was from eighteen countries in Africa, Asia, Europe and the North 
America with a response rate of 40.6% (N=350).  An inclusion criterion of completion of at 
least two of the three sections of the questionnaire finally led to an inclusion of 130 
questionnaires in the analysis.     
2.2.3 Enhancing the quality of the study tools 
An assessment of the content validity of both the survey tool (B. Dawson and R.G. 
Trapp, 2004) and interview guide was undertaken by the student under guidance of the 
supervisory team.  Yet, the survey tools were only approved in Tanzania on condition of being 
fielded in both English and Swahili, the national language.  Because the student researcher 
did not speak or write Swahili, all documents had to be translated by independent 
translators. The final version of both questionnaires and interview guides in English were first 
translated to Swahili and back translated to English by different translators.  Both translators 
were given a brief summary of the project to help them contextualize their translations. The 
back translator (Swahili to English) however, had no access to the original English document.  
A final comparison of the original English version and the new back translated one was made 
to seek corrections and amendments for differences.  It was a lengthy iterative process 
among the student researcher, English to Swahili translator, and Swahili to English back 
translator, sometimes involving complaints of each other (translators) being wrong in their 
translation.  The student researcher was unable to tell who was wrong.  Hence, the views of a 
third translator (a member of an REC) was sought to clarify the paragraphs for which finding 
agreement between the two translators was impossible.  The latter translators also helped to 
correct technical terms in research ethics that defied the general translations given by the 
other translators. The final versions of the Swahili translation was pre-tested for clarity with 
a colleague at the Ifakara Office, Mikocheni before the interviews were started in Tanzania.   
Ultimately however, all participants agreed to be interviewed in English in apprehension of 
the depth of confusion that translation of full transcripts could bring to the student. 
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2.3 Data Analysis 
The quantitative analysis was conducted using IBM SPSS Statistics Version 21.  
Closed-ended questions were analyzed via descriptive statistics while open-ended responses 
were entered initially as string variables and subsequently collated into relevant themes 
using content analysis (V. Braun and V. Clarke, 2006).   Numerical data was checked for 
errors and then analyzed using frequencies and proportions.   
Audio-recorded interview data and written field notes were transcribed verbatim 
using the MaxQDA software Version 12 (MaxQDA, 2013).  Detailed processes from 
transcriptions to codification into themes and sub-themes are provided in Chapters 3 to 6.  
Support for data analysis was given by my immediate supervisor to help improve reliability 
(N. Mays and C. Pope, 1995, V. Braun and V. Clarke, 2006).  A thematic analysis was used. 
2.4 Ethical considerations 
This study was undertaken with consideration to a critical understanding of research 
ethics principles in application to all human research as well as the subsequent use of the 
data emanating from same.  Procedures undertaken for data were virtues-based to include 
honesty and transparency with prospective participating institutions and participants.  The 
processes followed are aligned to international research ethics requirements including REC 
review and institutional permissions.  Independent ethical review of the project were 
given by the following seven RECs and one national regulating commission: (1) Ethics 
Commission of North Western and Central Switzerland, which oversees human research 
participation in projects of the University of Basel; (2) Ghana Health Service Ethical Review 
Committee; (3) Dodowa Health Research Center Institutional Review Board (IRB), Ghana; (4) 
Navrongo Health Research Center IRB, Ghana; (5) National Institute for Medical Research 
Ethics Committee, Tanzania; (6) Ifakara Health Institute IRB, Tanzania; (6) the Commission for 
Science and Technology, Tanzania; (7) The ethics committee of the Uganda Virus Research 
Institute, operated under the National Health Research Organization; and (8) The Commission 
of Science and Technology of Tanzania.  The REC approval from Uganda was however, 
rendered less relevant since data collection in Uganda had to be cancelled as earlier 
discussed.   
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Permissions were also sought from various executive and or scientific committees or 
heads of study institutions prior to the REC applications. Individual study participants 
received information leaflets and consent documents (see appendices) to read, agree and 
sign or otherwise, and return them without names to the researcher during or before 
interviews.  In the case of the quantitative survey completed by participants from several 
countries, most participants returned both the consent document and answered 
questionnaires.  These were however, received and compiled by the student in ways that did 
not foster their linkage. All study procedures were conducted as approved by the respective 
RECs.  
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3.0 Application of Ethical Principles to Research Using Public  
Health Data in the Global South: Perspectives from Africa 
This article has been published in the Journal of Developing World Bioethics (2018); 18(2):98-
108. doi: 10.1111/dewb.12138. Epub 2016 Dec 22.  
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3.1 Abstract  
Existing ethics guidelines, influential literature and policies on ethical research 
generally focus on real-time data collection from humans.  They enforce individual rights and 
liberties, thereby lowering need for aggregate protections. Although dependable, emerging 
public health research paradigms like research using public health data (RUPD) raise new 
challenges to their application.  Unlike traditional research, RUPD is population-based, 
aligned to public health activities, and often reliant on pre-collected longitudinal data.  These 
characteristics, when considered in relation to the generally lower protective ethical and 
legal frameworks of the Global South, including Africa, highlight ethical gaps.   Health and 
demographic surveillance systems are examples of public health programs that 
accommodate RUPD in these contexts. We set out to explore the perspectives of 
professionals with a working knowledge of these systems to determine practical ways of 
appropriating the foundational principles of health research to advance the ever growing 
opportunities in RUPD.  We present their perspectives and in relation to the literature and 
our ethical analysis, make context relevant recommendations.   We further argue for the 
development of a framework founded on the discussions and recommendations as a 
minimum base for achieving optimal ethics for optimal RUPD in the Global South.     
Key words:   The Global South; Public health research; Research ethics; Public 
health ethics; Health and demographic surveillance systems   
3.2 Introduction  
Global health thrives on large scale population health information and research 
which have changed considerably in volume and nature (Largent, 2016, O. Sankoh, 2015).  In 
the Global North, national health data is generally available from government implemented 
vital registration systems (R. Bayer and A. Fairchild, 2004).  In the Global South or South, that 
is developing countries which are located primarily in the southern hemisphere (United 
Nations Development Programme, 2016) and particularly in Africa, conducting such surveys 
is often constrained by inadequate resources(Demographic and Health Surveys Program, 
2016, O. Sankoh and P. Byass, 2012, INDEPTH, 2016a).   Instead, smaller scale household 
surveys are used to report nationally representative data for public health (Demographic and 
Health Surveys Program, 2016).  The health and demographic surveillance system (HDSS) is 
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one such framework for collecting, storing, and managing otherwise difficult to obtain public 
health data.  HDSS data is longitudinal and permanently connected to its population.  This 
enables population-based retrospective investigations or the nesting of prospective research 
into ongoing data collection (O. Sankoh, 2015, F. Levira et al., 2014).  In this paper, such 
systematic investigations designed to develop or contribute to generalizable knowledge 
(South African Medical Research Council, 2007, US Department of Health and Human 
Services, 2009)  and incorporated into the HDSS or extracted from its pre-collected database 
are referred to as research using public health data (RUPD).    
Research ethics has largely been shaped by principles, four of which are espoused in 
the framework of Principlism (T.L. Beauchamp and J.F. Childress, 2001, M. A. Rothstein, 
2015):  respect for persons (study participants and communities), beneficence, non-
maleficence, and justice.  These principles are contained in a range of international codes, 
national legislation, and regulations that have effectively guided research for decades (M. A. 
Rothstein, 2015, Largent, 2016).  Unlike traditional health research, RUPD’s public health 
dimension, sheer numbers involved due to its population based characteristic, and its 
database methodology make pursuit of these principles less straight-forward.  Scholars and 
ethicists have argued for waivers on the basis of “impracticality” (J. Sim and A. Dawson, 2012 
, CIOMS, 2016a, B.S. Elger, 2010) while some have suggested reliance on ethics review and 
opt-out options (where feasible) as adequate ethical safeguards (CIOMS, 2016a, B.S. Elger, 
2010, S. Bull et al., 2015).  There is ongoing debate on whether these proposals are the best 
mechanisms for similar research (M. A. Rothstein, 2015, Largent, 2016).   The debate is 
particularly important for the South and Africa in particular, where protective frameworks 
and levels of individual awareness about rights and abilities to exercise them are generally at 
developmental stages (S. Bull et al., 2015, E.J. Emanuel et al., 2004).  Hence, arguments for 
abandoning proven principles that have safeguarded populations in the name of optimizing 
science may hold less tightly in this context.  We conducted a survey involving professionals 
with a working knowledge of the HDSS and RUPD, mostly in Africa to (a) explore their 
perceptions, attitudes, and practices towards the implementation of basic ethical principles; 
(b) determine practical ways of optimizing the implementation of the principles; and (c) 
consider the results in relation to the literature to make context relevant recommendations.    
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3.2.1 Household surveys in the Global South 
Household surveys are commonly carried out in place of national level registries to 
support public health activities and research.  Two of the most notable organizations that 
undertake such surveys are the USAID which is responsible for the Demographic and Health 
Survey program (Demographic and Health Surveys Program, 2016) and the INDEPTH 
(INDEPTH, 2016a), involved with the HDSS framework.  This paper focuses on the latter as an 
example of a public health program that accommodates RUPD in the South.  
3.2.2 The HDSS and INDEPTH 
The HDSS concept started in the 1940s and 1960s in South Africa and Senegal 
respectively (Y. Yazoume et al., 2012).  The system involves house-to-house data collection 
from whole communities on annual, biannual, or quarterly basis.  Apart from the core data 
on births, deaths, migration, marital status changes, social, and economic indicators (F. 
Levira et al., 2014),  they may conduct assessment of health service effectiveness, mortality, 
and morbidity surveillance (O. Sankoh, 2015).  The data are thus used to analyze the 
population’s health, inform public health decisions, and support the conduct of research (F. 
Levira et al., 2014, Y. Yazoume et al., 2012).  HDSSs generally operate under domestic law (R. 
Bayer and A. Fairchild, 2004, Public Health Ontario, 2012) and regulatory institutions like the 
research ethics committee (REC).   
INDEPTH was established in 1998 to develop a network of HDSSs, unify them, help 
them tackle the technical challenges associated with the complexity and dynamic nature of 
their databases (O. Sankoh and C. IJsselmuiden, 2011), and conduct research using their data 
(O. Sankoh, 2015, F. Levira et al., 2014).  With a current number of 43 members, the 
Network collectively observes an estimated 3.5 million people in 20 countries across Africa, 
Asia, and Oceania (INDEPTH, 2016a, INDEPTH, 2015b).  New technological and analytical 
advances have opened immense possibilities for HDSSs to generate unbiased empirical data 
that is essential for developing and assessing interventions (O. Sankoh, 2015)  while 
contributing to scientific productivity (O. Sankoh and C. IJsselmuiden, 2011) like RUPD.  
INDEPTH has several innovative programs.  Its latest concept, the Comprehensive Health and 
Epidemiological Surveillance System, is for instance planned to integrate population and 
health facility data systems that will link demographic, epidemiological, mortality, morbidity, 
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clinical, and household data among others with a unique electronic individual identification 
system (O. Sankoh, 2015) in the future.  The HDSS thus offers an effective alternative for 
testing new hypotheses through RUPD without the rigors of starting research from scratch.  
Although RUPD can be smoothly incorporated into HDSS activities and be recognized for its 
role in the promotion of public health, it remains research.  There is therefore a need to 
optimize the implementation of ethics in the interest of participants and communities.   
3.2.3 Contextual issues surrounding RUPD and public health ethics  
For many communities in the South, the protection and awareness of individual 
rights and liberties that support international research ethics implementation may be 
limited, unknown or undesired (T. Metz, 2010).  This is due to differing perceptions and 
interpretations of essential values that form the basis of international ethical deliberation, as 
well as cultural practices which are more communal (T. Metz, 2010, H3Africa Working Group 
on Ethics and Regulatory Issues, 2013).  Ethical frameworks in these contexts are generally 
not fully developed and regulatory authorities including RECs are limited in numbers (T. 
Mduluza (eds), 2007, M. Kruger et al., 2014).  General protections instituted through 
national constitutions and awareness creation about human rights and individual liberties 
(A.M. Capron et al., 2009)  that spur ethical developments are also generally low. 
Concerning design, the connectedness of RUPD to core HDSS activities which have 
direct public health ends makes it difficult to balance research ethics and public health ethics 
principles.  Applying the former privileges individuals over the public (E. Vayena et al., 2015)  
and the latter does the opposite (Public Health Ontario, 2012).  One can either safeguard the 
implementation of protections at the broader population level or for the individual.  For an 
appropriate balance, scholars have suggested to focus on principles or issues of 
confidentiality and privacy, data ownership, data sharing and integrity (S. Bull et al., 2015, 
European Commission, 2013b, I. Jao et al., 2015), transparency, trust, accountability, 
openness, and global justice (European Commission, 2013b, E. Vayena et al., 2015).  Issues 
surrounding the underexploited value of databases are also gaining attention (J. Manyika et 
al., 2011).  Challenges such as the impracticalities of obtaining consent and providing 
benefits to the population have been documented (J. Sim and A. Dawson, 2012 , H3Africa 
Working Group on Ethics and Regulatory Issues, 2013).  The discussions have favored a focus 
on the ‘public’ that understates the interests of the individual (CIOMS, 2016a, B.S. Elger, 
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2010, Public Health Ontario, 2012) mainly because of challenges to implementation.  The 
debates however, miss two important issues that are unique to RUPD in the South:  (1) 
opportunity availed through the routine re-contact with residents during the HDSS activity; 
and (2) the huge populations that could have their welfare, interests, and protections better 
safeguarded when research ethics principles are upheld for the individual, especially in light 
of otherwise less protected environments. 
3.3 Methods 
A questionnaire based survey was conducted in Ghana from October to December 
2014 and during an INDEPTH Scientific Conference held in Addis Ababa, Ethiopia in 
November 2015.  In Ghana, the questionnaires were administered to personnel at the 
Dodowa and Navrongo HDSSs.  The INDEPTH Conference was organized for HDSS-member 
and partner institutions worldwide.  It offered a unique opportunity to reach stakeholders 
with a working knowledge of RUPD (INDEPTH, 2015a).  We did not aim for 
representativeness of the population, but rather sought knowledgeable participant 
availability, willingness to participate, and a quest to ensure that relevant issues were 
discussed to arrive at a useful view of how the ethics of RUPD could be cast in the South (K.J. 
Rothman et al., 2013, B. Dawson and R.G. Trapp, 2004).  Of the 350 questionnaires 
administered, 142 were returned, representing a response rate of 40.6%.  Completed 
questionnaires from eleven Ghanaian respondents at the conference who had earlier been 
administered questionnaires in Ghana were matched for hand-writing and socio 
demographic characteristics to enable exclusion based on possible double participation: six 
questionnaires were excluded.   An inclusion criterion of completing at least two of the three 
sections of the questionnaire was implemented.  In total, 130 surveys were included in the 
analysis.   
3.3.1 The Survey Tool 
A questionnaire was formulated, approved by all authors, and put through an 
internal review session by ethicists working at the Institute for Biomedical Ethics, University 
of Basel.  It was pilot-tested using five HDSS practitioners who did not participate in the main 
survey.  Questions were based on a vignette (Appendix 2) informed by features of RUPD and 
relevant literature to assure face validity.  The questionnaire was examined by the 
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supervisory team of experts to assure content validity (B. Dawson and R.G. Trapp, 2004).  
The vignette gave a short scenario of a retrospective RUPD, but questions relevant to 
prospective RUPD were also surveyed.  We posed closed-ended questions on familiarity with 
RUPD and specific expectations of what respondents deemed ethically acceptable practices 
linked to research ethics principles.  The closed-ended questions were either dichotomous 
(yes or no) or five point Likert-type questions (strongly agree, agree, neutral, disagree or 
strongly disagree).  Blank spaces were provided to enable respondents to add information if 
they chose to.  Although not exhaustive, the information given in the vignette was adequate 
to offer respondents an equal understanding of the research topic.   
3.3.2 Data Analysis 
Using IBM SPSS Statistics Version 21, closed-ended questions were analyzed via 
descriptive statistics.  We examined issues documented as problematic in other population 
and database research including informed consent and benefit provision (J. Sim and A. 
Dawson, 2012).   Open-ended responses were collated into relevant themes.  We 
characterized the HDSS as ‘custodian’ in line with literature that support organized systems’ 
data creation and holding status.  By implication, we assumed that while HDSS communities 
may not own their data in practical terms, they have a stake in its ownership (A.M. Capron et 
al., 2009). 
3.3.3 Ethical Considerations 
Ethical approval for the project was sought from the Ethics Commission of North 
Western and Central Switzerland and six other committees in Ghana and Tanzania where 
separate in-depth interviews were planned.  In Ethiopia, where conference delegates 
completed the questionnaires, ethics review was not required.  Questionnaires and consent 
documents were self-administered, anonymous, and returned to the researcher on site in 
Ghana, during the conference, or by email.  
3.4 Results 
The socio-demographic characteristics of the 130 respondents are shown in Table 1.  
Most respondents (84.6%) were based in Africa and were less than 50 years old.  On 
average, participants had spent 8.7 years (range 1 - 33 years) at their current roles.  More 
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than two-thirds of respondents (66.7%) had undergone some levels of training in research 
ethics: around half (n=66) had a month or less of training, six undertook fellowship 
programs, and eight had degrees in various fields of bioethics.   
3.4.1 General issues  
The majority of respondents (N=130; 93.1%) indicated that they had seen 
publications emanating from RUPD.  Around half (N =130; 54.3%) thought RUPD occurred 
‘often’, with a third (N =130; 31.5%) having personally undertaken it.  A quarter of 
respondents (N =130; 25.4%) disagreed that use of pre-collected HDSS data could be 
considered as research and more than two-thirds (N=124, 71.3%) supported it as a valid 
alternative methodology.   
3.4.2 Independent review and ethical governance of RUPD  
About three-quarters of respondents (N=111; 76.2%) thought RUPD should undergo 
REC review, but a minority either disagreed (9.2%) or declined to answer (14.6%). Nineteen 
respondents (N=126; 15.1%) opted for RUPD without any ethical requirement while 7.5% 
(N=120) would start RUPD without REC review until they had a publishable manuscript. Most 
respondents (N=115, 83.5%) were not aware of any written rule, policy or regulation 
governing RUPD.  When asked if there was a need for specific RUPD guidelines, 85.6% 
(N=125) agreed with 73.8% of them choosing ‘strongly agree’.   
 
 
 
 
32 
Table 1: Socio-demographic characteristics of survey participants (N=130) 
Variable                      Category           
Regions                       West Africa 
                                     East Africa 
                                     Southern Africa 
                                     *Asia, Europe, & North America 
                                     Unspecified 
Age (years)                <30                                             
                                     31-50 
                                     >50  
Frequency 
65                       
41 
 4 
 5 
15 
16 
92 
15 
Percentage (%) 
(50.0) 
(31.5) 
 (3.1) 
 (3.8) 
(11.5) 
(12.3) 
(70.8) 
(11.5) 
                                    Unspecified  7  (5.4) 
Primary training       Public Health (including Medicine) 48 (36.9) 
                                    Epidemiology 16 (12.3) 
                                    Statistics & Information Systems 16 (12.3) 
                                    Law and other fields 12 (9.2) 
                                    Demography & Social Sciences 7 (5.4) 
                                    Economics 5 (3.8) 
                                    Bioethics 2 (1.5) 
                                    Unspecified 24 (18.5) 
Institution of work   Research Institution                                 75 (57.7) 
                                    Ministry of Health 33 (25.4) 
                                 International Organization 6 (4.6) 
                                 Academic  3 (2.3) 
                                    Other 4 (3.1) 
                                    Unspecified 9 (6.9) 
Professional role      Researcher     59 (45.4) 
                                 REC Member or Administrator 18 (13.8) 
                                 Public Health Officer or Clinician 18 (13.8) 
                                    Data Management 8 (6.2) 
                                    Research Center Administrator 5 (3.8) 
                                    Policy Making 4 (3.1) 
                                    Other 9 (6.9) 
                                 Unspecified 9 (6.9) 
Ethics training         Yes 88  (67.7) 
                                 No 31 (23.8) 
                                 Unspecified 11 (8.5) 
* Due to small numbers, non-African respondents with a stake in HDSSs from Bangladesh, 
The Netherlands, Sweden, Switzerland, and the Unites States are pooled.         
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3.4.3 Respect for study participants and communities  
Respondents’ views on preferred stages for seeking permission and prior processes 
for conducting RUPD were sought (Table 2).  Majority (N=120, 95%) of them agreed to 
seeking prior permissions.  Of six possibilities given, obtaining permission from the custodian 
and REC approval was the most preferred (41.7%).  Six respondents would ‘use only personal 
and professional discretion’. 
Table 2: Preferred stages for seeking permissions to conduct RUPD (N=120) 
Step 1 Step 2 Step 3 N (%) 
Custodian REC - 50 (41.7) 
Custodian REC    Regional or national 
health authorities 
48 (40.0) 
Custodian  Analyze data.  If 
publishable take Step 3 
REC  9 (7.5) 
Use only personal 
and professional 
discretion 
- - 6 (5) 
Custodian  - - 5 (4.2) 
Custodian Regional/national 
health authorities 
- 2 (1.7) 
3.4.4 Informed consent 
Using Likert-scale responses, we assessed perceptions about practices associated 
with the principle of respect for persons.  Obtaining individual consent was rejected by most 
respondents (70.1%), but when RUPD involving genetic data was made a possibility, the rate 
of rejection was only 14%.  Table 3 presents the distribution of responses to practices that 
are argued against in the literature. 
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Table 3: Perspectives on informed consent  
Practice  Strongly 
Agree 
Agree Neutral Disagree Strongly 
Disagree 
Seek individual  consent for 
every study (N=127) 
13 
(10.2%) 
9     
(7.1%) 
16 
(12.6%) 
25 
(19.7%) 
64    
(50.4%) 
Prohibit RUPD involving 
genetic records, if individual  
consent is not sought (N=93) 
60 
(64.5%) 
14 
(15.1%) 
6     
(6.5%) 
6      
(6.5%) 
7        
(7.5%) 
Seek one-time consent for 
future publications (N=125) 
36 
(28.8%) 
16 
(12.8%) 
21 
(16.8%) 
26 
(20.8%) 
26    
(20.8%) 
Grant individual rights to 
withdraw their own data 
from RUPD (N=127) 
46 
(36.2%) 
17 
(13.4%) 
21 
(16.5%) 
19     
(15%) 
24    
(18.9%) 
Individual interests and 
consent could slow down 
RUPD (N=126) 
40 
(31.7%) 
29    
(23%) 
20 
(15.9%) 
15 
(11.9%) 
22    
(17.5%) 
In the “comment” section, six respondents stated that individual consent should be 
sought only at researchers’ discretion.  One respondent remarked that there was no 
question about participants’ rights to individual consent in any research, but the problem 
with RUPD was one of feasibility.     
3.4.5 Communities’ autonomy 
The majority of respondents (N=126; 65.9%) supported prior disclosure about RUPD 
to community leaders (N=120; 62.5%), but 23% disagreed.  Three respondents added that 
community advisory boards should be established; eight suggested local representation in 
RUPD discussions within the community; and three added that selected community 
representatives should inform themselves about RUPD and serve as REC members. 
Asked about concerns communities might have about RUPD, respondents mentioned the 
following:   
 conducting scientifically interesting but socially-undesirable studies  
 insensitive publications  
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 discontent about data use 
 doubts about RUPD findings and legal battles 
 exploitation and deception  
 absence of compensation for time and effort 
3.4.6 Providing benefits  
Only a quarter of respondents (N=124; 24.9%) agreed to the notion of providing 
benefits to RUPD participants.  More than half (55.7%) were against it and a fifth undecided 
(19.4%).  To a proposal for result dissemination to communities before publications, 69% 
agreed, 14% disagreed, and 17% were undecided.   
We sought examples of realistic benefits to provide in RUPD.  Respondents suggested 
building custodians’ data managing capacities to improve funding and employment (n=15); 
using RUPD to support policy legislation (n=7); prioritizing research that is of local interest 
(n=5); access to interventions (n=5); sustaining systems in which RUPD knowledge can be 
applied to improve health (n=4); focusing on  on-site data analyses to promote local 
leadership in RUPD, address local questions and speed result translation to relevant policies 
(n=2); and providing policy briefs (n=1).  Six respondents suggested that HDSS communities 
should proactively state what benefits they expect from RUPD for researchers to comply.   
3.4.7 Risks in RUPD and procedures for minimizing them 
Table 4 documents respondents’ opinions about risks that are suggested in the literature as 
well as risks they identified in their practice.  Compromise of personal and family data 
following release to researchers was the most (59.5%) endorsed, but   under a quarter of 
respondents (23%) thought that HDSS residents faced risks to confidentiality from RUPD 
publications.   
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Table 4: Perceptions about identified risks 
Risks  Strongly 
Agree 
Agree Neutral Disagree Strongly 
Disagree 
Risk to confidentiality in 
publications (N=126) 
14  
(11.1%) 
15 
(11.9%) 
32 
(25.4%) 
31 
(24.6%) 
34  
(27%) 
Rights to control use of personal 
and family data may be 
compromised (N=121) 
53  
(43.8%) 
19 
(15.7%) 
13 
(10.7%) 
20 
(16.5%) 
16 
(13.2%) 
Stigma and stereotyping, if 
results are negative (N=126) 
28  
(22.2%) 
26 
(20.6%) 
19 
(15.1%) 
22 
(17.5%) 
31 
(24.6%) 
Communal rights of control on 
data storage, use and publication 
(N=121) 
36 
 (29.8%) 
29   
(24%) 
18  
(14.9%) 
19 
(15.7%) 
19 
(15.7%) 
Feelings of being over researched 
(N=126) 
13    
(10.3%) 
12   
(9.5%) 
25    
(19.8%) 
29     
(23%) 
47    
(37.3%) 
Loss of trust in custodian for 
allowing RUPD (N=120) 
17    
(14.2%) 
21   
(17.5%) 
27   
(22.5%) 
30      
(25%) 
25  
(20.8%) 
Additional risks identified by respondents  
 Disregard for community dignity 
 Social embarrassment 
 Communal fear of being under international scrutiny   
 Unresolved issues after long years of research could cause local rage  
 Misuse of data 
 Data access by parties unknown to the community 
 Lack of opt-out opportunities 
 Mismatch between research goals and local interests 
 Non awareness  of RUPD by community 
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Figure 2 below shows respondents’ attitudes to risk minimization procedures.  Seventy four 
percent of respondents supported anonymizing data before release to researchers.  The 
least preferred option for risk minimization was limiting RUPD to non-sensitive studies.    
Figure 2: Attitudes to risk minimization procedures 
 
3.4.8 Fairness in assigning communities to RUPD  
Respondents did not consider community perceptions of being over-researched or 
burdened relevant in RUPD (Table 4).  The three most important conditions for RUPD to be 
considered acceptable were REC approval, potential to result in change in health policy, and 
local leaders’ agreement (Table 5). 
3.4.9 Respondents’ general recommendations  
Respondents recommended the following for RUPD ethics: (A) custodians should 
collaborate and create awareness about RUPD to enable residents know what their data is or 
should be used for, its importance to science, and what benefit communities stand to gain 
from being participants; (B) promote a working link between the community via its 
representative team and the respective REC; (C) develop institutional regulations and ensure 
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adherence to them;  (D) build capacity in use of analytical tools to improve funding and 
employment; (E) prioritize research that is of local interest; (F) negotiate access to health 
interventions; (G) sustain systems in which RUPD knowledge gained can be applied to 
improve health; (H) publish in ways that are culturally and socially appropriate; and (I) 
maintain community dialogue.    
Table 5:  Perceived conditions for fairness 
Condition of RUPD Strongly 
Agree 
Agree Undecided Disagree  Strongly 
Disagree 
Receives local REC permission 
(N=120) 
79    
(65.8%) 
24 
(20%) 
8         
(6.7%) 
2        
(1.7%) 
7      
(5.8%) 
Can result in change of health 
policy  (N=117) 
59    
(50.4%) 
31 
(26.5%) 
13     
(11.1%) 
7           
(6%) 
7          
(6%) 
Has the agreement of the 
community leadership (N=120) 
41    
(34.2%) 
34 
(28.3%) 
18     
(15.0%) 
17    
(14.2%) 
10     
(8.3%) 
Is in line with local or national 
health priorities (N=117) 
41    
(35.0%) 
32 
(27.4%) 
23     
(19.7%) 
11      
(9.4%) 
10     
(8.5%) 
Conforms to the custodian’s 
mission (N=118) 
40    
(33.9%) 
30 
(25.4%) 
22     
(18.6%) 
15    
(12.7%) 
11    
(9.3%) 
Receives permission from head 
of the custodian (N=118) 
38    
(32.2%) 
25 
(21.2%) 
22     
(18.6%) 
20    
(16.9%) 
13      
(11%) 
Does not involve sensitive 
questions (N=117) 
32     
(27.4%) 
19 
(16.2%) 
18     
(15.4%) 
28       
(23.9) 
20     
(17.1) 
Proposing team was involved in 
HDSS data collection (N=119) 
10      
(8.4%) 
11 
(9.2%) 
22     
(18.5%) 
29    
(24.4%) 
47   
(39.5%) 
 
3.5 Discussion 
This survey assessed perspectives of stakeholders experienced or knowledgeable 
about RUPD in relation to research ethics principles.  Each question attracted a high (>70%) 
response rate which is suggestive of practitioners’ acknowledgement of the relevance of the 
selected issues and their own awareness about the implied principles.  RUPD practitioners 
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support the literature which recommends data  use beyond the narrower purposes for 
which they are collected (CIOMS, 2016a, S. Bull et al., 2015, Public Health Ontario, 2012), but 
differ in perspectives on what, how, and when research ethics principles and governing 
regulations are needed.  The issues discussed are common to health research, but have 
dimensions peculiar to HDSSs.  To our knowledge, available empirical literature (A.M. Capron 
et al., 2009) on the closest methodologies to RUPD, such as biobanks (A.M. Capron et al., 
2009, B.S. Elger, 2010)  and epidemiological research (J. Sim and A. Dawson, 2012 , CIOMS, 
2016a) have structural and paradigmatic differences.  These differences do not enable 
effective comparisons with this survey.  Indeed, the evolution of health research renders 
available ethical provisions inadequate (Largent, 2016).  Ongoing updates to guidelines as 
relevant and authoritative as the ‘Common Rule’ (US Department of Health and Human 
Services, 2009) and the CIOMS Guideline s(CIOMS, 2016a) attest to this fact and justify this 
survey for RUPD.   
3.5.1 Independent review and ethical governance of RUPD  
The international requirement for the ethical review of health research (South 
African Medical Research Council, 2007, CIOMS, 2016a, World Medical Association, 2013, 
Nuffield Council on Bioethics, 2002, Nuffield Council on Bioethics, 2013) is clearly supported 
for RUPD. However, the perception that RUPD is not ‘research’ is substantial and can reduce 
practitioners’ adherence with seeking prior REC review.  To date, developments in  ethical  
research have been largely  based on compliance with guidelines, policies on best 
practices, and frameworks (S. Bull et al., 2015, E.J. Emanuel et al., 2004, Kass, 2001, G. 
Marckmann et al., 2015).  Low levels of awareness of the relevant provisions for RUPD and 
the high endorsement of the need for a RUPD-specific framework are suggestive of a gap in 
ethical RUPD.  Calls for the development of institutional regulations and adherence to them 
are justified and urgent.  We recommend that because scientists may rarely pay attention to 
the philosophical reasons for which ethical RUPD conduct should be or is the way 
it is prescribed (J. Sim and A. Dawson, 2012 ), including REC review, providing a 
specific ethical guidance framework for RUPD will improve ethical conduct.   
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3.5.2 Respect for study participants and communities  
Consistent with relevant literature (CIOMS, 2016a, B.S. Elger, 2010, A.M. Capron et 
al., 2009, J. Sim and A. Dawson, 2012 , H3Africa Working Group on Ethics and Regulatory 
Issues, 2013), individualized informed consent was not supported for RUPD.  Cost and 
impracticality (US Department of Health and Human Services, 2009, CIOMS, 2016a, J. Sim 
and A. Dawson, 2012 ), communal cultures of the collective against individualistic views (T. 
Metz, 2010) and the fact that relevant guidelines support general public health data use or 
research without informed consent (CIOMS, 2016a, Public Health Ontario, 2012, H3Africa 
Working Group on Ethics and Regulatory Issues, 2013) may account for this.  Nonetheless, 
individualized consent becomes necessary when research questions are sensitive.  
Researcher discretion is important. 
The importance of ‘community’ values was dominant in the survey findings.  Support 
for actively involving community leaders in RUPD exceeded the traditionally acclaimed 
importance of requiring institutional permission from custodians for similar methodologies (S. 
Bull et al., 2015, B.S. Elger, 2010, H3Africa, 2016).  These findings are suggestive of 
preferences for decision making that involve local leaders’ permission (group autonomy) 
(A.M. Capron et al., 2009).   Our endorsement mirrors attitudes in many cultures of the 
South, particularly Africa where seeking elders’ permissions for important activities are 
common (H3Africa Working Group on Ethics and Regulatory Issues, 2013, T. Metz, 2010).  
We recommend the following: responsibility towards RUPD should be entrusted to a 
recognized community team (I. Jao et al., 2015, Jao et al., 2015, Tindana et al., 2015); a 
working link among the community team, custodian, and REC would enable effective 
engagement of the community team to lead in creating local awareness about RUPD, its 
governance, conduct, and implications of RUPD results to promote ethics.  The community 
representative team becomes the practical unit for decision making and communal 
determination in RUPD.   
Another important dimension of the principle of respect for persons in RUPD, at least 
for traditional setups in Africa where humaneness and rightness are generally constituted by 
positive relation to others (T. Metz, 2010), is that what is right is defined in its harmonious 
relation to and contribution to one’s community.  Opt-out options which influential 
literature support as safeguards of voluntariness in database studies (Largent, 2016, CIOMS, 
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2016a, B.S. Elger, 2010, S. Bull et al., 2015, H3Africa Working Group on Ethics and Regulatory 
Issues, 2013)  may thus not be considered practical in these communal systems.  Since one-
time consent (CIOMS, 2016a, B.S. Elger, 2010) was also not a decisive option in the survey, 
the search for an ideal solution should consider alternatives to opt-out options.  We suggest 
optimizing the unique feature of re-contact with residents via the HDSS rounds. The 
following mix of procedural processes will also be helpful. 
First, essential information about RUPD should be shared with the custodian and 
community representative team for prior permissions.  REC review and approval should then 
be sought.  Second, brief information about RUPD should be provided orally or as an 
addendum to the routine HDSS document used during the house-to-house visits preceding 
or following the start of RUPD.  Tick boxes may be provided for options to the following 
issues:  (1) Sunset agreements (B.S. Elger, 2010) stating how often and how long residents 
may wish to be re-consented, for instance 5 years, 10 years or a lifetime; (2) what should 
happen with data upon death or emigration; and (3) broad topics a resident might wish to be 
informed about before RUPD or have their data excluded from.  Where societal pressures 
against opt-out are strong for communal reasons (T. Metz, 2010), dialogue and researchers’ 
assurance of the worth of individual rights both to consent or dissent to participation should 
be prioritized.  If paper-based activities may render these recommendations unbearably 
costly, documentation may be substituted with oral consent, but the remaining elements of 
informed consent expressed in disclosure, comprehension, voluntariness, and self-
determination (T.L. Beauchamp and J.F. Childress, 2001) can be upheld.   
3.5.3 Providing value and benefits  
The obligation for researchers to provide value and benefit (T.L. Beauchamp and J.F. 
Childress, 2001, E.J. Emanuel et al., 2004) often necessitates providing concrete gains on the 
basis of reciprocity and justice (Kass, 2001, G. Marckmann et al., 2015, E. Vayena et al., 2015).   
The principle itself is not questionable, but simply challenging to apply in RUPD given the 
general large numbers of individuals involved.  Practitioners’ several attempts to suggest 
realistic alternatives to individual benefit highlights their agreement in principle as well as 
their challenge, based on cost.  In line with the literature (CIOMS, 2016a, S. Bull et al., 2015, 
E.J. Emanuel et al., 2004, Kass, 2001), they settled on knowledge dissemination as the most 
practical benefit for RUPD.  However, there are problems even with this possibility, 
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especially in Africa.  With only 16% of internet access in Africa and 90% of households not 
connected to the internet (International Telecommunication Union, 2013), assuring even this 
minimal benefit is a challenge.  Further, many cultures have vernacular languages that are 
spoken and often not read (H3Africa Working Group on Ethics and Regulatory Issues, 2013).  
This necessitates oral forms of communicating results.  With 89% of people in these regions 
using mobile phones (International Telecommunication Union, 2013) exploring mobile 
technological knowledge sharing opportunities would better assure that benefit is possible 
in RUPD.  As some practitioners suggested, dialogue with community teams will also uncover 
other culturally and socially appropriate avenues including durbars and local radio stations 
for reaching the most inaccessible groups with RUPD knowledge.  Lastly, the opportunity of 
re-contact through the routine house-to-house visits should be utilized to share RUPD 
results.  
At the custodian and regulatory levels, practitioners’ suggestions for capacity building 
to improve funding and employment; use of RUPD to contribute to health policy 
developments (A.M. Capron et al., 2009), and legislation of policies; prioritizing research that 
is of local interest; negotiating access to health interventions; and sustaining public health 
systems in which new RUPD knowledge can be applied to improve health ought to be 
considered.  Additionally, HDSS communities are a good source of knowing and aiming for 
relevant benefits in RUPD.  
3.5.4 Risks and procedures to minimize them 
Much of the emphasis in the literature has been on issues of confidentiality and 
privacy (CIOMS, 2016a, A.M. Capron et al., 2009, B.S. Elger, 2010, S. Bull et al., 2015), but our 
study reveals significant ambivalence about these issues in RUPD.  The practitioners’ attitudes 
may be linked to characteristics unique to INDEPTH HDSSs.  We suspect that knowledge 
about ongoing processes of anonymization that are being introduced by INDEPTH’s iShare2 
Program (INDEPTH, 2016b) and the solidarity of member HDSSs may have influenced 
respondents to think that anonymization is already a norm for HDSS data and RUPD.  The 
communal nature of the contexts may also explain part of this.  Practitioners were more 
clearly concerned about negative reporting of studies that contribute to stigmatization, 
discrimination, and stereotyping of communities (T. Mduluza (eds), 2007).   Recognition of 
the commonality of HDSS communities in collectively facing risks led to much emphasis 
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being placed on publishing in culturally and socially sensitive ways.   Aligning RUPD’s goals to 
issues that are relevant to host communities also helps balance risks.  A helpful list of data 
protection and security measures is available internationally (CIOMS, 2016a, European 
Commission, 2013b, European Commission, 2016).  It is also expected that the upcoming 
updated CIOMS guidelines will, like its preceding ones, be a useful resource to RUPD and 
Africa.    
3.5.5 Fairness in the assignment of communities to RUPD  
Apart from selecting RUPD populations to ensure scientific validity and reduce risks, 
enabling community teams to contribute to RUPD decision making is an important approach 
to justice.  The survey revealed that careful assignment of communities’ data to different 
RUPD is important: communities with poor indices need not disproportionately be assigned 
to studies which stigmatize them for scientific benefit.  The values of trust, transparency, 
and accountability (E. Vayena et al., 2015) in these assignments are supported by 
practitioners and need to be integral to sustain the long term commitments, gains, and 
scientific growth that RUPD promises. 
It is distinctive to note that contrary to the literature (Y. Yazoume et al., 2012), 
practitioners thought that communities would not feel ‘over-researched’ over time.  Only 
HDSS communities could confirm or challenge this view.  In line with the literature (T. 
Mduluza (eds), 2007) nonetheless, practitioners’ concerns about stigma, discrimination, and 
discontent make it prudent to recommend that community inclusion in RUPD be driven both 
by scientific and socio-cultural considerations.  The level of engagement needed to exercise 
self-determination may sometimes be questioned because of low literacy rates and 
knowledge gaps.  However, collaborative efforts from custodians, community teams, and 
RECs via workshops, training, and education will help overcome these challenges for the 
benefit of science and the people.   
3.6 Limitations 
Information provided in the vignette may have influenced some responses or 
discouraged respondents’ own reasoning based on their experiences.  The choice of 
distributing the survey at the conference limited access of participation largely to delegates.  
Because participants who returned the questionnaires were mainly based in African HDSSs, 
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we missed cultural differences and operational diversities from the Asian and Oceanian 
regions of the South.  The study does not claim to be representative.  To the best of our 
knowledge however, this is the first survey of practitioners about the ethics of RUPD which 
can contribute to its future prospects.  Empirical research involving HDSS residents’ 
perspectives on the subject would further advance the understanding and reflections we 
have started.   
3.7 Concluding thoughts  
This survey has revealed some differing attitudes to the literature and current 
guidelines that are indicative of a need for education and re-examination of the extant 
ethical provisions that are relevant for RUPD.  For RUPD ethics to be robust, the following 
will be important: empowering communities to proactively contribute to planning, review, 
conduct, and dissemination of findings from RUPD; seeking appropriate permission from 
custodians; and undergoing REC review.  Where knowledge dissemination is the only 
realistic potential benefit, researchers’ obligations to provide it should be raised to assume 
the status that medical ethics, for instance places on doctors towards their patients.  
Collective risks need to be considered seriously.  Although practitioners’ interests in 
completing most questions is  suggestive of receptiveness to the idealistic possibilities of 
implementing research ethics principles in RUPD, RUPD ethics need not be left to individual 
or even institutional changes alone.  It needs a higher motivation which, from historical 
evidence and the progress made in health research, rests in raising standards through the 
development of a specific RUPD guidance framework.  The new CIOMS Guidelines are 
expected to be particularly useful to the South, but the presence of a specific framework for 
RUPD, gleaned from it and adapted to the South will be ideal. 
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4.1 Abstract 
Data sharing is a desired default in the field of public health and a source of much 
ethical deliberation.  Sharing data potentially contributes the largest, most efficient source 
of scientific data, but is fraught with contextual challenges which make stakeholders, 
particularly those in under-resourced contexts hesitant or slow to share. Relatively little 
empirical research has engaged stakeholders in discussing the issue. This study sought to 
explore relevant experiences, contextual, and subjective explanations around the topic to 
provide a rich and detailed presentation of what it means to different stakeholders and 
contexts to share data and how that can guide practice and ethical guidance. A qualitative 
design involving interviews was undertaken with professionals working in public health 
institutions endowed with data (HDSS), ethics committees, and advisory agencies which help 
shape health research in Africa.  A descriptive form of thematic analysis was used to 
summarize results into six key themes: (1) The role of HDSSs in research using public health 
data and data sharing; (2) Ownership and funding are critical factors influencing data 
sharing; (3) Other factors discourage data sharing; (4) Promoting and sustaining data sharing; 
(5) Ethical guidance structures; and (6) Establishing effective guidance.  The themes reveal 
factors regarding the willingness or not to share and an intricate ethical system that current 
discourse could reflect.  Many of the concerns resonate with the literature, but a whole 
other gamut of people and process issues; commitments, investments, careers, and the right 
ethical guidance are needed to realize a sustainable goal of reaching ‘share’ as a default. 
Key words:  Data sharing; Public health; Health and demographic surveillance  
         systems;  Research involving public health data; Research ethics;  
         Africa  
4.2 Introduction 
Datasets, databanks, and data repositories are rapidly multiplying and expanding 
opportunities for data sharing in order to advance global health (E. Pisani et al., 2016, 
Wellcome, 2016, E. Pisani et al., 2010, U.S. NIH, c2016).  Even in the Global South or the 
South, that is developing countries located primarily in the southern hemisphere (United 
Nations Development Programme, 2016, Demographic and Health Surveys Program, 2016, 
M. Brack and T. Castillo, 2015), many data repositories are being established.   Two of the 
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most notable public health database programs that feed into repositories in the South are 
the USAID’s Demographic and Health Survey program (Demographic and Health Surveys 
Program, 2016, INDEPTH, 2016a) and the International Network for the Demographic 
Evaluation of Populations and their Health’s (INDEPTH) health and demographic surveillance 
system (HDSS).  In 2015 for instance, HDSS data on cause specific mortality in low-to-middle-
income countries was the largest to have been ever published (K. Herbst et al., 2015).  Africa 
constitutes 88% of HDSSs globally, with the rest in Asia, Oceania, and Central America 
(INDEPTH, 2016a).  In this article, we use the HDSS as a profile example of public health 
systems that produce critical volumes of data for secondary research and for which data 
sharing is a critical resource.  We also refer to research based on the pre-collected routine 
public health data held by institutions like the HDSS as research using public-health data 
(RUPD).   
Data sharing is a non-negotiable source of HDSS activities and RUPD advances.  It 
increases data volumes, velocity, and variety to solve complex research problems (M. Brack 
and T. Castillo, 2015). It helps tackle the problems of irreproducibility in science, opens up 
methodological alternatives to otherwise costly research involving primary data (Wellcome, 
2016, E. Pisani et al., 2010, E. Pisani and C. AbouZahr, 2010), and enables scientists to fulfill 
their moral obligations to improve global health.  However, collecting data, storing data, 
owning data, collaborating on data, sharing data or not, transferring data, and publishing on 
data involves a complex mix of concerns.  Data is not a simple issue anymore: it is no longer 
based for instance on physical and specific storage on recognizable drives for controlled 
sharing.  Rapid duplication, storage in multiple places at any one time, and concurrent use 
for multiple research are easy and cheap.  This is perhaps one of the reasons why public 
health data sharing has been slow globally (W.G. van Panhuis et al., 2014).   As more data 
repositories develop, data requests increase (E. Pisani et al., 2016), advocacy for data sharing 
gets propelled (E. Pisani et al., 2016, S. Bull et al., 2015),  and the pressure to share data 
mounts from scientists, regulatory authorities, sponsors, and scientific journals (E. Pisani et 
al., 2016, Wellcome, 2016, D.B. Taichman et al., 2016),  considering what all these mean to 
both the scientifically productive and less productive sections of the scientific community is 
critical.  Moreover, regions like Africa which have high burdens and risks of diseases may 
produce rich data, but it may not necessarily advantage them in scientific productivity.   
Reasons for such failure include resource constraints which in turn motivate the ethical 
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considerations of contemporary data sharing (M. Brack and T. Castillo, 2015, S. Bull et al., 
2015). 
4.2.1 Public health data sharing and ethical guidance in Africa 
The HDSS model involves the collection, storage, and management of longitudinal 
population level data to help inform public health activities and facilitate RUPD.   The data 
undergoes annual, biannual, or quarterly updates that ensure their permanent connection 
to respective populations.  Data from ongoing research projects are also added to grow the 
database.  Although the HDSS is ideally planned like all public health institutions to operate 
under domestic law (R. Bayer and A. Fairchild, 2004),  legal and ethical provisions are 
generally insufficient in many African contexts (S. Bull et al., 2015, E. Anane-Sarpong et al., 
2018a).  The authority and responsibility to share data may be mandated at institutional or 
national levels and governed legally, ethically or both depending on available governing 
structures.  A code of conduct on public health data sharing may be initiated locally, built on 
international provisions (E. Anane-Sarpong et al., 2018a, Wellcome, 2016) or simply 
assumed.   There is yet to be an ethical guideline, endorsed reporting, or evaluative 
framework specific to public health data sharing even in comparatively advanced systems 
like South Africa (W.G. van Panhuis et al., 2014).  Legislative landscapes in the North serve as 
useful guides, but they are sometimes poorly understood even in the North (M. Brack and T. 
Castillo, 2015).  Moreover, research contexts in the North differ from those of the South.   
Reliance on the research ethics committee (REC) and guidelines from international ethical 
organizations including the Council for International Organizations of Medical Sciences –
CIOMS (CIOMS, 2016a); the US Department of Health and Human Services (US Department 
of Health and Human Services, 2009); Wellcome Trust (Wellcome Trust, 2010); and the 
H3Africa Working Group (H3Africa, 2016) is common and helpful.  They are however 
unmatched with the novelty, quick technological advances, and implications for data 
producers and production processes in ways which had not been present before or as 
complex as they have become.  
4.2.2 Concerns about data sharing 
Reported obstacles to data sharing in Africa include the following: loss of control 
once data is shared; sub-optimal gains to those who create and manage data; undue 
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advantages to more technologically resourced contexts because of technological imbalances 
and skillsets in their favor; and technical issues including data quality, interoperability, and 
risks of misinterpretation due to unfamiliarity with data-originating contexts (E. Pisani et al., 
2016, E. Pisani et al., 2010, M. Brack and T. Castillo, 2015, D.B. Taichman et al., 2016).  Many 
of the technical obstacles are understood to be largely resolved (M. Brack and T. Castillo, 
2015).  What remains less reported are issues pertaining to fears, risks, and uncertainties on 
the part of data-producers in under-resourced contexts like Africa, who may be unable to 
maximize the benefits of data sharing to match their burdens of data production.  That these 
contexts are also generally characterized by weak ethical developments (S. Bull et al., 2015) 
adds to the challenge.  Evidence-based views from Africa are limited, but it is by stepping 
into their context, experiences, and concerns that ongoing data sharing discussions can be 
brought in touch with practical standpoints that could inform data sharing calls more 
comprehensively.   
We undertook this study to explore relevant experiences, contextual, and subjective 
meanings, as well as values that public health stakeholders in Africa attach to the scientific, 
socio-professional, and ethical dynamics of data sharing.  The project is directed towards 
understanding the forms of skepticism that characterize data-producing scientists’ interests 
and willingness to share public health data.  We sought to explore and provide a rich and 
detailed collection of the informed perspectives of the selected stakeholders. The 
importance we attach to the views expressed by the participants is based on their practical 
engagement and direct experiences with data production and sharing.  The reported themes 
in this article are therefore descriptively derived from the data gathered, rather than 
advanced from the study team.  
4.3      Methods  
We employed a qualitative design in our exploration of the perspectives of 
stakeholders experienced or knowledgeable about the HDSS, public health, and RUPD.  Our 
choice of participants was based on their involvement in the relevant administration, 
conduct, and or scientific and ethical oversight of issues related to data sharing.  We also 
sought the views of independent experts who play advisory roles to international agencies 
involved in helping shape health research in Africa.   Our elaboration of the study results are 
based on the subjective, interpretative, and context based accounts of the participants.   
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4.3.1 Collaborators and study area 
This international study was undertaken as part of a PhD project in Switzerland in 
collaboration with INDEPTH-member HDSSs in Ghana and Tanzania (INDEPTH, 2016a). 
INDEPTH is the unifier-organization of HDSSs across Africa, Asia, Oceania, and Central 
America and has been particularly involved in promoting the sharing of HDSS data 
(Wellcome, 2016, O. Sankoh and C. IJsselmuiden, 2011). Four institutional and two national 
RECs which oversee HDSS activities were included in the study.  Practitioners from the 
ministries of health, international agencies, and the country offices of the WHO also 
participated in the study.  With seven HDSSs between them, both Ghana in the West and 
Tanzania in Eastern Africa have seen repository (HDSS) operations for over 20 years.    
4.3.2 Participants 
We purposively sampled 50 respondents via recommendations by HDSS leaders and 
REC administrators.  Further snowballing was done based on referrals.  The characteristics 
collectively shared by our sample in relation to the science, ethics, and regulation of RUPD 
provided diverse, rich, and relevant answers concerning the willingness, capacity, and 
enthusiasm to share data.  The directors, REC administrators, and several other participants 
had earlier met and interacted with the interviewer during scoping visits. With three experts 
unavailable at different appointed times and one participant’s withdrawal of his recording 
because he thought his responses may not have been good enough, our analysis eventually 
included 46 interviews. 
 
The mean age of participants was 44 years (range: 29-59).  Participants had spent six 
years (range: 1-15) on average at their current roles with all except two having participated 
in research ethics training.  Additional participant characteristics are shown in Table 6.   
4.3.3 Study procedure 
Ethical approval for the project was first sought from the Ethics Commission of 
North Western and Central Switzerland which oversees research at the University of Basel.  
In Ghana, the Ghana Health Service, Dodowa Health Research Center, and Navrongo Health 
Research Center RECs granted review and approval.  In Tanzania, approvals were obtained 
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from the National Institute for Medical Research and Ifakara Health Institute RECs as well as 
the regulatory Commission for Science and Technology.  Participant information leaflets and 
consent documents were sent to all prospective interviewees. The documents were 
returned signed to the researcher during or before interview dates. We undertook all 
procedures in accordance with the ethical standards of the respective RECs.  
A semi-structured interview guide comprising open-ended questions was developed 
by the research team.  The questions were broadly related to the HDSS-RUPD context, 
experiences around data sharing, descriptions of ethical structures, data sharing initiatives, 
perceived risks and benefits, and expectations about data sharing.  The guide made space for 
soliciting additional specific views relating to data sharing.  It was pilot-tested with 
colleagues at the Institute for Biomedical Ethics (IBMB), University of Basel, three HDSS 
student-practitioners studying in Basel, and two REC members in Ghana.  Authors 1 and 3, 
PhD students and research assistants at the IBMB organized and undertook the scoping and 
data collection visits.  They however, focused on interviews for different research questions.  
All interviews for this article were conducted by Author 1 in English, lasted 19 to 69 minutes 
(mean of 38), and took place at a venue of the interviewee’s choice.  Twelve participants 
asked to see and were availed the interview guide prior to the interview dates.  Of the 46 
interviews, 21 were conducted in Ghana between November 2014 and January 2015 and 25 
in Tanzania from January to February 2015.  The point of saturation was reached by the 
fifteenth interview in both countries (G. Guest et al., 2012), but to confirm saturation, delve 
into grey areas and clarify issues, already scheduled interviews were continued to 
completion.   
Except for two pairs of field-supervisors who asked for joint interviews, all interviews 
were individually conducted face-to-face, on site, and tape recorded with no one else 
present at the venue.  Notes were taken with participants’ permission if they had additional 
contributions before or after the interview. 
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Table 6: Characteristics of interviewed participants (N=46) 
Variable                             Category 
Ghana     
(n=21) 
Tanzania 
(n=25) 
Sex                                      Male 13 18 
                                            Female 8 7 
HDSS Role (n=26)             Director or ex Director 3 2 
                                           Chief Scientist 1 3 
                                           Head of Unit/ Field Supervisor 3 8 
                                           Site Manager 0 2 
                                           Scientist 2 2 
REC Role (n=14)               Chairperson                                 1 0 
                                           Committee Member 3 4 
                                           Committee Administrator 3 3 
Independent (n=6)          Policy Making Agency or  
                                            Ministry of Health   
2 0 
                                            Law 1 1 
                                             International Research  
                                             Organization 
2 0 
Primary Training              Social Sciences 4 9 
                                           Medicine 8 4 
                                           Health  and Allied Sciences  4 3 
                                           Epidemiology 4 2 
                                           Physical Sciences 1 4 
                                           Other  0 3 
Years of Experience        1-3 1 6 
                                           4-6 3 4 
                                           7-9 2 3 
                                           10-12 6 3 
                                           13-15 4 1 
                                           16-18 0 1 
                                           >18 2 6 
                                           Unspecified 3 1 
4.3.4 Data Analysis 
Author 1 transcribed the recorded data into a WORD document and subsequently 
checked a sample of the transcripts with the tapes to confirm accuracy.  The processes from 
transcription to coding assignments were as follows: (1) The transcriptions and initial checks 
allowed Author 1 some degree of immersion into the data; (2) Authors 1 and 2 carefully read 
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ten randomly selected transcripts to identify various concepts, ideas, and explanations given. 
During this process, relevant texts including concepts, information, and reasons for them 
were assigned codes that captured their descriptive elements.  We grouped the codes into 
ideas that complemented participants’ arguments and reasoning to result in themes and 
sub-themes.  Doing the initial coding together improved the accuracy of characterizing 
responses and served to control for reviewer biases (B. Dawson and R.G. Trapp, 2004). It 
resulted in an agreed basic coding framework; and (3) The rest of the coding was 
independently done by Author 1 using MaxQDA 12.  
The initial interpretation of the findings were compiled and sent to two authors who 
presented their critique of the results, organization, and interpretation of the themes. This 
iterative process continued until three authors agreed on the themes, sub-themes, and their 
meanings.  The thematic analysis was guided using Guest et al (G. Guest et al., 2012) and 
Braun & Clarke (V. Braun and V. Clarke, 2006).   
Because we used a qualitative thematic approach for data analysis, participants’ 
opinions were taken at face value and interpreted as depicting their true views, regardless of 
whether they were in line with the literature.   These opinions guided us in developing 
themes in line with our research questions and the relevant literature.  Six key themes were 
identified: (1) The role of the HDSS in RUPD and data sharing; (2) Ownership and funding are 
critical factors influencing data sharing; (3) Other factors discourage data sharing; (4) 
Promoting and sustaining data sharing; (5) Ethical guidance structures; and (6) Establishing 
effective guidance.   
In our presentation of the findings we avoid exact frequency counts, but use the 
following terms when a sizeable number of interviewees dwell on a theme or meaning: 
“most”, when more than twenty-three participants report a meaning; “frequently”, “many” 
or “often” for ten or more participants; and “some” or “other” for less than ten.  We 
corrected non-significant grammatical mistakes in the quotes to aid readability and 
comprehension.  For anonymity, we classified interviewees using participants’ sex (M or F), 
interview number, institution of affiliation, role, and background training.   Where 
descriptors were inadequate to protect anonymity, we dropped background training.  For 
instance, Interviewee Number 15, a female REC administrator with training in Sociology is 
denoted as F15_REC/Administrator/Sociology or only F15_REC/Administrator if 
identification is possible.  Independent experts are denoted by “IE”.   Combined descriptors 
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denote dual affiliation.  Once a participant is introduced in full, their subsequent quotes are 
identified by sex and number only.  
4.4 Results 
4.4.1 The role of the HDSS in RUPD and data sharing 
For most participants, the HDSS-RUPD and data sharing relationship revolved around 
the growing resourcefulness of accumulated HDSS data.  The data serves as a sampling 
frame for RUPD.   For instance, M1_HDSS-IE/Medicine-Epidemiology pointed out the 
following: 
The HDSS is community based.  There is a certain need for the population to serve as 
a platform for looking into the future as far as health problems are concerned.  The 
data provides a sampling frame. To that extent, there is a relation between the data 
and what is needed for research.   
Although we tried to explicitly delineate RUPD from core HDSS public health activities, 
responses frequently echoed a conflation of the two.  There were differing opinions on 
whether RUPD constituted research and whether it and data sharing required ethical 
considerations.   M8_HDSS/Medicine-Epidemiology for instance argued that “[They are] all 
for the general good and require no ethical interference”.  In contrast, most participants 
acknowledged a need for ethical considerations e.g., “Research is becoming more complex.  
Data is becoming the currency with which you can do a lot.  It is important that we take 
[ethics] seriously” (F16_REC-HDSS/Scientist).  
Many participants mentioned the growth and inevitability of data sharing and urged 
adequate preparedness e.g., “Science is evolving; technology is evolving.  With my 
cellphone, I can transfer data anywhere” (M32_REC, IE/Medicine-Public health). Another 
added the following statement:  
The world has become like a single village: information can move across very quickly. 
People have to be prepared or else they will collect lots of information only to find it 
out there in a span of one or two months. (M33_HDSS/Medicine-Epidemiology) 
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4.4.2 Ownership and funding are critical factors influencing data sharing 
 
One critical issue influencing the willingness to share data was the question of “who 
owns data?”  There were differing views ranging from institutional assumption of complete 
ownership to their role as custodians holding data in which other stakeholders have 
important stakes. Many respondents cited investments in data production as reasons for 
claims to ownership and hesitation to share:  
We (institution) own the data and it costs us so much not only in terms of finance, but 
also in terms of our time, managing it, and participants who we visit over and over.  It’s 
not really value for investment to just give out the data to a third party.  
F36_HDSS/Epidemiology 
 
Others believed that HDSS data was a public good that should naturally be shared:  
There is a public good here. There is some ceding of individual and community liberties 
towards this good [when communities supply data]. The liberty given to researchers is in 
the name of the public good.  If [HDSS] lacks integrity with the public good, it has no 
business being in existence. M1 
 
Some participants saw HDSSs as custodians who could not be the sole arbiters in decisions to 
share data:  
[HDSS] doesn’t own data.  They can advise that “ok we don’t have the right permission 
from the community. . . .”  That is why they (HDSS) also need to have guidelines in terms 
of releasing data to others. F16   
 
Funding was another critical factor in data sharing e.g., “once the data is funded by us 
[HDSS], nobody influences how it should be used.  But sponsors and funders have a say” 
(M14_HDSS/Epidemiology).  A clarification was made: 
The HDSS is not like the DHS which is funded by government to gather information 
and make them publicly available.  We have multiple people funding it and you 
cannot just say yes to anybody who needs the data. F17_HDSS, REC/Epidemiology  
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4.4.3 Other factors discourage data sharing 
Support for data sharing was deemed good at national and institutional levels, but difficult 
to implement at individual levels e.g., “the willingness [to share] is there at least at the 
management level, but it’s hard to get individuals to actually do it” (F23_HDSS/Unit-
Leader/Epidemiology).  
 
Reasons underlying low motivations to share data were mostly underpinned by distributive 
justice concerns (fairness), reciprocity, and inclusiveness.  F17 for instance argued that they 
“look at what that person can also contribute to the system, because over the years 
somebody else has built the system”.   Another stated that “we have issues with sharing 
data.  These days the thing that has come up all over the world is ‘open access’.  You cannot 
collect data using your own resources and put it on open access (M8)!  The need for the 
principle of reciprocity was emphasized in the following two quotes: 
I collected your data, what position are you going to give me in authorship?  Are you 
just going to acknowledge me or make me second author? Do I sell the data? 
Without me collecting data, there won’t be secondary analysis. 
F42_REC/Scientist/Bioethics 
You are not a primary source of the information: you earn a PhD or become an 
expert and those who are the source of the information have nothing? 
M4_IE/Medicine-Law   
Others bemoaned concerns with transparency e.g., “Data is used out of the country without 
the original collectors only to later hear of a new publication. It’s not fair 
(M43_REC/Theology)!  Another stated that “it’s all been taken for granted. . . .  If somebody 
at the country level does not raise eye brows, [data] just goes” (F17).    
 
Some participants were discouraged by the inadequacies of local resources and oversight: 
The complexity comes from investments in technology. We in Africa and poorly 
resourced countries do not have the capacity to make sure that we safeguard or 
monitor anything.  This is a very big challenge.  No matter how many laws or 
regulations there are, they cannot do anything.   We have the DTA [Data Transfer 
Agreement], but with these developments DTA cannot help.  M32  
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Trust was a major concern.  Participants noted risks to the HDSS-community relationship as 
noted in the following two quotes:  
When we go to collect data, they give it to us as an institution; people that they know 
and have worked with for decades. They have a relationship with us, but might not 
have a relationship with [secondary user].  F16   
People ask for analysis to be done left, right, and center without consideration for 
ethical standards. Scientists might overlook these things, but we forget that they can 
have a huge impact on our relationship with communities. M33 
Some participants pointed to gaps in international guidelines e.g., “some journals are even 
requiring [data sharing], but the guidelines around it are very loose” (F12_REC/Medicine-
Public health).  
 
Issues of professional ethics were also raised e.g., “I foresee stealing of other people’s data 
and issues of authorship” (F42).  
 
4.4.4 Promoting and sustaining data sharing  
Measures to promote and sustain data sharing were suggested.   Within descriptions 
especially by participants at management levels, it was observed that institutional policies 
were being developed to encourage data sharing while guarding data use and transfers.  F23 
explained that her institution “allows two years of use by [data producers], another two 
years of open access to staff and after these four years, openly avail the data to the world”.   
Other managers described different institutional arrangements: 
We have elements of data that you can freely download [institutional website], some 
that require institutional permissions and REC review, and others that you cannot 
download.  The latter have restrictions: obtain REC approval and we will analyze the 
data for you. M24 
 
We study our own data, state purposes of collection per dataset, and consider how 
the data could be used or not. M33   
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Financial contributions were deemed important for sustenance in data sharing e.g., 
“because data is maintained at a cost, there should be a fee for use.  You have to contribute 
to make sure we keep it going” (M41).   
For some participants, the principles of inclusiveness, collaboration, and capacity 
building were needed to promote and sustain data sharing e.g., “We want to see the 
involvement of local scientists.  We have limited capacity.  Hence, a PI who wants to share 
data must help add capacity” (M41).  Another requested that they should “be notified about 
data requests to enable them to plan collaborations and agreements” (F21/REC/Bioethics).  
To M11 (IE/Law) local scientists simply “want to finish their publications first.  When they are 
satisfied with what they can, they shall make data available”.    Equity and benefit sharing 
could not be over-emphasized e.g., “a researcher who is tapping into the data of another 
should give credit where credit is due” (F13_IE/Medicine-Public health).  “Transactions 
should be mutual for everybody to be happy. That’s the bottom line” (F42).   Another 
concluded that “issues of intellectual property, patenting, and ownership” (M4) were also 
critical.   
 
4.4.5 Ethical guidance structures  
This part of the results relates to the role that ethical structures were expected to 
play. Although national and international guidelines, institutional policies, and REC oversight 
were predominantly mentioned, most participants expressed uncertainty about their 
existence or how their provisions informed data sharing.   
Regarding international guidelines, F17 stated this: “I’m yet to see any guideline that 
talks about [data sharing]”.  M24 insisted that “It’s clear! As far as I know [guidelines] do not 
exist.  If somebody comes up and pulls one, it will be very useful”.  In contrast, REC members 
exhibited awareness about international guidelines on data sharing.  Some preferences were 
stated e.g., “the WHO guidelines seem ok, but CIOMS is quite appealing” (F16).  Another 
observed that “CIOMS gives you flexibility. It's too broad, but it makes it possible to adjust 
and to think of what suits particular issues” (F15_REC-HDSS/Administrator-Scientist). No 
specific provision on data sharing was mentioned.  
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National guidelines and institutional policies were seen as intertwined in their 
guidance relationship, relevance, and authority over data sharing.  A quote by M11 
succinctly captured several views by other participants: 
Regulatory institutions’ policies are useful because nations appreciate that they cannot 
make laws to regulate some situations (like data sharing).  Policies must fall within the 
law and become part of administrative processes. If [HDSS] has a policy, you must 
follow it.  You cannot substitute it with an international policy: you’ll fall into conflict.  
Precisely because we (Africans) have not found relevant national laws in some 
countries, let’s ask for acceptable terms and allow HDSSs to negotiate them within the 
country’s law. 
Reliance on institutional policies was however deemed to have a major flaw: “institutional 
policies, as regulatory procedures, are binding on individuals who subscribe to it. If an HDSS 
has a policy, it is their policy in-house” (M32).   By this assertion, scientists external to an 
HDSS were not necessarily bound by their institutional data sharing policies.   
The role of RECs in data sharing was largely recognized as necessary and protective, 
but developmental e.g., “until recently we [REC] were not reviewing HDSS activities and data 
issues” (F16).    A few participants opposed the involvement of RECs in HDSS data sharing 
issues e.g., “I don’t think National Births and Deaths or Statistical Service undergoes [REC 
review].  They don’t obtain any REC approval” (M8).  Nonetheless, some participants insisted 
that anyone wishing to share or use HDSS data secondarily should either “obtain REC review 
or go back to the community [for permission]” (M19_ HDSS/Epidemiology).  
 
4.4.6 Establishing effective guidance  
Given the perceived inadequacies of guidance structures explained above, participants 
justified a need for new provisions suited to their circumstances.   M5 (REC-HDSS/Medicine-
Public health) for instance argued for a new framework because he thought that “[data 
sharing] is an evolving area.  I’m sure the crafters of the original [guidelines] hadn't 
envisaged that this is the way things will grow”.    Others had had practical challenges with 
what exists: “[Named REC] once reviewed a protocol.  All members had different opinions. If 
we have a framework, it will be good” (M27_REC/Biostatistics).  
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Given the foregoing, some participants argued that “we need a new framework” 
(M26_REC/Theology) while others thought that “further expansions to the available 
guidelines would help” (M5).  Other ideas were suggested:  “Perhaps we should get one 
document that picks the strengths of the individual guidelines and put them together into 
one [guideline]” (F12).   To be effective, this process would “require an engagement with 
stakeholders to examine local norms, values, and assumptions” (M4) for inclusion in the 
framework.   
 
4.5 Discussion 
We have analyzed views expressed in an empirical qualitative study involving public 
health professionals from Ghana and Tanzania involved in the planning and ethical oversight 
of HDSSs.  Other participants were independent experts who play advisory roles for HDSS 
institutions.  Our goal was to explore and understand perceptions, experiences, practices, 
and attitudes influencing data sharing decisions.  We focused the study on contexts where 
the translation from data production to scientific productivity may be generally slow.  These 
contexts hold great prospects for producing quality useable data for useful data sharing 
because of the high burdens of public health issues (United Nations, 2015),  the perpetual 
growth of the data, the routine updates the data undergoes, and the under-utilized data 
they often hold, even at the stage of the publication of an analysis.  Data sharing is highly 
justified for such settings.  We sought to explore and understand challenges and reasons 
that constrain their data sharing potential, in spite of the prospects.  The study uncovers 
distinctive characteristics of under-resourced scientists and institutions relative to their 
resources including skillsets that may restrict their full realization of data sharing benefits 
and hence deter sharing.   
To the best of our knowledge, the extent of the risks and implications of data sharing 
remains unknown (M. Brack and T. Castillo, 2015).  They are also beyond the scope of a 
qualitative study.  What this study contributes are therefore simple but practical 
considerations and recommendations that could increase data sharing from contexts which 
may otherwise have reasons not to share. What is unique about the findings lies in the 
nuanced explanations regarding perceived and real risks behind the current low levels of 
public health data sharing (W.G. van Panhuis et al., 2014, S.G. Denny et al., 2015).  Despite 
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Africa and HDSSs’ great potential to share quality useable data, their voices have been 
largely unheard in the ongoing data sharing discourse.  There is no empirical data on their 
perspectives.    Some articles from the South share general perspectives on public health data 
sharing (W.G. van Panhuis et al., 2014, K. Hate et al., 2015), but they are dominated by issues 
pertaining to research data or individual level data.  The data in this article is not only 
informative for Africa, but for other contexts in the South which operate HDSSs and have 
comparable characteristics. 
The findings are suggestive of views that both align and conflict with the global 
interests and expectations in data sharing.  The community-related issues uncovered in the 
study were deemed largely dealt with in the literature (M. Brack and T. Castillo, 2015, I. Jao 
et al., 2015).  Hence we limited this discussion to issues concerning the scientist and the 
data-repository.     
The view that accelerated data growth makes data sharing a scientific and ethical 
imperative (CIOMS, 2016a, G. Aellah et al., 2016, K. Herbst et al., 2015, E. Pisani et al., 2016, 
E. Pisani et al., 2010, S. Bull et al., 2015) to increase new knowledge production, promote 
health, and save lives (E. Pisani et al., 2016, Wellcome, 2016, O. Sankoh and C. IJsselmuiden, 
2011) is largely supported by the study.  The results however, speak to questions of fairness, 
reciprocity, equity, transparency, inclusiveness, protection, trust, and capacity building in 
reaching the data sharing imperative. The results unearth duties and responsibilities which 
could exemplify a system of best practices and guidance for data-producing and user 
scientists.   Data sharing is expected to go hand in hand with minimizing risks and losses and 
assuring equity in benefit-sharing between the sharer and user.   
The general concerns of the participants—scientists, managers, administrators, 
consultants, REC chairpersons, and administrators—are not entirely new (E. Pisani et al., 
2016, M. Brack and T. Castillo, 2015).  The specific intuitions, meanings, and experiences 
expressed in them are rather clearer for aiding a better understanding of how data sharing is 
perceived, feared, and managed.  They also help conceptualize practices and expectations 
that could be motivated by these characteristics.  
First, the results indicate that data sharing is critically thought of in relation to 
ownership and funding, contrary to global interests and expectations (E. Pisani et al., 2016, 
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E. Pisani et al., 2010, Wellcome, 2016, Asia Pacific Association of Medical Journal Editors, 
2015).  Some of the reasons underlying this persistence are underpinned by Africa’s systemic 
resource constraints (G. Aellah et al., 2016) and an urge to maximize the value of data at the 
local level.   They reinforce the overarching call for equitable rather than free data sharing 
(O. Sankoh and C. IJsselmuiden, 2011)  to at least promote positive burden-benefit ratios in 
data sharing decisions.  While we agree with the general critique of data-ownership 
entitlements as detrimental to data sharing for the public good, we also acknowledge that 
investments in data production fuel feelings about rights to ownership that cannot be 
ignored.  Persons who believe in ownership rights generally lay claim to their investments in 
producing the data.  Disrupting ownership rights to open up benefits would require sharing 
in the burden of investments.  Thus, where feelings of entitlements are difficult to curb, cost 
sharing would help by first normalizing situations in which all contributors to the burden of 
data production become positioned as co-owners.  This will continue until such a time that 
ownership and perceptions of decisional-authority are too widespread to claim at individual 
or institutional levels.  We therefore argue for collaborative partnerships (E.J. Emanuel et al., 
2004) that share investment burdens as better arguments against “data ownership” than 
simple critique.  Ongoing developments like the Research Fairness Initiative (Council on 
Health Research for Development (COHRED)) could also be drawn on to complement quality 
data sharing partnerships, remove “ownership” hurdles, and introduce the needed balance 
to enhance accountability and responsibility in data sharing (European Commission, 2013b, 
European Commission, 2016).  
There is some indication that data sharing is ongoing at local and regional levels as 
evidenced by the increasing numbers of inter-HDSS publications (INDEPTH, 2015a) as well as 
specified provisions in institutional policies that are fashioned to enable local scientists 
maximize data utility before international data sharing.  This is suggestive of challenges to 
sharing that may be peculiar to international data sharing. 
The most extreme and feared form of international data sharing is deemed to be 
“open access” requirements (A. Ault, 2013).  Such data are generally stripped of both 
identity (participant/communities) and source (scientist/repository/community).  While this 
process reduces risks to participants and communities, it paradoxically reduces opportunities 
of benefit to the producing scientists and institutions.  This is because data is delinked from 
them as the original sources.   The situation evokes concerns about reciprocal justice and is 
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partly responsible for the reported sub-optimal gains in data sharing (E. Pisani et al., 2010, 
M. Brack and T. Castillo, 2015).  Many are therefore unwilling to accept open access data 
sharing in particular, approach it hesitantly, or insist on conditional sharing (K. Herbst et al., 
2015).  Likely conditions might include making only basic data available and leaving out data 
essential for fuller engagement and analysis.  The initiatives reported in this article to grant 
exclusive periods to data-producers to help maximize utility before sharing are good steps to 
safeguard producing scientists’ interests (E. Pisani et al., 2010, E. Pisani and C. AbouZahr, 
2010, M. Brack and T. Castillo, 2015, H3Africa, 2016).  They may slow down international 
data sharing, but help increase local scientific productivity in research that is aligned to local 
needs without crippling global needs.  
Dimensions revealed in our data about authorship and capacity development issues 
highlight a discourse on secondary-user duties: a duty to credit those who make data 
possible, invest (E. Pisani et al., 2016) in sustaining data production, and share tangible 
rewards like authorship opportunities.  Although data is acknowledged as a public good for 
the public good, the practice and recommendations of merely acknowledging data-
producers (E. Pisani et al., 2010, Wellcome, 2016) in publications is generally deemed 
inadequate.  Since collaboration may also not be desired by secondary-users at all times, 
good-faith negotiations that contain equitably tangible incentives for both data producing 
scientists and users should be promoted(E. Pisani and C. AbouZahr, 2010).  This would 
necessarily require proactive efforts by secondary data users to involve producing scientists 
in their secondary analysis and production of new knowledge.  The onus lies on the 
secondary user to take the necessary steps to invite and include intellectual input from data 
producing scientists to enable them access the ultimate benefits of their data production for 
science.  That ultimate is publications and its associated recognition in the scientific 
community.  Maximizing co-authorship opportunities in secondary research for the data 
producer would require their prior notification and invitation to contribute to manuscripts.  
Therefore, conducting secondary analysis and scientific writing independent of data-
producing scientists must be progressively directed to become exceptions rather than the 
norm in ethical data sharing.  Persons who have produced data that is good enough for 
secondary analysis that result in publications have certainly made prior intellectual input in 
decision-making on what data to collect.  Adding more to lead their data to its most effective 
ends of publications deserve optimal opportunity.   We therefore argue that authorship 
 
 
 
 
66 
involving data producers should be a matter of order ranking in authorship lists than a 
question of inclusion to promote inclusiveness in science. 
Data commodification via fee-for-use arrangements is considered a possible solution 
to funding shortfalls in under-resourced contexts.  It is however, unsustainable for our 
increasingly complex data world and the multiple parties involved in public health data 
production.   Questions about who to bear data-production costs for continuity in data 
sharing are legitimate, but they still find answers in the many organizations which are willing 
to fund public health and research for health.  The changing dynamics of governmental 
interests in research funding can also avert some of the funding concerns (M. Brack and T. 
Castillo, 2015).  
Regarding guidance structures, our findings highlight inadequate awareness, 
skepticism, and the absence of one go-to ethical framework for data sharing as limiting to 
data sharing prospects.  There is yet to be a unified international guideline that focusses on 
the totality of the data sharing issues raised.  There is no reporting or evaluative framework 
either (M. Brack and T. Castillo, 2015).  The virtuous researcher has to find relevant bits and 
pieces of different guidelines to consider in using secondary data produced by other 
scientists.  This practice is overly onerous for busy scientists and risks encouraging “cherry 
picking” of ethical considerations: provisions which are favorable and obvious to detect may 
be implemented while more demanding requirements like seeking and inviting intellectual 
input from those from whom data emanated may be ignored.  In line with the findings about 
challenges surrounding the authority of local guidelines and institutional policies in 
international data sharing, limitations in their application to scientists who are external to an 
issuing region or institution, and possible inter-institutional conflicts (M. Brack and T. 
Castillo, 2015), we support the study participants’ advocacy for developing a new 
framework.  One selected international document, preferably the CIOMS guidelines, given its 
reported advantages for developing settings (Largent, 2016) as well as its “flexibility” could 
be adapted to accommodate regional policies like the INDEPTH’s (INDEPTH Network, 2012).  
With effective consultation, such a document would be more universal in implementation 
and adherence.   Situating the foregoing indications with the calls for a new data sharing 
framework strongly supports the case for a new data sharing framework.  Its development 
should also benefit from relevant excerpts from other guidelines, note the identified gaps 
pertaining to the interests of producing-scientists as well stakeholder views about what 
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might additionally count as ethical in data sharing.  Figure 3 below conceptualizes the basic 
principles that could form part of this framework-development endeavor. 
Because national ethical and legal frameworks are generally at developmental stages 
in Africa (S. Bull et al., 2015), developing strong institutional policies will remain necessary.  
Institutional policies have the advantage of context, administrative, professional, and 
practice suitability when tailored to specific endeavors like data sharing.  Another key 
advantage they have is their preclusion of countries with weak national ethical systems from 
being completely orphaned in ethical safeguards.   
Regarding RECs, their acceptance seemed challenged and sometimes misunderstood. 
Their involvement in data sharing considerations is not always supported.  Even for pro-REC 
participants, the normal conflation of the HDSS, public health, and RUPD, backed by 
assumptions that public health activities do not require ethical considerations fuel apathy 
towards ethical review.  The inability of RECs to monitor secondary data use because of 
financial and infrastructural constraints also reduces researcher confidence in their oversight 
roles.  In spite of these challenges, we believe that they remain the best suited ethical 
authority to help control data sharing risks and institute requirements that could help data-
producers to maximize benefits.  It may be efficient for countries to invest their limited 
available resources in RECs to help them undertake effective monitoring of data sharing risks 
since they are fewer than research institutions and can concurrently serve many institutions 
and scientists.    Modern technological infrastructure like digital data finger-printing (N. 
Paskin, 2010) which enable tracing, monitoring, and informing of stakeholders about data-
shared could enhance REC oversight.  The literature has also theorized expedited reviews 
and training as helpful solutions to delays and other poor researcher-REC experiences that 
reduce researcher confidence (World Health Organization, 2011).  Finally, RECs could 
collaborate with local data repositories to define and document context appropriate ethical 
direction in data sharing for the future.  
The foregoing discussion provides an empirical frame of ethical dimensions that could 
be situated into key ethical principles and virtues for accelerating global data sharing goals 
with under resourced contexts.   Figure 3 diagrammatically presents essential principles 
underlying the study findings to re-conceptualize critical factors to reflect on when 
considering what data sharing could mean to under-resourced stakeholders and regions.
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Figure 3:   Relevant virtues and principles for designing an ethical framework for reaching 
data sharing goals 
 
 
 
 
 
 
 
 
 
 
 
* The proposed principles align with the Emanuel Framework (E.J. Emanuel, D. Wendler, J. 
Killen & C. Grady. What makes clinical research in developing countries ethical? The 
benchmarks of ethical research.  J Infect Dis 2004; 189(5): 930-937)   
**The study findings about community consent are not reported in this paper since, like 
other findings concerning community issues, they are largely dealt with and supported in the 
scholarly literature. 
The overall findings do beg for concerned authorities to consider the following:  
 Lead in defining and standardizing data sharing plans that stipulate adequate 
periods for local data optimization before wider sharing (E. Pisani et al., 2010);    
 Create an enabling environment for the growth and sustenance of the needed 
virtues and principles for promoting data sharing;   
 Institute guidelines and agreement templates that could guide equitable data 
sharing negotiations;  
GLOBAL HEALTH 
GOALS LOCAL GOALS 
PRINCIPLES*  
VIRTUES 
Fairness 
Reciprocity 
Equity 
Transparency 
Inclusiveness 
Trust 
Respect 
Professionalism 
 
Sharing 
Collaborative      
partnership 
Favorable burden-
benefit ratio 
Independent review 
   Community consent** 
    Capacity building 
Time flexibility 
 
       
Maximum data 
Productivity 
 
Maximum resources 
 
Maximum knowledge  
Productivity 
 
Optimal data sharing 
 
     Increased rewards 
 
     Social value 
 
Sustainable  
Practices 
 
Increased new  
knowledge from  
local scientists 
 
Increased result  
dissemination 
 
Increased translation  
of RUPD to health  
policies 
  
    Improved public  
    health 
 
Improved global  
health 
 
 
 
 
69 
 Need-based data sharing should be considered as an alternative to open access 
sharing which is deemed most risky (A. Ault, 2013), at least in the initial steps 
towards creating a new culture of sharing;  
 Collaborations can leverage technology and capacity building to increase Africa’s 
scientific productivity and align RUPD to local needs to spur improvements in 
public and global health.  They will also enhance skillsets, resources, and idea-
sharing.  Data sharing should be made an avenue for collaboration;   
 Secondary-users should be mandated to attest in their publications that their use 
of data is in accordance with prior agreements (D.B. Taichman et al., 2016, K. 
Herbst et al., 2015). This will encourage ethical adherence and inclusiveness;   
 RECs need to be resourced to monitor reports and publications involving data 
shared.  Increased confidence in their ability to reduce data sharing risks will help 
encourage the practice;   
 Incentivization of quality data-production and sharing is long overdue (E. Pisani 
and C. AbouZahr, 2010).  Efforts must be made to include quality data production 
in the global recognition framework.   Assessment of scientists’ suitability for 
research career progressions must for instance recognize quality, useable data 
production as a step to sustain data-production for increased data sharing.  
Africa remains the bearer of the highest burden of diseases globally and is behind in 
reaching the SDGs (United Nations, 2015).  Local scientists have moral obligations to 
increase scientific productivity for the populations’ and global health.   The region also 
remains largely challenged by resource constraints.  RUPD via data sharing is an efficient 
option for resource constrained scientists, but their confidence in fair data sharing will go a 
long way to validate their obligations to increase new knowledge for health.  Much attention 
to the new data sharing culture is focused on data.  It should however, shift to consider 
issues underlying people and processes that make data possible.  We risk sacrificing diversity 
of ideas for speed in data-utility in creating new knowledge (publications) if the under 
producing sections of the scientific community are not helped to catch up on productivity 
rather than competing too early for data they produce and share.  There are inconveniences 
in being ethical in every endeavor, but they are not comparable to the ultimate benefits.  As 
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this study has shown, there is room for making data sharing more ethical with a little 
ingenuity.  
4.6 Limitations 
The varied contributions across levels of staff, fields of experience, and institutions 
allowed us to explore diverse perspectives.  Regardless, lead professionals and those who 
were recommended to be invited for participation could likely have had perspectives 
different from those who were not.  Generally, qualitative studies cannot claim 
representativeness (N. Mays and C. Pope, 1995 ).  Although the findings are suggestive of 
hesitations about data sharing, we should be wary of assuming that Africa may necessarily 
be vulnerable in data sharing.     
 
4.7 Conclusions 
We have explored and unpacked the perspectives of public health professionals who 
operate in under-resourced regions and discussed their implications for international data 
sharing.  We considered their expertise and roles to enable us bring together practical and 
diverse views underlying general hesitations to share data in spite of the indisputable global 
gains attached to it.   There are institutional, administrative, financial, ethical, legal, 
scientific, and relational views about why this is so.   The following issues are highlighted as 
the major impediments to international data sharing prospects: 
 risks faced by under-resourced scientists and institutions which are slower in 
translating data produced into new knowledge; 
 the absence of a harmonized guideline and structures to help address the risks and 
institute fairness in data sharing rewards;  
 inadequate confidence in available protective safeguards including guidelines and 
RECs.  
Scientists and institutions which produce great volumes of rich data (problem-wise) may 
not be able to direct their data cycles into knowledge production at the speeds ideal for 
reaching global health goals.  The differences in data production and knowledge production 
strengths across different sections of the global resource divide must motivate collaboration 
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to maximize both data and scientific productivity.  It is important to note that although 
scientists are generally not a population which requires ethical safeguards, this study’s 
findings indicate need for a new dynamic of ethics which could protect the interests of 
under-resourced scientists in the new data sharing era.    Meanwhile, data sharing 
deliberations need to shift from the focus on access to data to considering the whole gamut 
of people and processes that make data possible. The ongoing data sharing discussions 
should therefore be placed within a broader context of safeguarding science, data 
production, and human systems.    
We finally recommend that because the true extent of data sharing risks is yet to be 
measured and beyond the scope of qualitative research, a comparative quantitative study 
that involves under-resourced settings which are advantaged by the proposals advanced in 
this article and in the literature versus settings without would help quantify the level of 
threat to data sharing.  Such a study would help validate our recommendations and attract 
the needed global responses to them. 
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5.1 Abstract  
A powerful feature of global health research is data sharing with regions which bear 
the heaviest burden of disease. It offers novel opportunities for aggregating data to address 
critical global health challenges in ways higher than relying on individual studies.  Yet there 
exist important stratifiers of the capacity to share data, particularly across the Global North-
South divide.   Systemic challenges that characterize the Global South, including sub-Saharan 
Africa and disadvantage the region’s scientific productivity threaten the burgeoning data 
sharing culture too.  Like all endeavors requiring equal commitments under unequal 
circumstances, a strong ethical impetus is needed to help reduce inequities and imbalances 
to encourage adherence.  This article discusses mandatory data sharing in relation to 
peculiar challenges faced by sub-Saharan African scientists to suggest ethical principles for 
rethinking and reframing solutions.  We propose six principles which mirror guidelines from 
the Institute of Medicine and encapsulate principles from the Emanuel Framework, Nairobi 
Data Sharing Principles, and the COHRED guidelines. 
   
Keywords:   
Data sharing; Mandatory sharing; Systemic challenges; Inequities; Fairness; sub-Saharan 
Africa; Global South 
 
5.2 Introduction 
The dominant paradigm of health research that necessarily involves primary data 
collection is decisively shifting to incorporate secondary data. Advances in technological and 
analytical tools help scientists to source different health research datasets to help in the 
creation of new knowledge, insights, and innovation for improving and saving lives (E. Pisani 
et al., 2016, L. Merson et al., 2016, Wellcome Trust, c2016). Combined datasets, used alone 
or in addition to primary data, yield research solutions often superior to results from 
individual studies (E. Pisani et al., 2018a, M. Gottesman, 2015). Other advantages make data 
sharing desirable as follows:  
 Reduced duplication of research data collection;   
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 Access to data that cannot be readily replicated; 
 Rapid reuse of shared data to generate new insights; 
 Maximized scientific knowledge returns and value on research investments as new 
analysts bring novel ideas and perspectives to the data;  
 Validation of research to promote reliability of results and improved methodology for 
strengthening findings;  
 Re-purposed analyses to address issues left unexplored in original studies;  
 Enhanced statistical significance (e.g., rare diseases through merging of datasets and 
combined analysis/methods otherwise difficult to realize within small samples; 
 Respect for and recognition of research participants’ altruism;  and  
 Acceleration of knowledge translation into health products and procedures (Pisani et 
al., 2018a, D.B. Taichman et al., 2017, L. Merson et al., 2016, U.K. MRC, 2016. D.B. 
Taichman et al., 2016, Pisani et al., 2016).  
Data sharing is in itself thought to promote trust, integrity, and completeness in 
science (L. Ferguson, 2014, T. Lang, 2011, S. Dallmeier-Tiessen et al., 2014).  It is increasingly 
becoming a new marker of scientists’ responsibility and openness (E. Pisani et al., 2018a, 
Brack M and T. Castillo, 2015, E. Pisani et al., 2016; T. Lang, 2011; M. Parker and S.J. Bull, 
2009).  To these ends, there are increasing global efforts to make all possible data findable, 
rapidly available, ethical, equitable, eternal, accessible, interoperable and reliable (E. Pisani 
et al., 2018b).   
Particularly, for the Global South (or South) which comprises developing countries 
primarily in the southern hemisphere, including sub-Saharan Africa (UNDP, 2016), sharing 
health research data provides an effective avenue for increasing research. The costly 
processes of contact with research participants, data collection, and management are 
reduced in studies that can rely on shared research data (E. Pisani et al., 2018a, E. Pisani et 
al., 2010). Consequently, there is a growing body of literature and global actors pushing for 
mandatory early and complete data sharing (U.S. NIH, c2016, U.K. MRC, 2016; Royal Society, 
2013).  In 2008, a draft international code on public health data sharing was discussed in 
Mali (E. Pisani et al., 2010). Earlier, and for over a decade starting 2005, the WHO began 
encouraging transparency in research through data sharing. Other global actors have joined 
in codifying rules and guidelines to promote health data sharing. Notable funding 
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organizations including the National institutes of Health and the Bill and Melinda Gates 
Foundation have made data sharing a condition for sponsorship (U.S. NIH, c2016, U.K. MRC, 
c2016, E. Pisani et al., 2018a).  Several influential Journals and publishers have also instituted 
data sharing as a condition for publication (D.B. Taichman et al., 2017, L.  Ferguson, 2011).  
To date, genomic research and clinical trials seem to attract the most advanced 
obligatory thresholds for data sharing (E. Pisani et al., 2018b).  Requirements have generally 
been for scientists to commit part or complete research data to publicly accessible 
databases following stipulated periods after publication (E. Pisani et al., 2018). The data to 
be shared are largely embedded as supplementary material in published articles, on 
institutional or project webpages, or deposited in repositories (E. Pisani et al., 2018b, L. 
Ferguson, 2014). 
The reach of influence of the burgeoning new culture of data sharing, the compelling 
advantages outlined above, and others put forward in the literature (L. Bezuidenhout,  2019, 
E. Pisani et al., 2018a, D.B. Taichman et al., 2017, CIOMS, 2016, E. Pisani et al., 2016, U.S. 
NIH, c2016;  L. Merson et al., 2016, U.K. MRC,2016)   make it reasonable to expect that the 
scientific community will adopt obligatory data sharing across all health disciplines and 
perhaps beyond (L. Merson et al., 2016).  
Yet there are risks in data sharing which are less deliberated (L. Bezuidenhout, 2018, 
S. Bull., 2016, Wellcome Trust, 2016, L. Merson et al., 2016, G. Aellah et al., 2016, E. Pisani et 
al., 2016), especially when considered in relation to the inherent equality assumed between 
data-producing scientists and user scientists.  Some of the risks stem from lack of confidence 
in data sharing; doubts concerning utility and quality of data; unwillingness to invest 
additional resources to make data sharable; and a general disconnect between data-
originators and data-users (E. Pisani et al., 2018b).  These risks are thought to be aggravated 
in research environments like sub-Saharan Africa which bears the greatest burden of global 
health problems and yet has the least dedicated resources for research (CIOMS, 2016, M. 
Rani  and B. Buckley, 2012, G. Aellah et al., 2016).  
This article is written to align our experiences in working in sub-Saharan Africa with 
relevant literature to explore the most typical risks facing science and scientists in the 
region.  We contend that the risks we outline pose critical ethical hurdles that give moral 
grounds for giving obligatory data sharing a second look. It also gives a strong basis for 
treating the South unequally under the emerging culture. The issues are however, neither 
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peculiar to sub-Saharan Africa nor solely pertaining to the Global North-South divide.  They 
are also of interest and relevance to all collaborations that are characterized by substantial 
differences in expertise, financial, and technological capacities among scientists/researchers 
(L. Bezuidenhout, 2019). For sub-Saharan Africa, the issues are generally underlain by 
systemic factors that are embedded in historically and politically rooted structural issues 
beyond solving by the scientific community. We raise them nonetheless because there exist 
well-established ethical principles that could help address or reduce their potential to 
perpetuate data sharing risks in the region. We recommend six principles, three of which 
mirror the principles espoused by the Institute of Medicine (IOM) for sharing patients’ data 
(IOM, c2015, E. Pisani et al., 2018), and more broadly encapsulate the Nairobi Data Sharing 
Principles (Committee on Data for Science and Technology,  2014).  For clarity, the views 
expressed exclude data sharing issues relating to data solicited for challenging results, 
exposing errors, or verifying manuscripts; data sharing inhibitions related to research 
participants’ welfare; and data sharing related to commercial potential and intellectual 
property rights.   
 
5.2.1 Producing quality health data in sub-Saharan Africa 
Large scale collection of health research data is limited in sub-Saharan Africa largely 
because of resource constraints (E. Pisani et al., 2018, M. Rani and B. Buckley, 2012). Rather, 
models like the health and demographic surveillance system (HDSS) with global presence 
across Africa, Asia, Oceania, and Central America collect and aggregate data through small 
scale household surveys (INDEPTH Network, c2018, K. Herbst et al., 2015).  The aggregated 
data is used to report nationally representative data, support population health analysis, and 
inform national and international health decisions and policy.  The introduction of projects 
like INDEPTH iSHARE and Data Documentation Initiative and have encouraged data sharing 
among sites and across the North-South divide to facilitate research (E. Pisani et al., 2018a, 
INDEPTH Network, c2016, Y. Yazoume et al., 2012).  With 88% of HDSSs in Africa, the 
successes of the model and its global data sharing ratings point to advantages that sub-
Saharan Africa can realize from promoting data sharing (E. Pisani et al., 2016, K. Herbst et al., 
2015).  Yet, even among HDSS scientists, many are unconvinced and hesitant to share data 
(E. Anane-Sarpong et al., 2018b).  Globally, some 54% of all authors do not share their data 
(L. Ferguson, 2014) while some 65% of those who publish peer reviewed articles also desist 
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from sharing data or providing information that allows readers to discover or access data 
underlying their articles.  Even for data storage in repositories, only 20% of authors deposit 
their own data while less than 9% of all authors share links to their data (Pisani et al., 
2018b). 
 
5.2.2 To share or not to share data: the paradox of being production-rich and reward-
poor  
Because of sub-Saharan Africa’s high burden of disease and other conditions of global 
health interest (Global Forum for Health Research, 2008), the region plays host to essential 
data that are unavailable in other regions.  Scientists are keenly aware that this ironically 
presents comparative advantages since many of the issues are less likely to threaten the 
North.  The situation therefore presents international and scholarly interests for local 
scientists to collect data, access resources, produce scientific papers, and build research 
skills (E. Pisani et al., 2018b).  The region’s poor health indices also mean that given the right 
research, it has the greatest potential to make an impact on global health and the 
Sustainable Development Goals - SDGs (United Nations, c2015, UNDP, 2016, T. Lang, 2011). 
Yet, limited essential skillsets in scientific productivity, scarcity of technological resources, 
and emigration of trained and experienced staff among other limitations stifle the region’s 
capacity to create new knowledge and innovations for health (E. Pisani et al., 2018b, G. 
Aellah et al., 2016). Analyzing large datasets is sometimes too cumbersome for locally 
available analytical tools (D. Serwadda et al., 2018, D. Boyd and K. Crawford, 2012) while 
resources for searching and accessing data, linking and comparing, cross-referencing, 
aggregating, and merging datasets to identify patterns for generating insights are in limited 
availability (D. Serwadda et al., 2018, G. Aellah, 2016). Health institutions and scientists may 
therefore have rich data in terms of the critical nature of health issues still confronting the 
region, for which there are no existing solutions (CIOMS, 2016).  Yet, rich data production 
may neither necessarily advantage local scientists in increasing publications, attaining 
professional reward systems which are heavily allied to publications (S. Dallmeier-Tiessen et 
al., 2014,  S. Hodson, 2013), or helping the region bail itself out of its problems. The paradox 
of being production-rich and reward-poor is that producing rich data becomes both a reason 
to share data and also for discouraging present data sharing in the hope of potential future 
rewards.  This paradox represents a complex issue underlain by inequalities and imbalances 
 
 
 
 
79 
which posit a unified risk to data sharing by the South that may be bigger than the sum and 
implications of data sharing disadvantages espoused in the scholarly literature (L. 
Bezuidenhout and E. Chakauya, 2018, E. Pisani et al., 2016, D. Boyd and K. Crawford, 2012, S. 
Dallmeier-Tiessen et al., 2014,  E. Pisani and C. Abouzahr,  2010). 
5.2.3 Burden-benefit discrepancies 
In producing and sharing data for health research, those who contribute data 
(burdens) must be given credit of benefits. The fundamental principle of producing 
interoperable, reliable quality health data (Committee on Data for Science and Technology, 
2014) using basic technological tools goes beyond regular research processes which are 
often possible for one person to do within a short time. Yet they are critical because 
potential user-scientists have limited ways of checking the quality of those data (E. Pisani et 
al., 2018a).  The burdens of running lengthy simulations, studying complex trends, designing 
and creating appropriate databases for data collection, and narrowing data to suit different 
research questions are demanding and expensive when resources are limited (S. Hodson, 
2013).  Yet, these investments are needed to increase the likelihood of utilizing data for new 
findings (E. Pisani et al., 2018a).  Moreover, the long manual processes benefit greatly from 
producing-scientists’ aspirations, ideas, and intellectual goals which we deem substantial 
enough to compare in value with post-publication secondary analysis leading to new 
publications (E. Pisani, 2018b , D. Boyd and K. Crawford, 2012).  Meanwhile, scientific rigor is 
as central to data production as for the ultimate knowledge production (D. Boyd and K. 
Crawford, 2012).  However, prominence in recognition and rewards in science remain 
largely, if not solely, on publications (S. Dallmeier-Tiessen et al., 2014, S. Hodson, 2013, E. 
Pisani and C. Abouzahr, 2010). Data production is rarely rewarded (E. Pisani et al., 2018, E. 
Pisani et al., 2016), creating a burden-benefit discrepancy against scientists whose 
competitive advantages lie in data production (D. Serwadda et al., 2018, E. Pisani et al., 
2016), but who for one reason or the other may fail to complete the continuum from data to 
knowledge production.  The discrepancy discourages data sharing from the South.  
5.3 The “values-adherence gap”  
It is reported in sub-Saharan Africa that the ethical values of data sharing are 
generally embraced at institutional levels, but not as much at individual levels (L.  
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Bezuidenhout, 2019, E. Pisani et al., 2018a, E. Pisani et al., 2018b, E. Anane-Sarpong et al., 
2018b).  Apart from hints of underlining security and actuarial concerns, the reluctance 
stems from scientists’ hopes of waiting to make the most of their data before sharing.  
Broader utilitarian losses arise.  Figure 4 pictorially depicts a conceptualized phenomenon 
which we name the “values-adherence gap”.  It shows good faith in data sharing and a 
reluctance to adhere as a fear of it.   
First, the values-adherence gap in data sharing is fuelled by reluctance to share data 
in spite of good faith and trust in the benefits of doing so.  The factors for reluctance which 
we sum in the model point to inequities in the environment, privileges, burdens, incentives, 
opportunities, and rewards.  
Sub-Saharan Africa has the least gross domestic product globally and the least 
support for scientific infrastructure (UNDP, 2016, G. Aellah et al., 2016, United Nations, 
2015). With 85% of households not connected to the internet (International 
Telecommunication Union, c2017), the region arguably has the least access to scientific 
journals and publications, much less Open Access Journals (L. Bezuidenhout, 2019). Post 
graduate student earnings in the North are often three to four times higher than young PhD 
graduate professional earnings in the South.  Young lecturers earn monthly salaries 
equivalent to about USD1200.00 immediately following PhD studies, a figure two to three 
times less than what they earned as PhD students in Europe (Personal communication with 
two returnee-lecturers from Tanzania and Ghana, 2018; see 
http://www.snf.ch/SiteCollectionDocuments/Annex_XII_Ausfuehrungsreglement_Beitragsre
glement_E.pdf). 
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Figure 4: The values-adherence gap 
 
 
 
Computers and basic analytical tools and reference software such as EndNote which 
are easily available in Northern institutions at no cost to scientists must be bought by 
individual producer-scientists, out-of-pocket in the South (L. Bezuidenhout, 2019).  The 
implications of these challenges include slow speeds to write and publish as well as limited 
potential to access and share other scientists’ data.  Besides, scientists who invest personal 
incomes in research (limited though they might be) face raised magnitudes of the perils of 
losing data if mandatory sharing periods elapse before they can maximize publications. For 
them, concerns about override normative motivations towards taking the practice up as the 
right action (L. Bezuidenhout, 2019).  Under-resourced scientific environments thus impede 
adherence to data sharing in spite of scientists’ faith in it.    
Second, data which is under-utilized at first publication due to manual processes or 
use of sub-standard analytical tools holds the greatest potential for further analysis and new 
manuscript preparations because of their untapped knowledge-potential. Under-resourced 
scientists are the most likely to contribute such data because of the reasons earlier 
explained. When mandatory sharing times prove inadequate, producing scientists may get 
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catapulted to a field of stiff competition for use of their data with better resourced 
competitors, without rights or privileges (S. Dallmeier-Tiessen et al., 2014, S.  Hodson, 2013). 
The fear of ideas being overtaken by more resourced competitors in the subconsciously 
imposed and growing global professional race of “publish or perish” takes effect (L. 
Bezuidenhout, 2019, E. Pisani et al., 2018a, L. Ferguson, 2011, E. Pisani and C. Abouzahr, 
2010).  The corollary may include rushed thought processes and premature manuscript 
submissions as a means of reducing risks, perceived or real in adhering to data sharing 
requirements.  This values-adherence gap requires instituting protections such as data 
priority and exclusive user rights for producing-scientists.   
Third, preserving data in ways that make for effective aggregation and third party 
analysis without the participation of producing scientists requires interoperability provisions 
which are generally beyond the competencies of under-resourced individuals. Additional 
expertise like biostatisticians may be sought at an extra intellectual and financial cost.  This 
fuels the values-adherence gap: the involvement of additional expertise does not preclude 
need for the remaining work to benefit from the producing-scientists’ efforts; leadership, 
aspirations, and ideas. They must also remain linked to the initial intellectual goals of the 
project, demanding continuing attention from originating-scientists (L. Merson et al., 2016, 
D. Boyd and K. Crawford, 2012, E. Pisani and C. AbouZahr, 2010). Ignoring such onerous data 
sharing efforts may encourage the sharing of technically unusable data.  Therefore, scientists 
who go the extra mile to shoulder future scientists’ data needs by making data interoperable 
and accessible must be duly recompensed during secondary use. The scientific community 
could help bridge this adherence gap in two ways: institute data sharing rewards that have 
comparative professional weights to the current ultimate of authorship; or make quality 
data production a sufficient criterion for it. The “publish [paper] or perish” paradigm must 
shift to encapsulate “publish [data] or perish” (E. Pisani et al., 2018a, L. Merson et al., 2016,  
S. Hodson,2013, E. Pisani and C. AbouZahr, 2010), if the virtue of health research data can 
remain in its knowledge generation ability. 
Fourth, because of the relatively lower availability of trained health expertise, sub-
Saharan Africa like other poor regions is characterized by scientists who perform multiple 
roles and work under extreme pressures in congested health and or teaching facilities.  
There is fear that relatively better resourced researchers who are not simultaneously under 
similar conditions can quickly analyze and publish data before data-originators. A vicious 
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cycle ensues (Figure 2).  An intuitive response to this cycle may include the following: (a) 
holding on to data with plans of fuller use in manuscript writing; (b) delaying the submission 
of ready manuscripts until the highest number of manuscripts is ready for concurrent 
submission to retain control of data for as long as one is engaged in other roles; and (c) 
avoiding the publication of novel complex new ideas requiring release of copious data and 
perhaps metadata.  Not only can quality, depth, urgency, and novelty in finding critical 
solutions be sacrificed in this cycle, but there may be reduced capacity for training and 
imparting scientific writing skills to upcoming scientists who get caught in the cycle (U.S. NIH, 
c2016, U.K. MRC, c.2016, G. Aellah et al., 2016).  This reluctance-factor against publishing 
novel findings would perpetuate the already low scientific productivity from the region, 
reduce aggregated data availability for new knowledge, and slow down the region’s reach of 
the SDGs (United Nations, 2015). 
 
Figure 5: The vicious cycle of multiple roles and their effect on scientific productivity  
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5.3.1 Closing the values-adherence gap through principles-based solutions  
It is clear that the global health vision of optimizing health research data sharing for 
the common good is not by itself sufficient for promoting data sharing from under-resourced 
sections of the scientific community. Attention to the potential safeties and perils for data-
producing scientists need consideration (E. Pisani, et al., 2018b, E. Pisani, et al., 2016).  It is in 
the very nature of knowledge to be a public good, but data is not necessarily a public good, 
except when needed for health emergencies (E. Pisani, et al., 2018).  Mandatory sharing of 
what is not necessarily a public good attracts diverse individual valuing options. Calls for 
obligatory data sharing should therefore be considered within a broader context beyond 
promoting science. It must necessarily target areas of intervention that focus on the 
individual:  Attention is necessary to promote the interests of scientists who make both the 
science and data for making this science possible (L. Merson et al., 2015).   
Although there may be much good will in data sharing, many scientists do not wish to 
simply share data. They wish to benefit from other scientists’ data, the journals publishing 
them, and to contribute constructively to matters arising (U. Schuklenk, 2018, L. Merson et 
al., 2015).  They thus want their scientific interests protected and to make positive net gains.  
The data sharing aspirations will develop lopsidedly until and unless the scientific community 
formally acknowledges this. 
A key strategy for addressing the issues raised and promoting data sharing with sub-
Saharan Africa is through a framework of ethical principles, rules that are universal, 
desirable, and feasible for general implementation.  The relevant actors include scientists, 
research institutions, funders, open-science advocates, regulatory bodies, and 
journals/publishers.  We propose six principles to help reflect on how the burgeoning new 
culture could be grown differently.  The principles are (1) Justice; (2) Respect for scientists 
whose data are shared; (3) Minimizing risks; (4) Maximizing benefits; (5) Collaborative 
partnership; and (6) Transparency.     
5.3.2 Justice  
Synonymous with fairness and equity (T.L. Beauchamp and J.F. Childress, 2001), this 
principle could be expressed in the new data sharing culture via respect and reciprocity 
among scientists.  Applying the principle requires the general benchmark of treating 
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unequals unequally.  Scientists receive different levels of support in the research 
environment that they work in.  Until such support becomes comparable, scientists will 
remain unequal as far as data sharing governance is concerned.  Research environments 
characterized by limited sponsorship necessitate support to reduce personal individual-level 
research investments.  Personal investments encourage perceptions of data as “owned 
property”, a concept that is far from data sharing ideals (Anane-Sarpong et al., 2018, M. 
Brack and T. Castillo, 2015, L. Ferguson, 2014, A.M. Capron et al., 2009).  Yet, ownership 
claims constitute genuine entitlements that should not be ignored from the data sharing 
discourse either. This is because when a scientist finances, resources, generates, and 
preserves data in formats useable by others, they are entitled to some basic rights to 
“ownership”.  So then, how much tolerance can be given to such entitlements, especially 
when perpetuated by global inequalities and most impacting on individual scientists?  What 
role can the different actors play in addressing it?  We can borrow protocols from the 
pharmaceutical arena that direct that well-meaning ethical science should not encourage 
free-riding or disproportionate benefiting off the investments of others (L. Diependaele, 
2017, S. Hodson, 2013, E. Pisani et al., 2010).  Under-resourced scientists risk losing their 
“investments” or utility of their data too soon.  Their data may also be under-utilized 
because of technological limitations to data analysis and usability (E. Pisani et al., 2016).  
They need protections (L. Bezuidenhout, 2019). 
We propose that the principle, Justice be actualized via formal attempts by 
journals/publishers, regulatory bodies and where applicable, funders to vary the periods 
required for mandatory sharing (E. Pisani et al., 2018a) and incorporate negotiable levels of 
privileges including data exclusivity.  Protected periods will grant temporary exclusive user 
rights to data-originators as is used to protect drug originators against unfair commercial use 
(L. Diependaele, 2017).  
As regards the systemic challenge of limited access to journals and articles “published 
out of reach” for many under-resourced scientists, we take cognizance of the efforts of some 
publishers and the WHO to increase accessibility and affordability for scientists from the 
South (U. Schuklenk, 2018). However, the imbalances that remain are enough to still render 
the sharing culture unfair.  In light of this, a sub-principle of Justice, Reciprocal Justice is 
implicated in requiring actions that make appropriate return on gains made (A.M. Capron et 
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al., 2009, T.L. Beauchamp and J.F. Childress, 2001).  It can be applied in data sharing if 
requests for data are made to proceed on case-by-case or solicited-basis rather than 
uncontrolled, unrestricted, open, and free access (Committee on Data for Science and 
Technology, 2014).  This gives opportunity to prospective users to negotiate data sharing 
with data-originators. The involvement of the latter will likely increase obligations to 
reciprocate efforts. This will promote inclusivity in knowledge creation (G. Aellah et al, 
2016).  
The foregoing proposals do not preclude other forms of compensation outlined 
below to compensate for secondary use of other scientists’ data.  This is particularly 
warranted if users require datasets in whole to address new research questions.   
Another application of the principle of Justice is for the public and funders to extend 
sponsorship to all quality research thereby reducing demands on individuals to fund 
research out-of-pocket.  This is because compliance with data sharing is significantly 
dependent on available financial and technical resources (L. Merson et al., 2015).  Justice 
must also support the protection of young and or busy (slow) scientists in the critical post-
first-publication period when perceived and real risks of losing data are greatest. Even where 
this risk is barely perceived, its interpretation could be informed by traditions and concerns 
which nonetheless influence actions and reactions to mandatory data sharing (L. 
Bezuidenhout, 2019). Justice will increase the generation of new ideas from otherwise 
under-producing scientists, assure equity in the new culture, and show empathetic 
recognition of effort and the stumbling blocks that handicap scientists’ own exploitation of 
data.   
 
5.3.3 Respect for scientists whose data are shared  
The principle of respect is generally underlain by values of dignity and considerations 
for the welfare of the “other” (T. Metz, 2010).  In relation to data sharing, it relates best to a 
conscious recognition of the efforts of all who share data and considerations that benefit 
them.  At the point of first publication when health data is intellectually prepared, analyzed, 
and ready for secondary use, user-scientists have much effort and cost taken off their work.  
The now smaller (not necessarily inclusive of metadata) datasets require minimal processing 
and fewer resources to translate into new knowledge.  By this principle therefore, we 
 
 
 
 
87 
advocate for recognition and subtle rights of producing scientists to benefit from all 
potential arising from the data they share.   
Many cite acknowledgements and citations for such effort, but other forms of 
recognition are more commensurate.  In agreement with Pisani and colleagues (E. Pisani et 
al., 2018a, Pisani et al., 2016) that prioritizing the recognition of publications need not 
preclude other deserving efforts in science, we appeal for international backing from the 
global academic/scientific community, including institutions to the inclusion of quality data 
production in the assessment of scientists’ suitability for research career progression.  Other 
professional incentives can be created and given international recognition.  Respect for 
scientists who share data should therefore revolve around recognition, incentivization, and 
motivation (E. Pisani et al., 2018a, L Merson et al, 2015). to ensure continuity of quality data 
production, especially from the most unreached sections of the research community.   
5.3.4 Minimizing risks to scientists who share data 
It is our view that some of the risks outlined stem from sheer unfamiliarity with the 
data sharing concept and its potential benefits.  For these, training and resourcing may be 
adequate (L. Bezuidenhout, 2019, L. Merson et al., 2015). Participation would help change 
perceptions and the fear factor too. Our focus is however, on risks revolving around unfair 
competition.  Ethical sharing necessitates the removal of anything unfair that is preventable 
and in this case outweighs potential benefits (E.J. Emanuel et al., 2004). Scientists are 
generally not a population who needs protection.  The literature rarely discusses risks they 
face and where mentioned are downplayed in order not to sound patronizing of the noble 
profession.  Mandatory data sharing in spite of systemic and professional inequalities is a 
recipe for vulnerabilities in research and sharing relationships.  Yet, even apart from major 
research funders in the region that are overt with their sanctions (E. Pisani et al., 2018b), 
mandatory data sharing is inherently punitive when compliance is non-negotiable. As the 
under-resourced regroup, rethink, and re-plan additional manuscripts, they would require 
protections including periods longer than the proposed six months after publication (E. 
Pisani et al., 2018a, D.B. Tiachman et al., 2017).  Institutions, publishers, and data 
repositories may further grant priority access and exclusive use during these periods.  In the 
absence of such considerations, losses on data use to more resourced user-scientists are 
unjustifiable.  The pressures and genuine strain on producing scientists should compel 
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flexibilities in mandatory data sharing periods.  This recommendation is especially relevant in 
minimizing risks following a project’s first publication.  
Other ways of relaxing the risk of “use or lose” include requirements for data-
originators to be notified about other scientists’ intentions to use their data.  At systems’ 
levels, funders could also consider adding substantial investments into building analytical 
capacities and infrastructure across academic institutions to ease researchers’ efforts and 
support those for whom analyzing data is problematic (L. Bezuidenhout, 2019, E. Pisani et 
al., 2018a)  Incentives could also be made available for private researchers whose data are 
consciously and consistently made usable.  As perceived and real risks are reduced, 
hesitations to share will decrease (L. Bezuidenhout, 2019). 
 
5.3.5 Maximizing benefits to scientists who share data 
For an endeavor to be ethical, its benefit to risk or cost evaluations must necessarily 
be positive (E.J. Emanuel et al., 2004). Benefits necessarily form the flip side of risks or costs.  
The value of data sharing is therefore justified by its benefits.  
We earlier explained data sharing hesitations that stem from dissatisfaction with having 
producing and using scientists on two sides of an incentive-dichotomy that 
disproportionately benefits the latter.  We also suggested support for rewards and 
recognition to be equitably spread across data production through to knowledge creation, 
regardless of whether the research process is a continuum or separated by different actors.  
We have also made the case that quality data production already has intellectual properties 
from contributing scientists that deserve high valuing.  These arguments point to the 
persuasion that sharing data must be accompanied by reward.  Need for a benefit model is 
thus a matter of both Justice and Beneficence -moral obligation to act for the benefit of 
others- (D.J. Hurst, 2016, T.L. Beauchamp and J.F. Childress, 2001).  We therefore suggest 
the following beneficent options as critical for promoting quality data production: co-
authoring opportunities, global recognition, professional promotions, partnering for mutual 
exchanges of data, cost-sharing, training, and skills strengthening.  We wish to emphasize 
that closing the research-output gap can be helped if quality data that solely supports 
successful peer-reviewed secondary publications can be considered as containing adequate 
intellectual content to justify originating-scientists’ authorship status (Anane-Sarpong et al., 
2018).  Additional contributions may be warranted in accordance with the ICMJE’s 
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authorship requirements (ICMJE, c2017), but the discussion should at that point be left to a 
matter of author ranking than possibility.  Ethics committees and research institutions 
should give this recommendation their backing to make data sharing more attractive for the 
South.  
 
5.3.6 Collaborative Partnership 
The complexities of contemporary health issues, the uncertainties surrounding data 
from unfamiliar contexts, and the need for diversity of ideas necessitate collaboration (S. 
Bull., 2016).  When scientific teams of diverse backgrounds collaborate on research, the 
quality, quantity, and rigor improves. Team effort, networking, and large scale analysis help 
build critical pillars for future research. The principle of Collaborative Partnership, especially 
across the North-South divide is important for data sharing in the following ways: (1) it is 
effective for diversifying, respecting, and encouraging different types of knowledge and 
processes of their creation; (2) minimizing “data ownership” claims for smoother and early 
sharing of data; (3) encouraging the formation of formal and informal sharing networks in 
which mutual analysis of one another’s data can increase scientific productivity (e.g., closed 
consortia, trust-based networks, and small-scale internally-funded institutional repositories); 
(4) improving the responsiveness of new analysis to the health needs of communities from 
whom data originated; and (5) strengthening attachments, impact, and commitment to 
translate findings into policy and tangible health products.  These advantages in-turn 
strengthen collaboration within and across the sub-region’s institutions and scientists as 
seen in the INDEPTH experience, the Global Health Network which shares research data 
across many low and middle income countries (INDEPTH, 2013, E. Pisani et al., 2018a, E. 
Anane-Sarpong et al., 2018a,  E. Anane-Sarpong et al., 2018b) and several other research 
facilities for instance in Kenya and South Africa (L. Bezuidenhout, 2019).  
Emanuel and colleagues (2004) outline several benchmarks of Collaborative 
Partnership relevant in application to data sharing with sub-Saharan Africa.  Key among 
them is the determination of research value, responsibilities, equality in partnership, 
respect, and benefit sharing.  The Council on Health Research for Development’s Research 
Fairness Index (COHRED, c2017) also provides guidelines, tools, checklists, and agreement 
templates that can complement the implementation of the principle.  What remains is for 
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the international regulatory organs to reflect on adapting the relevant provisions into a 
globally accepted principles-based data sharing framework.  Collaboration in data sharing 
will however, not always be possible or practical.  Prospective producer-scientists could be 
controversial or in disagreement with new research plans (D.B. Taichman et al., 2017).  
Therefore, while the principle remains largely desirable (D.B. Taichman et al., 2017, S. 
Dallmeier-Tiessen et al., 2014), producing-scientists should be left to make good faith efforts 
to work effectively with user-scientists who express interest in their data.  Much however, 
depends on user-scientists to notify and make opportunities for collaboration available and 
discoverable. Collaborative partnership is also strengthened through Reciprocal Justice.  This 
requires setting obligations for reciprocation on the part of user-scientists corresponding to 
whether data is required to be released or shared in partial or complete forms.  In 
anticipation of unequal intellectual contributions, written agreements are helpful.  We 
strongly recommend that except where the aim of secondary analysis and new manuscript 
writing from shared data is to challenge original results or where major conflicts of interest 
exist, Collaborative Partnership should be promoted or subtly mandated by Journals and 
data repositories.  
5.3.7 Transparency  
For shared data to be Findable, Accessible, Interoperable, Reusable (FAIR), Equitable, 
Ethical, and Efficient as advocated by public health research funders in 2010 (E. Pisani et al., 
2018a, E. Pisani et al., 2018b), the principle of Transparency is necessary.  Transparency 
encapsulates trust and accountability (E. Pisani et al., 2018, E. Pisani et al., 2018b, L. Merson 
et al., 2015) in an intricately woven fashion.  Transparency enhances trust in assuring 
fairness; trust motivates accountability by assuring that data sharers and users take 
cognizance of each other’s risks and benefits; and the process altogether enhances trust and 
motivates further transparency towards accountability.  If data shared can be trusted, 
scientists who share them must be trustworthy; trustworthy scientists are likely transparent 
and accountable.  A virtuous cycle ensues. Yet, Transparency will likely not come naturally to 
the culture of freely available data after first publication, especially among unequal 
scientists.  Experiences reported in the literature of researchers’ low commitment to 
research participants following completion of research (E. Anane-Sarpong et al, 2018b, R. 
Purvis et al., 2017, D.J. Hurst, 2016) are suggestive that commitments to originating-
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scientists will generally wane once data is available. Commitment generally wanes when the 
object of attraction is reduced or moved; if data can be gotten without its originator, any 
commitments to the latter will reduce or vanish. The situation worsens with distance, non-
familiarity, and the absence of guidelines (S. Molyneux et al., 2016).  Only international 
regulation can elicit the kind and scope of adherence needed to remove this challenge. 
Overall, in noting that mandatory data sharing requirements presuppose a certain 
level of equality towards compliance, transitioning to the new culture should necessarily be 
guided by further reflections around inequalities, opportunities, privileges, benefits, and 
incentives.  Voices from relevant authorities’ in sub-Saharan Africa are critical because of 
successes and challenges in the region that may not be familiar to the North, where most 
global scientific actors are based (E. Pisani et al., 2018a, E. Pisani et al., 2016).  Besides, there 
has been a marked absence of empirical engagement with scientists from the region on data 
sharing (L. Bezuidenhout, 2019).  Any planned international guidelines will thus benefit 
from the early involvement of research ethics committees and scientists in the 
South before the data sharing rules get established. 
5.4 Conclusion 
Mandatory data sharing signifies the future standard for best ethical science and is 
critical for the growing technological dispensation and the generation of new knowledge.  It 
offers hope for new opportunities, innovations, relationships, and products that can improve 
health and save lives at minimum costs and optimum speed.  Yet, it is clear that the strong 
global health vision of optimizing data sharing for the common good alone is not sufficient 
for good faith adherence. Particularly for sub-Saharan Africa where several generative issues 
impede the realization of favorable risk-benefit ratios in data sharing, the culture may not as 
yet be favorable relative to their expected outcomes.  It is our view that the absence of 
established guidance to correct existing imbalances also makes acceptance, adherence, and 
promotion difficult.  Motivating appetite for data sharing under unequal circumstances will 
therefore not come naturally; the change must be spurred by technology, new beliefs and 
norms, and incentives. It requires transformative steps that are persuasive of increasing 
scientific productivity from the South, maximizing benefits and minimizing risks, respecting 
stakeholders, reciprocating effort, encouraging collaboration, and exhibiting transparency.  
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The six ethical principles proposed will help address these by providing protections for the 
under-resourced scientists in the South, improving the realization of various scientific 
aspirations, access to technological infrastructure, helping close the global research-output 
gap and accelerating the South’s reach of the SDGs through research.  On our part, 
conducting a future empirical study on the application of the principles would provide 
additional insights into the discussion to complement this paper.  
5.5 Declarations 
5.5.1 Conflict of interest 
The authors declare no conflict of interest. 
5.5.2 Acknowledgement 
This paper was written as part of an academic project made possible with support 
from the Institute for Biomedical Ethics (IBMB) and the Swiss Tropical and Public Health 
Institute of the University of Basel.  Partial funding for the project came from the Basel-Stadt 
Commission for Scholarships for Young Professionals from Developing Countries.  We are 
grateful.  We wish to also thank the anonymous reviewers of this journal for their critique 
and comments on the earlier version of the article which has made the final product better. 
 
 
 
 
93 
6.0  Improving public health in sub-Saharan Africa through optimal  
ethics in database research: perspectives from Ghana and 
Tanzania 
This manuscript is under the review by the Journal of Public Health in Africa (JPHiA). 
  
 
 
 
 
 
94 
Improving public health in sub-Saharan Africa through optimal 
ethics in database research: perspective from Ghana and Tanzania 
Anane-Sarpong Evelyn,1,2,3  Wangmo Tenzin,1  Tanner Marcel,2  Sankoh Osman,,4,5,6,7  Elger 
Bernice1 
 1 Institute for Biomedical Ethics, University of Basel 
2 Swiss Tropical and Public Health Institute, University of Basel 
3 School of Medical Sciences, University of Cape Coast 
4INDEPTH Network, Accra, Ghana 
5 School of Public Health, University of the Witwatersrand, Johannesburg, South Africa 
6 Faculty of Public Health, Hanoi Medical University, Hanoi, Vietnam 
7 Department of Mathematics and Statistics, Njala University, Njala, Sierra Leone 
 
Expected Citation: Anane-Sarpong E, Wangmo T, Tanner M, Sankoh O, &  Elger B.S.  
Improving public health in sub-Saharan Africa through optimal ethics in database research:  
perspectives from Ghana and Tanzania.  Journal of Public Health in Africa.  
  
Impact: The JPHiA jointly publishes the Journal with the Africa Centers for Disease Control 
and Prevention (Africa CDC). JPHiA has since January 2019 become the official publisher of 
Africa CDC 
 
 
 
 
 
95 
6.1 Summary of the submitted paper under review 
Sub-Saharan Africa has an urgent need to increase scientific productivity to promote 
public health and global health.  The region is however bedeviled with limited research 
resources and worse, is largely dependent on external and dwindling support.  The situation 
calls for innovative solutions that can survive the region’s systemic challenges which are 
beyond solving in the short term.  In terms of research in public health, many possibilities 
exist for combining archived clinical and public health databases from designated 
communities in place of the more costly collection of large scale data for such research.  To 
this end, longstanding public health institutions such as HDSSs which have since the 1940s 
(Y. Yazoume et al., 2012) been collecting such data hold a key to the future of public health 
research in the region.  This is because these systems incorporate routine and scheduled 
longitudinal data collection from designated local hospitals and communities, resulting in 
large volumes of longitudinal databases that are traceable to their respective populations (K. 
Herbst et al., 2015, O. Sankoh, 2015).  HDSSs already undertake research using both the 
public health data they have accumulated, processed, aggregated, and sometimes curated 
and sometimes, in addition to prospective data.  This article, as in the remaining articles in 
this thesis, refers to such research as research using public health data (RUPD).   
What is critical to note however, is that in spite of the prospects of RUPD for the sub-
region, its genre of research is yet to be made whole, formalized, and excellent.  Its 
processes are yet to attract the fullness of ethical resources and deliberations at the 
international level.  Therefore, as expected of contexts with less well established, less 
effective, and developing legal and ethical infrastructure, the scientific community risks sub-
optimal ethical benefits from the furtherance of RUPD, particularly in the Global South and 
sub-Saharan Africa where ethical development is generally young.   
We conducted face-to-face interviews in Ghana and Tanzania with 46 key informants 
who were varied by fields of expertise, ranks, roles, and institutions to improve diversity. The 
study attracted a response rate of 92% of all invitations sent out.   The enthusiastic response 
from busy scientists is quite suggestive of an acknowledgement of the relevance of the issue 
to them.  Indeed, the high interest on the part of practitioners and research stakeholders to 
reconsider ethical practices in relation to RUPD is particularly significant because it is these 
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researchers who specialize in the methodology, understand what ethical processes do to 
research processes, and hence must bear the privilege and responsibility of finding the right 
ethical standard for its quality and rigor.  The interview data was thematically analyzed.   
Our findings in this article also pointed to the substantial consensus that the practice 
of RUPD in sub-Saharan Africa introduces nuanced ethical dimensions for which current 
international guidance is, at best, narrow.  Participants also noted that international 
provisions for ethical review of the methodology are still generally unclear and inadequate.  
More interestingly though, there was acknowledgment that following 70 years of the UN 
Declaration of Human Rights, a key foundation of research ethics, old pledges such as 
"health for all” (United nations, 2015, WHO c2017) must invoke thoughts like “bioethics for 
all”.  Hence, in reference to HDSSs, public health activities, and RUPD, that extrinsic need for 
something ethical, new, and appropriate remained justified.  Contributions by participants 
reflected fresh insights into the following questions pertaining to research ethics in RUPD, 
the generic nature of ethical guidelines for it, and optimal bio- and public health ethics in 
general: 
 What ethical obligations are appropriate to make of RUPD researchers? 
 How might RUPD optimize social value/beneficence to communities?  
o How can researchers be encouraged to optimize data cycles to increase 
social value? 
 Which technology-based risks are important to consider in RUPD ethics? 
o What considerations are acceptable for assessing risk-benefit ratios when 
benefits could be generally “far-fetched”? 
 What considerations are necessary to ensure fairness to communities who supply 
data? 
 How can less elaborate forms of informed consent like group consent be 
implemented to achieve the greatest good in RUPD? 
o What standards can be used to assess the effectiveness of group consent 
in communal and non-communal systems? 
The article synthesizes the study findings from the various answers received to the above 
questions for further reflections.  Our initial deliberation on the matter first led us to align 
the ideas and views on the way forward to the principles of the Emanuel Framework (EF).  
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Further reflections resulted in an evaluation of our decision and a subsequent conclusion 
that the EF was less exacting for RUPD largely as a result of it being designed for clinical 
research.  We therefore propose modest adaptations.  We also make a strong 
recommendation for the international scientific community to engage with what we have 
begun as a modest starting point for further reflections.   
The main proposal we make in the paper encapsulates six ethical principles proposed by 
our key informants to assure the quality and rigor RUPD needs.  The principles are described 
in the following order of importance, based on participant’s views and the emphasis they 
placed on discussions surrounding each principles: (1) Scientific and ethical review of RUPD; 
(2) Social value; (3) Risk reduction; (4) Scientific integrity; (5) Collaborative partnership; and 
(6) Respect for study populations.  For ease of implementation, ethics committees would 
need, upon further deliberation, to re-frame new guidance via standard operating 
procedures at the local levels for RUPD.   They would also need to re-orient scientists about 
the new framework and practice in the overall quest to optimize ethics in RUPD as part of 
achieving optimal benefits in public health and research in sub-Saharan Africa.  
Our strongest opposing argument to scholarly opinions in the article centers on 
general proposals for narrowing ethical application in database studies (S.S. Cargill, 2016, J. 
Sim and A. Dawson, 2012).   The article submits that while such suggestions may apply to 
RUPD in sub-Saharan Africa and could be scientifically healthy, they fall short of helping 
achieve universality in the optimal realization of bioethics and its benefits first for the 
methodology and most especially for the “naive” research populations (in terms of research 
ethics development and application) in these contexts.  
We finally disclaim in the article that as it is with all qualitative studies, the interview 
data contained subjective notions for which the analytical processes may sometimes have 
seemed multifarious and vague (J. Ives at al., c2017).  Determining objectivity was thus 
sometimes elusive.  However, we assure readers that we did our utmost best to reduce 
biases through reflective and iterative processes which we explain in detail under the 
materials and methods section of the article.  Some quotes were also of answers that 
seemed indirect or deviating from the substantive questions asked.  These quotes were still 
used and supported based on emerging writing innovations that may be challenging for 
those not familiar with qualitative research (J. Ives at al., c2017).  We fully acknowledge that 
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although the respondents were varied by fields of expertise, ranks, roles, and institutions to 
improve diversity, the results and conclusions may not necessarily be transferrable to all 
contexts in sub-Saharan Africa.  These limitations regardless, the findings espoused in this 
article when published, will inspire more ideas about optimal alternatives for promoting 
ethics in RUPD.   
6.2 Future research proposed in the article 
We noted our firm belief and continuing advocacy that there is good cause to 
promote optimal ethical practices in all kinds of research, regardless of methodology.   
Concerns to the contrary may be several in the literature, but are mostly theoretical.  More 
empirical quantitative evidence is needed to ascertain whether those arguments that 
research ethics principles pose obstacles to non-traditional research or our proposals form 
the overall project reflected in this article and the overall thesis could indeed promote equity 
in public health and global health through research ethics.  Our study findings therefore set a 
good platform for more empirical enquiries, particularly from different contexts in the 
Global South towards these ends.  
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7.0    Discussion 
7.1 Outline 
This chapter provides a composite explanation of the perspectives collated from both 
the quantitative survey and the qualitative interviews in order to bring the primary and 
secondary aims of this project to a coherent whole.  First, the discussion focusses on how 
RUPD aligns with and how it evades existing research ethics guidance and traditional ethical 
practices such that the resultant vacuum created can be filled.  The discussion then shifts to 
an examination of issues related to data sharing in RUPD with a focus on data-producing 
scientists of the Global South, represented by HDSS practitioners in sub-Saharan Africa.  The 
latter discussion delineates the risks of the new technological data environment for these 
scientists relative to the ongoing data sharing deliberations spearheaded largely by 
stakeholders including open-science advocates, regulatory bodies, and journals and 
publishers (U.S. NIH, c2016, OECD, 2013, H3Africa, 2016, European Commission, 2016).  The 
overall goal to this part of the discussion is to examine whether ethical safeguards are 
necessary to protect the interests of scientists and ultimately RUPD.   
  This thesis is focused on perspectives shared mostly by African stakeholders.  The 
qualitative data was largely collected from stakeholders in Ghana on the west coast of Africa 
and Tanzania in the east.  Data forming the quantitative part was collected in Ethiopia, but 
with the participation of delegates from 16 countries apart from Ghana and Tanzania.  The 
three core participating countries, Ethiopia, Ghana, and Tanzania, serve appropriately as 
under-resourced contexts in the South with several HDSS-RUPD among them.  They are also 
characterized generally with ethical structures that are at developmental levels as well as 
populations that are relatively naive to research ethics.  Participating practitioners were 
selected on the basis of their knowledge, interest, and or involvement in public health and 
its related disciplines associated with RUPD; membership with RECs which have oversight 
responsibilities in HDSS-RUPD; and independent experts knowledgeable about the current 
practice base of RUPD as well as general developments in research involving HDSS data.  On 
the basis of the findings from these scientists and key stakeholders, I argue that the fast 
developing technological world that supports RUPD fails to offer both an adequate frame of 
ethical applications in RUPD and a fair field of competition in the scientific community for 
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under-resourced data producing scientists.  I therefore make a case for what is needed to 
build ethics for RUPD and also for data sharing. 
7.2 RUPD and research ethics application: Conceptualizing new ideals for 
safeguarding research populations’ interests and wellbeing 
 Findings from the quantitative survey analysis involved 130 effective 
respondents from countries represented at the 2015 INDEPTH Scientific Conference in 
Addis Ababa, Ethiopia.  They also include in-depth insight from the interviews with the 46 
key stakeholders.  They indicate general support for making more out of public health data 
beyond the narrower purposes for which they are collected (CIOMS, 2016a, S. Bull et al., 
2015, Public Health Ontario, 2012) by using such data for research and other purposes.  RUPD 
is thus established and acknowledged as public health research.  What remains less 
established is knowledge and practice in respect of the ethics of this research (RUPD).   Its 
methodological and contextual differences from both traditional and database research and 
the limited availability of international ethical provisions and scholarly input for them posit 
perceptions of low thresholds in the ethics of RUPD.   
The closest and arguably best known comparable research to RUPD is database 
research.  They have similar methodology, but scholarly literature on the ethics of database 
research is better known and advanced.  It generally limits ethical practice to REC review and 
to a lesser extent, permissions of custodian-institutions and protection of confidentiality and 
privacy (CIOMS, 2016a, U.S. NIH, c2016, A.M. Capron et al., 2009, H3Africa, 2016).  In the 
absence of any other alternative guidance, RUPD ethics is presumed to follow the same lines 
of database research ethics.   This thesis has sought to make a contrary argument to this 
presumption and practice.  In line with this and to solidify my ultimate argument in justifying 
the need for this thesis, it is important to bring back to mind the huge successes that 
research ethics has brought to traditional research over the past six decades.  Further, we 
should consider the impact of such successes on the welfare of research participants 
(Grodin, 1992, World Medical Association, 2013, CIOMS, 2016a).   It is equally important to 
note that since implementing research ethics principles is still not challenge-free even in the 
older paradigms and genres of research which characterize the biomedical field (CIOMS, 
2016b), there should be no discouraging of optimal ethics in RUPD on the basis of 
challenges.  The goal as has and will continue to always be for the scientific community is to 
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aim for the best possible practices by setting ideals which stakeholders can use to evaluate 
their conduct and those of others in the quest to optimally reach global health goals.   
7.2.1 Structural differences between RUPD and other research methodologies  
             matter  
Participants in this study explained the unique features of the HDSS that warrant 
ethical possibilities beyond what is commonly known and accepted for database research.   
An important difference unearthed in the course of discussion lies in the characteristic 
routine house to house visits and the sustained re-contact with the people to collect data on 
quarterly, biannually, or annual basis.  The empirical views discussed in Chapters 3 and 6 on 
how this feature changes the dynamics of RUPD ethics relative to database research ethics 
reinforce the theoretical arguments I make in this thesis for optimizing ethics for RUPD.   
Per participants’ observations, the differences between practicing research ethics in 
RUPD and what is generally known for other health research involving humans in real time 
pertains largely to what, how, and when the research ethics principles are needed as well as 
pragmatic ways to deal with the challenges of impracticalities (S.S. Cargill, 2016, J. Sim and A. 
Dawson, 2012).  None of the participants objected to any of the ethical principles per se.   As 
explained below, independent review which is mostly the purview of RECs; beneficence and 
social value for the common good; non-maleficence as expressed in collective risk 
assessments; fair assignment of the data of different communities to address RUPD 
questions; and informed consent representing respect for persons and community 
engagement (E.J. Emanuel et al., 2004, T.L. Beauchamp and J.F. Childress, 2001) were the 
most notably perceived as necessary for RUPD ethics.   Challenges they posed in practice 
were not uniquely different from the known ones in other health research and thus possible 
to overcome with a little ingenuity.   
The challenges observed centered on the sheer number of subjects or participants 
involved in RUPD due to its population based characteristic; the inseparable link between the 
public health activity (HDSS) that provides RUPD data and RUPD; the longitudinal nature of 
the HDSS; and RUPD’s database methodology which is deemed straight-forward and free of 
human (research participant) involvement at the point of conduct.  These same 
characteristics underline the arguments in the literature that support the waiving of core 
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research ethics principles in many epidemiological studies, database research, and public 
health in general (S.S. Cargill, 2016, J. Sim and A. Dawson, 2012 , R. Bayer and A. Fairchild, 
2004).  However, even the closest specific public health methodologies to RUPD such as 
biobanks (of the genre of database research) and cluster-randomized research have major 
structural and paradigmatic differences from RUPD that do not enable effective comparison 
and a simple translation of their ethical provisions to each other (S.S. Cargill, 2016, J. Sim and 
A. Dawson, 2012 ).  My work has provided empirical evidence of these differences to 
facilitate the argument for ethics in RUPD to be allowed to thrive beyond reservations about 
impracticalities theorized in the literature.  It has further shown that the HDSS has a larger 
structural, contextual, and methodological frame within which research ethics principles can 
be rendered practical for RUPD.    
7.3  Conceptualizing ethical principles for RUPD 
7.3.1 Independent Review 
Independent review which is generally normalized through REC review was deemed 
the least debated and most feasible research ethics principle for RUPD.  It was also deemed 
the most relevant for RUPD. As evidenced in Chapter three however, perceptions that RUPD 
does not constitute “research” are substantial among practitioners.  The corollary is that 
decision-making around seeking REC review for RUPD is influenced by whether a researcher 
deems it research or a part of their routine public health practice.   Perhaps this perception 
that RUPD is not research is one of convenience to avoid the hurdles of seeking REC review, 
but even the majority who said they would apply for REC review for RUPD also had 
reservations.  They largely complained about inadequacies in known ethical provisions 
(international and national guidelines) for it as well as challenging REC processes.  They 
explained the latter challenge as that REC processes for RUPD were not standardized or 
worse, too cumbersome for research “as simple as RUPD”.  Therefore, in the absence of a 
specific international ethical guidance framework for RUPD, the virtuous scientist is left to 
locate relevant portions of different guidelines and use discretion on what is ethical to 
observe.  Even then, they found these relevant provisions in international guidelines unclear 
and thus inadequate as an ethical guide.  Consequently, scientists would look for the least 
burdensome ethical approaches, if any to consider relevant for RUPD.  Such decisions often 
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favor utilitarian choices, that is,  seeking to make the most output, gains, happiness or other 
goals perceived as “good” while making the least of or avoiding losses, risks, and burdens 
which are collectively deemed “bad” (T.L. Beauchamp and J.F. Childress, 2001).  These kind 
of decisions concerning consequentialist ethical approaches speed science, but I ague that 
they also relegate ethical issues of comparable worth like the “good” of the research 
participant or the community to the background.    
REC member-participants in this study also reported their challenges in the review of 
RUPD.  They were sometimes similar to the challenges associated with RUPD conduct, that 
is, issues flowing from the distinctions between RUPD and routine health research and the 
non-specificity of ethical guidelines for the nuances between them.  More critically 
expressed however, was the effect of poor technological resources available to RECs to 
enable effective monitoring after RUPD is approved.  To them, the characteristic digital 
nature of contemporary datasets which can be rapidly duplicated, stored in many places 
across the globe at any one time, and be used and shared simultaneously for multiple RUPD 
requires a level of review and monitoring that the South and sub-Saharan Africa in particular 
is not ready for.  Further, if REC review is the main research ethics requirement of RUPD but 
informed consent is assumed impractical, then RECs must assume a stronger responsibility 
to safeguard the interest of the participants and communities as a core part of RUPD ethics.  
To do this, a specific framework for review is needed either separately or as a part of their 
standard operating procedures.   
7.3.2  Beneficence and social value for the common good 
Beneficence (T.L. Beauchamp and J.F. Childress, 2001) and social value (E.J. Emanuel 
et al., 2004) are linked in research ethics by their common end of “value in research” 
(CIOMS, 2016a).  In respect of either principle, beneficence or social value which may be 
used synonymously in many public health research contexts in their ultimate aim at the 
common good, there is an imputed obligation to provide value and benefit to RUPD 
participants.  This obligation is also underlined by a broad reference to the values of 
reciprocity and justice (Kass, 2001, G. Marckmann et al., 2015, E. Vayena et al., 2015).  Both 
principles are acknowledged by the study participants as relevant to RUPD in that populations 
who supply data to enable RUPD must in turn be benefitted in kind.  Implementing benefits 
can however, be addressed more realistically at the community rather than individual levels 
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(common good).  Four main challenges were emphasized: (1) the general “abstract” nature 
of potential RUPD benefits to participants; (2) under-utilization of data in generating new 
knowledge to benefit local populations; (3) sub-optimal realization of result translation into 
policies and health outcomes; and (4) poor dissemination practices that minimize the impact 
of research on the populations’ health.  These issues are also indicative of an increasing view 
that increased scientific productivity or publications do not necessarily benefit populations, 
unless they serve as a means of promoting public health and global health.  Ultimately, they 
must aim at the more macro goals of SDGs.  Dissemination of RUPD findings to communities 
and to local authorities involved with health policies (A.M. Capron et al., 2009) was therefore 
supported as a critical and realistic RUPD benefit.  It can be practically implemented in RUPD 
by using the routine house to house visits and the re-contact with participants that HDSS 
visits allow.  Dissemination of RUPD findings must therefore be included in minimal ethical 
requirements for RUPD.   
I strongly urge that as the region with the biggest gap in attaining global health goals 
in spite of being home to high volumes of research, it is incumbent for sub-Saharan Africa to 
mandate RUPD scientists and institutions to balance interests in publications in peer 
reviewed journals with local dissemination of results to participants.  This would not only 
satisfy beneficence and social value, but social justice and reciprocity (T.L. Beauchamp and 
J.F. Childress, 2001).  These would in turn uphold the principle of respecting the populations 
who contribute data to sustain HDSSs and RUPD (T.L. Beauchamp and J.F. Childress, 2001, 
E.J. Emanuel et al., 2004, G. Marckmann et al., 2015). It can therefore be argued as I have 
that at a minimum, beneficence is imputed in RUPD for its consequential values in global 
health.  Therefore, the obligation to disseminate new RUPD knowledge to communities 
should be raised to the status of clinicians’ duties to informing their patients.  Similarly, the 
rights of communities to know the results of RUPD can be equated to those of patients in 
the doctor-patient relationship. 
7.3.3   Non-maleficence as practiced via collective risk assessments 
Findings related to risks in RUPD were generally communal and centered on negative 
reporting of studies that could lead to stigma, discrimination, and stereotyping of 
communities.  Although the probability of such risks may be low in RUPD, participants 
explained that the magnitude of impact when they happened could be high because of the 
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commonality of facing risks collectively as communities in public health systems.  RUPD 
researchers should therefore be sensitive in their presentation of results, particularly to 
audiences who might be able to ascertain the identification of the communities.  Analysis of 
data by scientists who are unfamiliar and not connected to research populations are likely to 
remove connections to the data as well as commitment to minimize risks to the community.  
Besides, RUPD which is conducted away from its populations has reduced chances of being 
disseminated locally.  Therefore, important risks lie in the perceived failure of institutions, 
RECs, and regulatory bodies to adequately monitor RUPD oversight. This has been hinted on 
under independent review above, yet in relation to risks, it requires solutions in coordinated 
risk management because of Africa’s general challenges with technology and resources.   I 
therefore propose for instance, that the burden of responsibility for technological 
monitoring could be shifted to a selected REC rather than all RECs.  This way, the expensive 
technologies required could be made available to fewer institutions who can then be 
assigned responsibility for overall monitoring of issues thus related.   In other words, 
resourcing one REC per country for instance with the advanced technological digital software 
for data finger-printing, which is otherwise unavailable to critical research institutions, would 
enable the tracing and monitoring of data use elsewhere (N. Paskin, 2010, T. Lang, 2011) on 
behalf of the country and its research community.  
Related to the issue of data sharing, this proposal would ensure that scientists are 
better informed about the secondary use of data they publish to enable users contact and 
involve them in the analysis and report of new publications.  Such involvement would also 
assure the RUPD population of scientists they are familiar with who they can look to for 
information and new knowledge from RUPD.    
7.3.4  Fair assignment of communities to RUPD 
Ensuring fair assignment of communities to RUPD is yet another principle.  It has 
close links with risk minimization and scientific validity (E.J. Emanuel et al., 2004) because it 
directs the selection of datasets on more justifiable or fair basis like scientific reasons rather 
than the ease of access or mere availability of data for use.  Implemented, it ensures for 
instance that datasets that may be of scientific interest, but is of concern to some groups 
which may be at risk of being found out, discriminated against or stigmatized are adequately 
protected.  Social justice is implied (T.L. Beauchamp and J.F. Childress, 2001).  
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Anonymization, the generally proven risk minimization method for database studies (S. Bull 
et al., 2015, CIOMS, 2016a, World Medical Association, 2013, Hawkins and Longstaff, 2015), 
becomes necessary.  More so for RUPD because of its advantages of permanent connection 
to the populations through the routine HDSS contacts and the soon to be rolled out model of 
the INDEPTH CHESS (F. Kirakoya-Samadoulougou et al., 2016, O. Sankoh, 2015, K. Herbst et 
al., 2015).  This system will boost RUPD data by connecting the routine public health data to 
the clinical data of members of the HDSS.  This would render RUPD data even more 
personalized warranting more ethical responsibility towards protection. 
7.3.5 Informed consent via community engagement 
The substantive processes of informed consent were downplayed for RUPD both the 
quantitative and qualitative aspects of this project.  This is in large agreement  with the 
literature (CIOMS, 2016a, B.S. Elger, 2010, A.M. Capron et al., 2009, J. Sim and A. Dawson, 
2012 , H3Africa Working Group on Ethics and Regulatory Issues, 2013, S.S. Cargill, 2016).  
Participants however, maintained interest in its procedural forms.   They acknowledged that 
although effective individual consent that fulfills the elements of full disclosure of 
information, comprehension, voluntariness, capacity in decision-making, and authorization 
at the individual level is not practical for RUPD ethics (T.L. Beauchamp and J.F. Childress, 
2001) may be impractical, other forms of consenting are available for RUPD.  Group 
autonomy which highlights preferences for allowing decision-making by local leaders or 
representatives on behalf of the people whose data are sought was largely supported.  This 
is in line with the literature on genetic databases and biobanks (A.M. Capron et al., 2009, T. 
Metz, 2010).  Such consent processes do not adequately cover individual rights and 
freedoms to accept or refuse RUPD, yet they optimize what is possible to gain from the key 
elements of consent including disclosure, comprehension, voluntariness, and authorization 
which are universally acclaimed ((T.L. Beauchamp and J.F. Childress, 2001).  Implementation 
is therefore justified and possible through the routine HDSS data collection visits.  At the 
macro level, community gatherings at which public health issues are usually announced can 
serve for obtaining group consent.  An important implication for this level of consent relates 
to the role of the REC in RUPD.  Effective group consent would require a more heightened 
oversight role by the REC as they double up their responsibilities to compensate for what 
would traditionally have been given and borne by research participants.   
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From the foregoing and the structural insights gained about the HDSS-RUPD, I 
propose that a regional team, preferably operational under the INDEPTH Network, as the 
mother organization of HDSSs, should in consultation with selected national ethics 
committees of HDSSs, undertake a process of developing an ethical framework for RUPD.   
My observations in the field showed that INDEPTH or the more experienced HDSS member 
institutions of the network are best suited to lead in the consolidation process for an ethical 
framework to improve acceptability when completed.  The framework would also benefit 
greatly from the relatively new CIOMS guidelines (2016) and should additionally select 
provisions in other existing guidance documents that have relevance for RUPD (CIOMS, 
2016a, World Medical Association, 2013, Nuffield Council on Bioethics, 2002, US Department 
of Health and Human Services, 2009). The selected provisions could then be consolidated in 
line with selected member-countries’ national laws and ethical guidelines, HDSS institutional 
policies, and the scholarly literature.  The principles outlined in Figure 6 for working with and 
ensuring data integrity (European Commission, 2016, OECD, 2013, H3Africa, 2016) would 
help in reflections.  A concurrent dialogue with key international collaborators would be 
crucial to this process.  The advantage of holding such inclusive deliberations would be in the 
diversity, comprehensiveness, and contextual relevance which will together make the 
framework useful, practical, locally accepted, and universally acknowledged.  
7.4 RUPD ethics and data sharing: Conceptualizing ethical ideals involving 
under-resourced scientists  
The second main question of this project concerned the inevitability of data sharing 
as a need and goal of RUPD and the emerging ethical issues to anticipate particularly from 
under-resourced environments and scientists involved in the evolution.   Data sharing has 
important implications for RUPD.  This study’s critical applied ethics approach therefore 
warranted analyzing parts of the empirical data within the main RUPD data that is of 
relevance to the data sharing discourse.  This approach to applied ethical deliberations is 
supported in the literature (A.M. Hedgecoe, 2004).  This part of the discussion is therefore 
directed towards understanding the level of skepticism about data sharing which is under-
reported in the literature.  The focus is on the under-resourced RUPD scientist of sub-
Saharan Africa or the South in general who has rich data (problem-wise) and has strengths in 
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data production, but weaknesses in directing their data cycles to their complete ends of 
knowledge production.      
Discussions on data sharing are largely focused on the advantages of increasing data 
availability for research including RUPD.  The overall goal is to promote data availability and 
access to scientists to achieve the most possible number of new ideas and additions of new 
knowledge about health to save lives (D.B. Taichman et al., 2016, WHO, 2015, CIOMS, 2016a, 
W.G. van Panhuis et al., 2014).  Much of the discussions have been hinged on theoretical 
arguments in favor of data sharing (E. Pisani et al., 2016, D.Carr and Katherine Littler, 2015, 
M Walport, 2011).  Many influential organizations have moved a step further to propose or 
oblige data sharing in endeavors they are affiliated to (Wellcome, 2016, U.S. NIH, c2016, 
OECD, 2013, European Commission, 2016).    
Less common in the deliberations however, are skeptic arguments about data sharing 
including those that question the valuation of the downsides of sharing.  Some have argued 
that despite the importance that data sharing holds, there is yet to be a measurement of its 
full effects on matters of indirect bearing on science and consequently RUPD (M. Brack and T. 
Castillo, 2015, E. Pisani et al., 2010).  There are institutional, professional, relational, and 
personal factors that influence and are influenced by data sharing, but there is limited 
discussion on the issue.  Of the literature available on public health data sharing in particular, 
only a limited number share perspectives from the South and much less of those is based on 
empirical data (K. Hate et al., 2015).  The literature is also dominated by issues pertaining to 
individual level data (S. Bull et al., 2015, S.G. Denny et al., 2015, I. Jao et al., 2015) with a few 
on public health data sharing (W.G. van Panhuis et al., 2014, K. Hate et al., 2015).   The 
empirical data available from this research is therefore useful for informing an ethical 
reflection on data sharing as pertains to models like the HDSS which hold significant 
influence in public health database capacity in the South.   The motivation for this discussion 
is to examine how RUPD data sharing can be promoted in line with increasing scientific 
productivity and in ways that support favorable risk-benefit assessments and justice 
particularly for under-resourced scientists.   The issues outlined are from the in-depth 
interviews in Ghana and Tanzania alone.   
Data sharing in public health has been slow at the global level (W.G. van Panhuis et 
al., 2014) with sharing outputs from the South comparatively acknowledged as positive (E. 
 
 
 
 
109 
Pisani et al., 2016).  In the case of HDSSs, accelerated data growths from routine public 
health data collection and the additions of data from various research undertaken on the 
HDSS platform generally support data sharing as a scientific and ethical imperative (K. Herbst 
et al., 2015, E. Pisani et al., 2016).   Findings of this study however, show that data sharing is 
challenging to normalize, at least in sub-Saharan Africa.   
Figure 6: Designing an inclusive ethical framework of principles for RUPD in resource  
   limited contexts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The study findings aligned with the literature on the following as factors mitigating 
against data- sharing: (1) risks of loss of control once data is shared; (2) sub-optimal gains to 
data-producing scientists including poor recognition for their roles in data-origination; (3) 
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lack of technological resources to enhance maximum utility in analysis and publications 
before sharing; (4) limited capacity to enable fairness in sharing, that is the capacity of the 
under-resourced scientist to access and use other scientists’ data just as other scientists use 
the under-resourced scientists’ data; and (5) limited international guiding principles on data 
sharing (E. Pisani et al., 2016, M. Brack and T. Castillo, 2015, E. Pisani et al., 2010, W.G. van 
Panhuis et al., 2014).     
What is quite unique about the findings of this project, as described in detail in 
Chapters 4 and 5, lies in the nuances underlying the explanations found behind the scientists 
and other key stakeholders’ views on why these factors must be put at the center of the 
data sharing discourse.  The views pertain largely to justice issues on processes, 
commitments, investments, and careers in public health. The issues are further complicated 
by historically rooted structural issues bordering on socio-economic factors that face the 
region (G. Aellah et al., 2016) and which are beyond the remit of the scientific community 
alone. Nonetheless, the issues form formidable stumbling blocks to data sharing, RUPD 
productivity, increasing new knowledge (publications) about problems especially those 
experienced in the region and understood better by local scientists, and promoting public 
health in general.    
The intrinsic challenges outlined in relation to hesitations to share data in time, in 
fullness and in usability evoke considerations to broad ethical dimensions of fairness, 
reciprocity, equity, and solidarity to help safeguard the interest of the under resourced but 
data rich scientist.  Since these ethical concepts fit within the wider frameworks of the 
ethical principles of justice and inequality, I argue that if the envisaged environment of data 
sharing is such that both resourced and under-resourced scientists producing data with 
varying capacities and under differing circumstances have to be equally obliged to share, 
then there is need guidance on assuring fairness and reciprocity principles (E.J. Emanuel et 
al., 2004, G. Marckmann et al., 2015, E. Pisani et al., 2010, G. Aellah et al., 2016).  A serious 
consideration of the recommendations in Chapters 4 and 5 of this thesis is warranted for the 
ongoing data sharing deliberations.   Indeed, any upcoming or revised data sharing rules as 
well as global actions have potential to lessen the impact of risks faced by the under-
resourced members of the scientific community.   Safeguarding their interests is a sure way 
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of increasing RUPD productivity and indirectly helping accelerate sub-Saharan Africa’s 
progress towards meeting the SDGs.    
Below is a brief principles-based discussion that helps engage with the intuitions, 
meanings, and experiences gathered about why stakeholders in this study may resist data 
sharing or fail to share their data, unless perhaps mandated; a situation that is not ideal for 
the professional growth of the scientific community.   
7.4.1 Favorable burden-benefit ratio 
There has been some effort to discourage the  concept of “data ownership” in order 
to  enhance research (E. Pisani et al., 2016).  It however, remains a large determinant of the 
extent and willingness to share.  Removing this hurdle requires a balanced act between the 
burdens that motivate claims to ownership and the benefits that arise from ownership.  
Producing scientists’ investments of effort, skillsets, finances, and careers leads to increased 
connection with the data they collect and hold for different public health uses.   This explains 
the commonly reported hesitation to share on the basis of fears of losing control of data 
after it is shared (S. Bull et al., 2015, D.Carr and Katherine Littler, 2015, E. Pisani et al., 2016).  
For this reason, I argue that optimal data sharing in RUPD can best be conducted on need-
based negotiated sharing (A. Ault, 2013). This would allow collaboration with data producers 
and reciprocate their investments by sharing the rewards of further uses of their data.  
Rewards like sharing of skillsets, resources and ideas would in turn increase co-authorship 
opportunities in publications.  This raises benefits to the producing scientists to offset or 
balance the weight of costs (burdens) in data production.   Controlling “ownership” claims 
also be addressed by an awareness creation about the reality that the populations and 
communities who provide data for the public good, funding agencies, and governmental 
institution have important stakes in the data held by scientists and institutions.  Therefore, 
data holding must be considered more as a matter of custodianship than ownership (A.M. 
Capron et al., 2009). 
7.4.2 Sustainability  
The South and sub-Saharan Africa in particular remains heavily reliant on external 
funding for public health activities including data collection and research (Largent, 2016, 
Rani and Buckley, 2012).  The paradox of data sharing is that while it increases access to data 
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and make data availability free or cheap, it generally decreases the motivation to fund data 
collection.   Easier and cheaper global access to data without the burden of investment 
reduces the necessity of investment, or at least the motivation to invest.  As long as external 
funding remains critical to the region, “sustainability” for data collection and subsequent 
sharing will suffer.  This risk must be considered within the equally challenging issue of 
rarely increasing local funding commitments to global health and research. Southern 
scientists and institutions must therefore strategize on how to sustain RUPD by optimizing 
the utility of data in quicker speeds while they enjoy minimal priority rights between data 
sharing times and deadlines for release.  One opportunity lies in southern scientists re-
directing some scientific efforts away from data production to knowledge production to 
complete data cycles and help make the most use of their data in publications before 
sharing.  This would require more local networking such as south-south and HDSS-HDSS 
partnerships that harnesses the strengths of the collective to increase scientific productivity 
and make data more fully exploited before sharing (D.Carr and Katherine Littler, 2015).   That 
way, as the scientists complete data cycles and optimize data use via increased publications, 
the benefits would outweigh the costs of data collection and motivate continuity and 
sustainability in data collection.  Fears of sharing would be reduced as data-producers would 
have been satisfied with the optimal use of their data.   
7.4.3 Upholding deontological principles  
A key ethical dimension of the findings concerning data sharing relate to 
deontological approaches to RUPD ethics: the duty to credit those who make beneficial 
contributions to other people’s ends (T.L. Beauchamp and J.F. Childress, 2001).   Using 
shared data without the notification or involvement of data producers is akin to violating the 
categorical maxim against using people as a means to an end.   The consequential benefit of 
an endeavor must be shared with the effectual burden of input.  For this reason, I argue that 
conducting and benefiting from secondary analysis independent of data producing scientists 
must be an exception rather than a rule in ethical RUPD and ethical data sharing.    Scientists 
and institutions specialized in knowledge production or benefitting from secondary data 
must assume a duty towards data production.  Thus, in relation to the principle of 
sustainability above, user-scientists who intend to use data without collaboration must be 
duty bound to invest in sustaining data production (Wellcome, 2016, E. Pisani et al., 2010).  
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The resulting reciprocal investment can be aligned to the weight of expected benefits to 
producer scientists.  The findings from this project were also indicative that the practice of 
merely acknowledging data-originators for instance in publications that solely use their data 
is deemed woefully inadequate and ethically unacceptable (E. Pisani and C. AbouZahr, 2010).  
User-scientists must make optimal effort to invite the intellectual input of producing 
scientists if their data is good enough to be re-used for further analysis leading to new 
knowledge.  I support arguments that data production involves intellectual processes which 
require urgent recognition and agree that such recognition must be professionally aligned  
to the recognition given to publications (M. Brack and T. Castillo, 2015, E. Pisani and C. 
AbouZahr, 2010).  Good-faith negotiations between data producers of the South and 
secondary-users require data sharing agreements that contain equitably tangible incentives 
for both sharers and users and oblige the necessary duties. 
7.4.4 Collaborative partnership 
Different institutions have differing advantages.  Those rich in data deemed critical 
for addressing global health issues may not have the analytical advantages to translate the 
wealth of data into relevant knowledge.  Institutions highly resourced in technological and 
analytical infrastructure may not have data that matches the most important needs of global 
health at any given time.  This makes collaborative partnership a critical ethical principle in 
RUPD ethics (E.J. Emanuel et al., 2004, M. Parker and S.J. Bull, 2009).  The importance of 
funding, skillsets, and technological infrastructure, and diversity of ideas towards 
accelerating the achievement of global goals cannot be over-emphasized.  Participants in the 
study emphasized how limited access to technological and analytical resources slowed down 
their use of the data they produced and use of data shared by others.  It is also well known 
that even differing writing styles and thought processes could account for differences in the 
success rates of translating data cycles into scientific publications.  The low infrastructural 
advances of internet and information technology access in the South and sub-Saharan Africa 
in particular (International Telecommunication Union, 2013) escalates situations where 
scientists are themselves denied access to  new knowledge emanating from data they 
produced.   These are matters that do not adequately feature in the literature but account 
for low contributions of new health information from the South.  They pose worse risks; slow 
finding of solutions to problems affecting the respective regions of slow scientific growth 
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impedes their reach of overall global health goals.  As limited resources push under-
resourced scientists to share data which is least exploited and hold the most potential for re-
use by others or the capacity to compete for further use once shared with more resourced 
scientists become limited by resources (E. Pisani et al., 2016, S.G. Denny et al., 2015), the 
challenged lose the opportunity to crawl get out of their challenges.  This is why I argue for 
collaborative partnership as a key strategy for data sharing with the South.  Apart from 
capacity building and sharing of ideas towards increased scientific productivity, it would 
more importantly ensure that RUPD is collective, inclusive, and of most relevance in 
addressing the respective health problems of the communities who produced and 
understand their challenges best.   
7.5 Developing new ethical guidelines  
There is yet to be a unified international data sharing guideline that considers the 
relational, professional, and personal issues at the center of this study’s findings (W.G. van 
Panhuis et al., 2014, M. Brack and T. Castillo, 2015).   At least none among those best cited 
by the study participants, CIOMS (CIOMS, 2016a), Helsinki declaration (World Medical 
Association, 2013), and the Code of Federal regulations (US Department of Health and 
Human Services, 2009) has guidance on data sharing.  Awareness about national guidelines 
and relevant data sharing provisions in the scholarly literature was also low among study 
participants.  Many participants therefore believed that such guidelines are needed before 
current data sharing proposals are concretized into rules for RUPD.  Considering that even 
the more-resourced countries of the South like South Africa do not have national guidelines 
relevant to the data sharing concerns raised (W.G. van Panhuis et al., 2014), I propose that 
the INDEPTH network, the mother organization of HDSSs in the South should lead in 
developing a RUPD-specific guideline on data sharing that gives particular attention to the 
issues raised by its scientists in this study.  The Network has a known reputation for 
anticipating and addressing HDSS and its allied issues (O. Sankoh and C. IJsselmuiden, 2011, 
E. Pisani et al., 2016)  and is in the best position to bring together the right stakeholders to 
dialogue for inputs into such a guideline.  In the interim, southern institutions would benefit 
by developing institutional level policies on data sharing given the  general limitedness of 
national ethical and legal structures in the South (M. Kruger et al., 2014).   Institutional 
policies must however, be viewed in their limited scope of influence since, as gathered from 
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the project’s legal practitioner-participants, institutional policies are helpful, but nor 
adequate as instruments of international data sharing.  This is because scientists and 
institutions external to a policy instituting institutions are not necessarily bound by its policy 
requirements.  Therefore, when data use is planned to be done away from data producing 
institutions, data-users may choose to or not to comply with the policies of the producing 
institution.    Conflicts may also arise between an incoming data user’s home legislations 
abroad and the data producing institution’s policies (M. Brack and T. Castillo, 2015) to force 
relegation of the latter’s rules.  Specific international guidelines on data sharing are 
therefore required and they must necessarily consider the relational issues to do with the 
scientist and the institution.  Concurrently, education and advocacy on what already exists 
cannot be over-emphasized. 
Finally, I urge that the steps towards reaching the SDGs and other global health goals 
may have obstacles at different stages, but Figure 7 helps re-conceptualize ethical principles 
that would optimize the value of data sharing and enhance the scientific productivity.   
Figure 7:  Ethical principles for promoting data sharing towards global health goals 
 
As Figure 7 diagrammatically presents the essential principles imputed by the study 
findings, it posits them as necessary to optimize ethics in RUPD and also data sharing.   As for 
the systemic challenges of the South, they may not be redeemable by the most optimal 
ethics alone, but there is a much that can be done to help reduce the full and continual 
effects of their impact and those are seen in Figure 6.  The overall, experiences, opinions, 
fears, doubts, and concerns shared by the participants in this project, key stakeholders in the 
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endeavors of both RUPD and data sharing are worth considering.  Left uncontrolled, the 
corollary would be a vicious cycle of low data production, low scientific productivity, reduced 
funding, reduced investments in technological and analytical resources, reduced analytical 
capacity, reduced scientific productivity, low capacity building, reduced diversity in the 
creation of relevant ideas for solving critical problems, and an overall reduction in the 
capacity of RUPD to impact on global health.  Therefore, on the basis of utilitarian 
beneficence (Singer, 2009), the crux of my argument in this thesis remains that it is within 
the power of the scientific and ethical community to enhance ethical practices in RUPD to 
maximize potential benefits to RUPD populations and to scientists in the South without 
sacrificing any benefits of comparable worth.  Hence, the scientific and ethical community 
ought to exercise that power by adopting a fuller and more comprehensive ethical 
framework for RUPD and for data sharing.     
7.6 General limitations 
Like every study, this work has limitations which have been explained in the various 
chapters.  This section describes the limitations more broadly.  First directing the study on 
the two broad terrains of traditional ethical issues in RUPD as pertain to RUPD participants 
and encapsulating the seemingly extrinsic issues pertaining to data sharing may seem to 
show a disconnect which is actually only on the superficial level.  The idea is not to look at 
the two issues differently, but to consider their origins in the same study, methodology of 
qualitative interviews, and key informants who form a holistic endeavor for which each part 
of the discussion has a crucial vacuum to fill.  The whole, RUPD ethical development is bigger 
than the sum of all other issues at the levels of scientists, RECs, and other interests including 
data sharing.  The focus should therefore be on the broader goal of reaching global health 
goals using what research is most feasible to the under-resourced (RUPD) and how that can 
be optimized with the critical human resource to reach the most benefits.   
As expected the second limitation concerns representativeness (B. Dawson and R.G. 
Trapp, 2004) in the survey and transferability of results from the qualitative methods (V. 
Braun and V. Clarke, 2006).  However, ethical arguments and reflections are not be hinged 
on numbers (CIOMS, 2016a).  The diversity and in-depth nature of the perspectives shared 
were enough to inform normative reflections on addressing the two main questions.  
Obtaining data physically in three countries and getting an additional input from 
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representatives of fifteen more is good enough diversity that should outweigh absolute 
numbers.   
A final limitation borders on the familiarity of the research student to participants, 
particularly those encountered in the interview sessions in Ghana and Tanzania.  Her known 
involvement in earlier clinical trials involving some of the study centers made her a familiar 
face at all sites.  This may have introduced some social desirability biases via participants 
giving answers thought to be more acceptable to the interviewer.   
Despite these limitations, the words of an anonymous reviewer of Article 1 sum up 
the overall positivity of this thesis.  He or she wrote that even if the project could “not 
change the world, it is very informative.  The ethical discussion of this specific kind of 
research might benefit from more insight from stakeholders”.   
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8.0 Conclusions and implications for action  
A re-conceptualization of the ethics of RUPD is a developing area for the future of 
technology enhanced research with large population-level public health datasets.  The initial 
ethical infrastructure has revolved around ethics review and anonymization of data to protect 
confidentiality.  Yet, the results from the empirical findings from this doctoral research inform 
a normative analysis that suggests a wider frame of opportunity for ethical considerations in 
RUPD.  The traditional research ethics principles are practical for RUPD albeit to differing 
extents.  The means of optimizing the principles are more akin to the principles and 
benchmarks framework proposed by Emanuel and colleagues (E.J. Emanuel et al., 2004) for  
the conduct of ethical clinical research in developing countries.   The ease of fit demonstrates 
a level of universality in research ethics practice and support the case for the requirement of 
more ethics for RUPD.  What remains critical is to ensure that the suggestions made in the 
thesis both on ethical regulations for RUPD and data sharing are carefully reconsidered in 
order for them to be sufficiently sensitive to the gaps in RUPD and data sharing without 
needlessly being restrictive to scientific progress. 
The release of the new CIOMS document in 2016 when this thesis was being finalized 
is a timely ethical intervention and complement.  The CIOMS’ focus on issues that affect the 
South help lay a stronger foundation for the RUPD ethics framework being sought by 
scientists and REC members alike in this study.  Complemented by the existing scholarly 
literature (S. Bull et al., 2015, E. Pisani et al., 2016), there is enough to develop a new 
comprehensive ethical framework for RUPD in the South.  At a more decentralized level, local 
RECs and HDSSs may henceforth revise their standard operating procedures and policies 
respectively to extract and inculcate the relevant portions of the following: (1) RUPD-suited 
provisions in Guidelines 3, 7, 8, 12, and 24 of the new CIOMS document;  (2) Available 
guidelines concerning open access which is considered the most extreme form of data 
sharing (European Commission, 2016, A. Ault, 2013).  This would signal attention to the most 
important risks in the data holding and sharing endeavor and point to ethical provisions to 
minimize them; and (3) Relevant provisions from the H3Africa project (H3Africa, 2016) which 
is deliberating issues in genomic and database research which have relevance to RUPD. 
When these are done, further dialogue for instance at the level of the INDEPTH network will 
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impart additional intuitions on what might count as ideal and what is pragmatic for the 
future of RUPD and sharing. 
Although scientists are generally not a population that require ethical safeguards, 
findings in relation to data sharing in this thesis are suggestive that under-resourced 
scientists may require safeguards in the future.  Obligations have inherent punitive 
measures.  Therefore, as the global calls for data sharing crystalize into rules, they will soon 
be non-negotiable regardless of risks to scientists who for various reasons cannot optimize 
their data in the required speeds before sharing. These vulnerabilities on the part of 
scientists will have implications for research and global health.  Solutions can be found in 
collaborations, flexible time-allowances that permit maximum data utility before sharing, 
equity in reward systems, and above all, showing solidarity by sacrificing part of the speed 
expected in science for diversity of ideas.  For long term purposes and sustainable data-
production, global actors must assume the responsibility to re-instate quality data 
production in the global recognition framework.  Assessments of scientists’ suitability for 
research career progressions that consider data production is for instance a step to protect 
RUPD sustenance through continued production of quality data production, regardless of 
whether originators translate data into knowledge (S. Hodson, 2013, G. Aellah et al., 2016).  
This satisfies justice.  The indirect fashioning of scientists to “publish or perish” is beneficial 
to science, but lack much applause in its impact on population’s health in the South partly 
because of the ambivalence to whether or not southern scientists contribute to scientific 
productivity.  Just commitments to fulfil ethical obligations generally wane with distance, 
non-familiarity, and absence of guidelines, as does commitments to disseminate new 
knowledge where it can make the most global health impact.  As global scientific actors push 
for data sharing, there needs to be ethical actors of comparable authority to inject each 
scientific step with an optimal amount of ethical reflections.  Data sharing deliberations and 
the ethics of RUPD must go beyond focus on quick analysis and maximum publications.  
There is a whole gamut of people and processes for which realizing this culture must reflect.  
Because journals, organizations, and funders advocating data sharing are mostly northern 
based and challenges to sharing are largely southern, Africa’s voice must be heard in 
highlighting concerns peculiar to the systemic challenges they face. These discussions must 
be placed within a broader context of safeguarding science, data, and the human systems 
that make the whole endeavor possible.    
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Finally to the under-resourced scientist, mandatory data sharing will soon signify that 
data sharing is a determinant of the ethical status of RUPD and a standard for best ethical 
practice.  The onus lies on all scientists to prepare themselves better for the burgeoning new 
sharing culture.  There will be inconveniences in being ethical and sharing data speedily for 
science, but the inconveniences are not comparable to the benefits that stand to be lost to 
populations whose data may yield new knowledge, ethical developments in the growing 
data world, scientific breakthroughs, and the ultimate attainment of global health and the 
SDGs.   If it must, research ethics must be re-instated in its fullest practicable limit in RUPD 
and data sharing and as this thesis has shown, both are possible with a little ingenuity.    
8.1 Future research 
This study has charted a course in empirical research and critical applied ethics for RUPD and 
data sharing with the South.  The arrival of the CIOMS document during the latter part of the 
project’s implementation opens a unique opportunity to examine the principles espoused in 
the thesis in relation to the RUPD-relevant aspects of the document namely Guidelines 1, 2, 
3, 7, 8, 12, and 24.   Conducting additional empirical studies using other settings in the South 
would enable a critical examination of how the proposals in the thesis can be adapted into 
one go-to guideline for RUPD ethics.  I cite the CIOMS document in particular because it is 
best-suited among other guidelines for the South in general (Largent, 2016).  Moreover, its 
current status attracted extensive dialogue, making it comprehensive and abreast with the 
technology-enhanced and epidemiological features of RUPD.     
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APPENDICES  
Appendix 1 
Information Leaflet and Declaration of Consent (Respondents) - Survey 
Project Title: New Models of Public Health Research:  Optimizing Ethics in Research Using 
Public Health Data in Resource Limited Countries” 
Dear Sir/Madam, 
I am a PhD student at the Institute for Biomedical Ethics (IBMB), University of Basel, 
Switzerland.  As part of the requirements for my doctoral degree in Public Health Ethics, I am 
undertaking this project funded by the Swiss Tropical and Public Health Institute in 
collaboration with the IBMB.   
The project aims at exploring characteristics of research involving use of pre-collected 
surveillance data (RUPD) as well as documenting challenges researchers and ethics 
committees face in applying existing ethics guidelines to RUPD.  The ultimate goal of my 
project is to develop a practical and context appropriate guidance document to support 
future ethical conduct and review of RUPD. 
I am, through this letter, requesting your kind participation in the study by responding to the 
study questionnaire.  Questions will center on your expert experiences and opinions about 
RUPD, as well as your recommendations for its ethical conduct.  Your responses, together 
with that of other colleagues will be synthesized with existing literature on public health 
ethics, surveillance ethics and research ethics to, if feasible, develop a RUPD-specific ethics 
framework. 
Participants will be from Ethiopia, Ghana, and Tanzania, and representatives of Health and 
Demographic Surveillance Sites who will be present at the October 2014 meeting of the 
International Network for the Demographic Evaluation of Populations and their Health in 
Addis Ababa, Ethiopia. 
Please be assured that you are free to choose not to participate in this study, even if your 
name was suggested or recommended by someone else.  You may also decline to answer a 
specific question without any consequence or prejudice to you.  Be informed that because 
consent documents are de-linked from questionnaires and the process is anonymized, there 
will be no attempt to link answers to you as an individual or your institution.   
I thank you in advance for your time and support. 
Sincerely yours, 
Ms. Evelyn Anane-Sarpong  
Institute for Biomedical Ethics and The Swiss TPH 
University of Basel, Bernoullistrasse 28,    
4056 Basel, Switzerland 
Email: evelyn.anane-sarpong@unibas.ch 
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This leaflet summarizes key points necessary to allow you to reach a decision to or not to 
participate. 
1. Who is participating in the study? - You have been approached to participate in this 
study because you are a/an:  
 key stakeholder who provides professional services for the activities of Health 
and Demographic Surveillance Systems (HDSS) centers; 
 head of an HDSS; 
 ethics committee administrator and or member in  Ethiopia, Ghana, and 
Tanzania;  
 independent (non-HDSS) public health professional with expertise in health 
systems surveillance and research activities in  Ethiopia, Ghana, and Tanzania;  
 senior personnel of the national health ministerial agency in  Ethiopia, Ghana, 
and Tanzania; 
 public health expert working with a locally based international health agency 
such as the WHO. 
2. Study procedures you will be involved in - You will be asked to spend 20 - 40 
minutes of your time to respond to a self-administered questionnaire on the project 
topic (please see Page 1).   Both open and closed ended questions will be used to 
document your opinions about a short vignette (scenario).   
3. Risks and Benefits - Except for your time to answer the questionnaire or to be later 
interviewed, if you agree, there is no foreseen risk associated with taking part in this 
study.  Upon study completion, only anonymized data will be presented in reports 
and publications resulting from the data.  The results of this project will contribute to 
the development of a framework for RUPD, or at a minimum, increased knowledge 
on ethical issues surrounding RUPD.  This will help improve advancements that HDSSs 
are making in research and scientific publications. As a token of appreciation for your 
time, a small souvenir (Basel embossed pen) will be presented to you.  At the close of 
this project, access links to all published pieces will be communicated to you or your 
institution.   
4. Confidentiality - Be assured that because the process is anonymized, there will be no 
attempt to link answers to you as an individual or your institution.  Signed consent 
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documents will not at any point be linked to completed questionnaires or interview 
records.  I will personally pick up completed questionnaires to ensure that responses 
you give will be confidential, and they will not be shared with anyone other than 
members of the PhD project team.  
5. Participation and Withdrawal from the study - You are free to choose not to 
participate in this study, even if your name was suggested or recommended by 
someone else.  You may also decline to answer a specific question without any 
consequence or prejudice to you.    
6. Ethical Approval - This proposal has been ethically reviewed by the Ethics 
Commission of North Western and Central Switzerland that oversees ethics review at 
the University of Basel, and ethics committees in all participating sites in Ethiopia, 
Ghana, and Tanzania.   
7. Contacts - If you have any question concerning this study, during and/or after data 
collection, please contact evelyn.anane-sarpong@unibas.ch. You may also use the 
following phone contacts: +233 (0)20 820 00 23 (Ghana), +255 (0)<<Tanzanian 
number to be stated>> and <<Ethiopian number to be inserted>> until January 31, 
2015, and subsequently, +41 61 2671788.    
If you have any complaint, you may communicate to me at the address above, or to the 
Administrator of the [name of IRB], [name of administrator]  at [administrator’s email 
address] , if appropriate.    
Declaration of Consent 
I understand that: 
 this is an academic project, the content of which has been explained to me  
 my participation is given of my own free will without any consequence or prejudice  
 all correspondence, including completed questionnaires and audio recordings will be 
kept confidential 
 no identifying information will be used in discussions and publications from this study 
 if I feel unable or unwilling to answer any question, for any reason, I may move on to 
the next or discontinue with the questionnaire or interview, without providing any 
reason. 
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I have been given the opportunity to ask questions which were answered to my satisfaction.  
I agree to participate in this study. 
  
 
………………………………………………………              ……………………………………………………….. 
          Signature of Participant                       Place, Date  
 
Thank you very much. 
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Appendix 2 
Study Questionnaire:   Research Using Public Health Data (RUPD) 
Please read the following scenario to answer the questions below 
Proposal to re-use previously collected health and demographic surveillance data 
The Tanghu Center (a fictitious health research center) was established in 2000.  It has a 
population of 99000 under its surveillance.  It has received local community support and 
significant funding to invest in modern facilities for health and demographic data collection, 
and storage.  Researchers at the center now suggest that this surveillance data should be 
explored and analyzed for scientific publications.  Many topics are immediately proposed.  
Dr. Ghutan for instance wishes to use the data gathered between 2005 and 2012 to compare 
issues between old and new residents after tuberculosis infection.  It is agreed by many 
members present that such a coordinated effort to re-use existing data for such publications 
could increase scientific capacity, enable young and new researchers to gain analytical skills 
and ensure the fullest use of the hard earned data.  Others note that the evidence from such 
publications will impact health policy, and result in new ideas and research questions.  Some 
members however, think that there could be ethical issues to consider. 
SECTION A: GENERAL QUESTIONS 
1. Have you ever seen a publication involving use of previously collected demographic 
surveillance data?       
Yes            No  
2. Have you ever used Dr. Ghutan’s approach to publish? 
Yes                        No      
3. How often do you see use of demographic surveillance data for publications occur?  
Very often            Often             Sometimes          Rare                 Not at All 
4. Do you consider the use of only previously collected data for publications as 
research?  
Yes                        No 
5. Should use of previously collected surveillance data for publications require 
research ethics review?         Yes                   No 
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SECTION B: QUESTIONS ABOUT ETHICS IN PUBLIC HEALTH AND RESEARCH 
1. Please indicate what you think about the following   
statements:  (Please circle only one response per statement) 
Strongly                                                      Strongly  
Agree                                                         Disagree 
a.    The Tanghu community, via its leaders, should be told  
        about Dr. Ghutan’s proposal to re-use their data before   
        any publication 
1 2 3 4 5 
b.    Individual Informed consent of Tanghu community        
       members should be sought for every publication    
       involving their data 
1 2 3 4 5 
c.    Tanghu residents should have rights to withdraw their  
        data from being analyzed for publications 
1 2 3 4 5 
d.    Tanghu residents face risks to confidentiality of data  
       with such publications 
1 2 3 4 5 
 
e.   The Tanghu community will face stigma and  
       stereotyping if negative results are published 
1 2 3 4 5 
     Please indicate what you think about the following  
        statements: (Please circle only one response per  
        statement) 
Strongly                                                     Strongly  
Agree                                                          Disagree 
f.     The Tanghu community faces risks of being over-  
        researched with continued publications involving their  
        data 
1 2 3 4 5 
g.    If publications like Dr. Ghutan continue, it will  
       Tanghu residents from providing surveillance data in the  
       discourage future 
1 2 3 4 5 
h.    Each time a proposal like Dr. Ghutan’s is made, every  
       should have a right to disagree with the re-use of their   
       resident data for publication  (i.e. opt-out options for  
       community members) 
 
1 
 
2 
 
3 
 
4 
 
5 
Your own suggestions are most welcome. 
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2.   In relation to Dr. Ghutan and his colleagues’  
      proposals, please indicate your agreement or  
      disagreement with the following: 
      (Please circle only one response per  statement) 
Strongly                                                     Strongly  
Agree                                                          Disagree 
a.   Ethics committee review should always be sought   
      before using existing surveillance data for new  
      research 
 
1 
 
2 
 
3 
 
4 
 
5 
b.   Specific ethical guidelines need to be developed to   
       govern re- use of existing surveillance data for     
      publications 
1 2 3 4 5 
c.   The use of surveillance data for purposes that help  
      improve the community or public health should not be  
      slowed down by individual    residents’ interests such  
      as informed consent 
 
1 
 
2 
 
3 
 
4 
 
5 
d.   Residents whose data meet the inclusion criteria  
      should be given some benefit when publications arise  
      from re-use of their data 
 
1 
 
2 
 
3 
 
4 
 
5 
 
e.   Surveillance data should be permanently open to use  
      without restrictions by ethics committees 
1 2 3 4 5 
f.    Surveillance data involving sensitive issues (e.g.  
      genetics)should be released to researchers only after  
      names of residents have been removed from the data 
 
1 
 
2 
 
3 
 
4 
 
5 
g.   One consent at the beginning of surveillance data  
      collection is enough for use and  for all future  
      publications 
1 2 3 4 5 
h.   Whenever data analysis for a publication cannot be  
      effectively done without first removing names from the  
      datasets, re-use should not be permitted 
 
1 
 
2 
 
3 
 
4 
 
5 
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i.    Research approaches like Dr. Ghutan’s should be  
       encouraged  
1 2 3 4 5 
Comments 
 
 
 
3. Using the scenario, please explain any general concerns (e.g. social, legal, 
economic, cultural etc.) that might affect the following: 
Individuals residing in Tanghu: 
 
The Tanghu Community as a whole:  
 
4. Using the scenario, please explain any ethical issues that might affect the  
            following: 
Individuals residing in Tanghu:  
 
The Tanghu community as a whole:  
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 5.  Considering the scenario, what would be your advice to  
       the Tanghu Team.  Re-use of surveillance data for      
       publications should be permitted only if …  
       (circle only one response per  statement) 
Strongly                                                     Strongly  
Agree                                                         Disagree 
a.   it conforms to Tanghu Center’s objectives or mission 1 2 3 4 5 
b.   the head of the Center grants permission 1 2 3 4 5 
c.   Tanghu community leadership consents to it 1 2 3 4 5 
d.   it is in line with local or national health priorities  1 2 3 4 5 
e.   it can result in change of health policy relevant to the   
      community 
1 2 3 4 5 
f.    investigators asking to re-use the data for publications were  
      themselves  involved in the original data collection 
1 2 3 4 5 
g.   the expected  publications do not include sensitive issues    
      like genetics 
1 2 3 4 5 
h.   the local ethics committee reviews the proposal and grants  
      permission 
1 2 3 4 5 
      Please suggest other desirable conditions below 
 
 
 
6.  The following ethical issues should be considered by Dr. 
Ghutan if he goes ahead to analyze the data for publications 
(Please circle only one response per statement) 
Strongly                                                     Strongly  
Agree                                                        Disagree 
a.  Personal  and family confidential  data may be compromised  1 2 3 4 5 
b. Tanghu community members’ rights to control how their   
     personal and family data is stored, used and publicized may    
     be violated   
1 2 3 4 5 
c.  It is alright for Dr. Ghutan’s  request to be permitted without   
     informed consent from community members 
 
1 
 
2 
 
3 
 
4 
 
5 
d.  Research proposals involving genetic records should not be  1 2 3 4 5 
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      permitted without informed consent 
e.  Tanghu community may lose trust in the Tanghu Centre for  
      allowing Dr. Ghutan to use their existing surveillance data   
      for new publications 
1 2 3 4 5 
f.   Results of the analysis should be first disseminated to  
      Tanghu community before publication 
1 2 3 4 5 
Your own suggestions are most welcome. 
 
 
 
7.    In your opinion, what should Dr. Ghutan do before using the data?  (Please select only one 
answer for 7a)       
Seek official permission from the Tanghu Centre only 
Seek official permission from the Tanghu Centre, as well as ethics committee review  
Seek official permission from the Tanghu Centre, and proceed to use the data.  If the 
analysis leads to a publishable manuscript, then ethical clearance to publish should 
be sought  
Seek official permission from the Tanghu Centre, and notify the regional/national 
health authorities  
Seek official permission from the Tanghu Centre and the ethics committee, and then 
notify the regional/national health authorities  
Use personal and professional discretion about how to use the data in an ethical 
manner 
 (b)  Dr. Ghutan may also undertake the following processes. (Please recommend)  
 
 
8. Do you know of any written rule, policy or regulation governing the use of existing 
surveillance data for publication purposes?       Yes                    No 
(If yes, please assist by stating the name of this document and what it says in brief)  
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9. What role, if any, should the following stakeholders play regarding re-use of existing 
surveillance data for publications?   
Tanghu  Center:  
 
National Health Authority/Agency:  
 
Tanghu Community:  
 
Tanghu Leadership:  
 
Local Ethics Committees:  
 
The Government:  
 
Other Stakeholders: (please name and explain)  
 
 
SECTION C: BACKGROUND INFORMATION 
In which age category are you?        21-30       31-40          41-50         51-60      61-70     >70 years 
Sex:     Male             Female 
In which country do you work?  __________________________________________________  
Please describe your primary training. (please state e.g. BSc. Population Studies, PhD. Statistics) 
____________________________________________________________________ 
What type of institution do you work for?  (please select as many as apply) 
            Research          Health           Academic            Ministry/Agency of Health      
      International Organization       Other (please state)  
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What is your role in your institution? (please select all that apply)      Researcher     
     Administrator            Ethics Administrator            Ethics Committee Member  
     Public Health Professional           Policy Maker        International/Non-National Public Health   
      Expert          Clinician        Other (please state) ___________________________________  
How long have you performed this role? (please state in years)________________________ 
Have you ever attended a workshop or training in research ethics?            Yes          No  
(please select period of training)      <1 week            1 week          2 weeks        1 month              
                       fellowship program                degree 
Thank you very much for your time, attention and responses.  If you have questions or further 
thoughts, please feel free to send me an email to evelyn.anane-sarpong@unibas.ch.   Again, thank 
you. 
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Appendix 3 
Letter of Invitation, Information Leaflet, and Consent Declaration for Interview 
Project title 
New models of public health research:  Optimizing Ethics in Research Using Public Health 
Data in Resource Limited Countries 
Dear Sir or Madam, 
I am a PhD student at the Institute for Biomedical Ethics (IBMB), University of Basel, 
Switzerland.  As part of the requirements for my doctoral degree in Public Health Ethics, I am 
undertaking this project funded by the Swiss Tropical and Public Health Institute in 
collaboration with the IBMB.   
The overall project aims at exploring and documenting characteristics of research involving 
use of pre-collected public health data (RUPD): the experiences and challenges that 
researchers and ethics committees face in their practice and in applying ethics guidance.  
The ultimate goal of the project is to develop a practical and context appropriate guidance 
document to support future ethical conduct and review of RUPD. 
I am, through this letter, requesting your kind participation in the study by giving me an 
opportunity to hold an interview with you.  Questions will center on your expert experiences 
and opinions about RUPD, as well as your recommendations for its ethical conduct.  Your 
responses, together with that of other colleagues, will be synthesized with existing literature 
on public health ethics, surveillance ethics and research ethics to, if feasible, develop a 
RUPD-specific ethics framework. 
Participants will be from Ghana and Tanzania.   
Please be assured that you are free to choose not to participate in this study, even if your 
name was suggested or recommended by someone else.  You may also decline to answer a 
specific question without any consequence or prejudice to you.  Be assured that because the 
process is anonymized, there will be no attempt to link answers to you as an individual or 
your institution.   
I thank you in advance for your time and support. 
Sincerely yours, 
Ms.  Evelyn Anane-Sarpong  
Institute for Biomedical Ethics, and Swiss TPH 
University of Basel, Bernoullistrasse 28,    
4056 Basel, Switzerland 
Email: evelyn.anane-sarpong@unibas.ch. 
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This leaflet summarizes key points necessary to allow you to reach a decision to or not to 
participate. 
1. Who is participating in the study? - You have been approached to participate in this 
study because you are a/an  
a) key stakeholder who provides professional services for the activities of the 
Health and Demographic Surveillance System (HDSS);  
b) head of an HDSS;  
c) ethics committee administrator and or member in Ghana and or Tanzania;  
d) independent (non-HDSS) public health professional with expertise in HDSS 
and public health research activities in Ghana and or Tanzania;  
e) senior personnel of the national health ministerial agency in Ghana or 
Tanzania;  
f) public health expert working with a locally based international health agency 
such as the WHO.  
2. Study procedures you will be involved in - You will be asked to participate in an 
interview lasting no more than 1 hour.    A semi-structured interview guide will be 
used to lead the discussion.  If you permit it, the interview will be audio recorded.   
3. Risks and Benefits - Except for your time to be interviewed, there is no foreseen risk 
associated with taking part in this study. Upon study completion, only anonymized 
data will be presented in reports and publications resulting from the data. The results 
of this project will contribute to the development of a framework for RUPD, or at a 
minimum, increased knowledge on ethical issues surrounding RUPD. This will help 
improve advancements that HDSSs are making in research and scientific publications. 
As a token of appreciation for your time, a small souvenir (Basel embossed pen) will 
be presented to you. At the close of this project, access links to all published pieces 
will be communicated to you or your institution.  
4. Confidentiality - Be assured that because the process is anonymized, there will be no 
attempt to link answers to you as an individual or your institution.  Signed consent 
documents will not at any point be linked to completed interview records, which will 
not be shared with anyone other than members of the PhD project team.  
5. Participation and Withdrawal from the study - You are free to choose not to 
participate in this study, even if your name was suggested or recommended by 
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someone else.  You may also decline to answer a specific question without any 
consequence or prejudice to you.   You may stop the interview at any time.  
6. Ethical Approval - This proposal has been ethically reviewed by the Ethics 
Commission of North Western and Central Switzerland that oversees ethics review at 
the University of Basel, and ethics committees in all participating sites in Ghana and 
Tanzania.  
7. Contacts - If you have any question concerning this stud, during and or after data 
collection, please contact Evelyn at evelyn.anane-sarpong@unibas.ch. You may also 
use the following phone contacts: +233 (0)20 --- (Ghana) or +255 (0)--- (Tanzania) 
until February 28, 2015, and subsequently, +41 61 ---.  
If you have any complaint, you may communicate to me at the address above, or to the 
Administrator of the --- IRB, Ms.---,  if appropriate. 
 
Declaration of Consent 
I understand that 
 this is an academic project, the content of which has been explained to me  
 my participation is given of my own free will without any consequence or prejudice  
 all correspondence, including audio recordings will be kept confidential 
 no identifying information will be used in discussions and in publications 
 if I feel unable or unwilling to answer any question, for any reason, I may move on to 
the next or discontinue with the interview without providing any reasons. 
I have been given the opportunity to ask questions which were answered to my satisfaction.  
I agree to participate in this study. 
          
 
……………………………………………………               ……………………………………………………….. 
       Signature of Participant                           Place, Date  
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Consent for Audio Recording 
I agree to the audio recording of the interview to facilitate data collection.  I understand that 
due to possible risks to confidentiality of audio data (albeit minimal), transcripts made will 
be anonymized for both me and my research center.  If I inadvertently mention mine or my 
center’s name, they will be deleted during transcription. The tape will not be linked to this 
consent document.  The non-identifiable tapes will be kept safely until completion of the 
project when they will be destroyed.  Following their destruction, only anonymized paper 
transcripts or reports of the recordings will be kept.  
 
 
 
……………………………………………………               ……………………………………………………….. 
       Signature of Participant                           Place, Date  
Thank you very much. 
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Appendix 4 
New Models of Public Health Research:  Optimizing Ethics in Research Using Public Health 
Data in Resource Limited Countries 
To explore conceptual and practical issues of RUPD and its critical features (data-use, re-use, 
sharing etc.) as well as the application of existing research ethics governance structures to it.  
Responses obtained will enable us make recommendations for the future of public health 
research based on data  
 
THE INTERVIEW GUIDE 
 
Dear Sir or Madam,  
My name is ____________.   As we discussed during the consent process, I am a student of 
the University of Basel, Switzerland.  As a recap of the information I gave you earlier, we are 
conducting this survey involving experts with experience in the workings of the health and 
demographic surveillance system (HDSS), public health activities, research, and ethics.  The 
study specifically concerns research or publications undertaken by using pre-collected HDSS 
data.  The main purpose of this interview is to seek your expert opinions on RUPD, its 
characteristics, and challenges that arise in the application of existing ethics guidance to 
them.  The ultimate goal is to synthesize your opinions with those of other participants, 
existing literature, and if feasible, develop an ethics framework to guide the future conduct 
of RUPD. (Do you have any question up to this point?) 
So, we are meeting today to explore your own experiences as an expert involved either in 
public health research and or HDSS activities including research conduct, management, 
and oversight.  I will be posing questions concerning the use of pre-collected HDSS data for 
new research analysis and publications and would like to hear your personal opinions 
about them. 
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Main questions in Bold, follow-on questions in Ordinary Font and Prompts in italics 
1. Could you please describe your experience with the health and demographic 
surveillance system (HDSS) in this country? (How have you been involved with 
them)?   
a. What kinds of research do they undertake?    
b. Do you think HDSS surveillance differs from research (How so?) 
c. What is the relationship between the data collected and research or 
publications by the center? 
d. Do you think that HDSS activities should be distinguished from research, for 
ethical regulation purposes? 
2. Could you share any ethical issues you have experienced or which you anticipate 
from the secondary use of HDSS data for publications?  
3. In your opinion, how should institutions like the HDSS that have large datasets 
proceed with conducting research or publications using [or sharing] the data?  
a. What processes should be required, if any, before access and use of such 
data? (e.g., seek official permission from HDSS, apply for ethics review etc.)  
b. What conditions, if any, should a scientist or researcher satisfy in order to use 
or access the data?  (e.g., s/he should have participated in the data collection; 
s/he should be locally based)  
c. What factors should be relevant to determine access and use of the data?  
d. Should there be limits to the scope of further use of HDSS data for research or 
publications?  
e. What have been your experiences? 
4. What experiences with using, sharing or re-using HDSS data for RUPD (in your own 
application or anticipation) have you found difficult to address? (You may consider 
issues like data integrity, benefits etc.) 
a. Why is it that difficult? 
b. How can they be solved? 
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5. What role, if any, does or should the following play in connection with the issues 
you have raised? 
a. HDSS institution (What are your expectations here? [Repeat for b - e) 
b. Ethics committee 
c. National bodies you know to be linked to the HDSS 
d. International guidance   
e. Others (please explain) 
6. Which international research ethics guiding documents would you recommend for 
guidance in these matters of our discussion?  
a. Does your selected ethics guideline properly tackle RUPD? (E.g., the problems 
you mentioned earlier such as benefits, fairness?)                
b. What gaps or weaknesses exist in relying on this document for RUPD?  
c. What could be added to make it more appropriate?  
d. What could be deducted to make it more appropriate for RUPD?  
e. Which other guidelines have you found helpful in your work? 
7. From your experience so far, do you think that developing a separate ethics guide 
document (e.g., a framework) is necessary?         
a. What among issues, ethical principles etc. would you recommend to be given 
priority consideration in such a document? 
b. What among your own concerns would you recommend to be given priority 
consideration? 
I would like to close our discussion by gaining some information about you, if that is 
alright: 
1. If you don’t mind, could you please tell me how old you are (if s/he hesitates - in 
what age category are you)? 
2. Please describe your primary training? (e.g., BA. History) 
3. What type of institution do you work for?  
4. What is your role in your institution?  
5. Have you ever attended a workshop or training in research ethics before? 
6. Is there anything else that you would like to add concerning our topic of discussion?  
 
Thank you very much for your time and responses.  Please feel free to send me an email at 
evelyn.anane-sarpong@unibas.ch, if you have questions or further thoughts.   
Again, thank you. 
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